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Abstract 
Background: There have been numerous studies describing the body composition of 
children with quadriplegic cerebral palsy (CP). Most of these studies have focused on 
measurements of body fatness and the validation of various methods to predict fat 
stores. There have been no studies directly measuring total body protein (TBP) in 
children with quadriplegic CP. Furthermore, sophisticated technology used to measure 
body composition, such as neutron activation analysis (NAA), and dual-energy x-ray 
absorptiometry (DXA), is not always readily accessible, particularly in the clinic or 
community setting. No studies have determined whether alternate simpler measures of 
body composition, such as skinfold anthropometry, can accurately predict body 
composition (particularly TBP and body fat) in children with quadriplegic CP. 
Additionally, despite the many studies reporting a high incidence of malnutrition in 
children with severe CP there have been limited studies investigating the effects of 
nutritional intervention on body composition parameters. The few studies that have 
been done have investigated changes in growth parameters (weight and height) and 
body fat only, with no exploration into the effects of weight gain on TBP, bone 
mineral content (BMC) and resting energy expenditure (REE). 
Aims: The aims of this thesis were (i) to measure body composition parameters in 
children with quadriplegic CP, specifically TBP, fat mass and BMC; (ii) to compare 
methods for measuring body composition in children with quadriplegic CP, 
specifically, (a) to determine whether simple indirect measures of body composition 
can accurately predict TBP; and (b) to compare methods for measuring percent body 
fat (PBF); (iii) to measure REE and energy and nutrient intake in children with 
quadriplegic CP, and to relate these measures to their body composition; and (iv) to 
conduct a randomised controlled trial (RCT) to (a) compare gastrostomy tube feeding 
 v 
with oral feeding using oral nutrition supplementation and speech therapy, and to (b) 
determine if nutritional rehabilitation, i.e. weight gain, results in an increase in TBP, 
fat mass, BMC, and REE in children with quadriplegic CP. 
Methods: A cross-sectional study was conducted of children with quadriplegic CP 
between the ages of four and 19 years. All participants were recruited through the 
Dysphagia Clinic at the Children’s Hospital at Westmead. During an outpatient visit 
to the hospital the children underwent measurements of anthropometry, TBP by NAA 
(TBPNAA); BMC, lean tissue mass (LTM), and percent body fat (PBF) by DXA; and 
REE by indirect calorimetry. The parents/carers were asked to complete a three-day 
weighed food record at home for dietary analysis. In addition, TBP and PBF were 
estimated from both skinfold anthropometry (TBPSKIN and PBFSKIN, respectively) and 
DXA (TBPDXA and PBFDXA, respectively). The agreement between methods for 
estimating TBP and PBF were tested using Bland and Altman plot analysis. Finally, 
an RCT of gastrostomy tube feeding versus oral feeding combined with speech 
therapy was attempted. 
Results: The cross-sectional study revealed that the children with CP were 
significantly stunted and wasted with markedly reduced body fat, TBP, and BMC. 
Evaluation of methods to measure body composition, by Bland & Altman plot 
analyses, found that despite TBPSKIN and TBPDXA both being highly correlated with 
TBPNAA, and PBFSKIN being highly correlated with PBFDXA, there was poor agreement 
between methods, and wide individual variation. Furthermore, the measured REE of 
the children with CP was significantly reduced and widely variable in comparison 
with that predicted from control data based on fat-free mass (FFM). Comparison of 
energy intake with measured REE found that on average the three-day food records 
grossly overestimated energy intake. No parents/carers consented to their child 
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participating in an RCT; therefore this was abandoned and replaced with a 
longitudinal cohort study of gastrostomy tube feeding. The nutritional rehabilitation 
study revealed that significant weight gain in gastrostomy tube-fed children with CP 
produced significant gains in height, fat mass, measures of muscle mass (FFM and 
LTM), TBPNAA and BMC. In addition, these children demonstrated significant 
improvements in their standard deviation (SD) score for weight and for TBPNAA when 
expressed as a percentage of predicted for height from control data. However, there 
were no significant improvements seen in height SD score, TBPNAA expressed as a 
percentage of predicted for age, or for BMC when expressed as an SD score for age or 
height. 
Conclusions & significance: Children with quadriplegic CP in this study had greatly 
reduced TBP, fat mass, and BMC. Both skinfold anthropometry and DXA showed 
wide individual variability in the estimation of TBP and PBF in this group of children. 
Further studies using a four-compartment model of body composition are required in 
order to validate skinfold anthropometry and DXA before they can be accepted as 
reliable measures of body composition in children with CP. The REE of the children 
with CP was significantly reduced and widely variable making it difficult to predict 
from the existing predictive equations. Current recommendations are to either 
measure REE using indirect calorimetry, or to roughly estimate energy requirements 
using the available predictive equations and then adjust energy intake according to 
weight gain. Food records grossly overestimated the energy intake of these children 
and appear to be of little value in this population. Gastrostomy tube feeding of 
children with CP resulted in significant improvements in weight, TBP and fat mass, 
but not height or BMC. Further studies including larger numbers of participants with 
longer term and more structured follow-up are required to confirm these findings. 
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1 Aims and Hypotheses  
1.1 Aims 
A. To measure a three-compartment model of body composition in children with 
quadriplegic cerebral palsy, specifically total body protein, fat mass and bone 
mineral content. 
B. To compare methods for measuring body composition in children with 
quadriplegic cerebral palsy, specifically, 
(a) to determine whether indirect measures of body composition can 
accurately predict body protein; and 
(b) to compare methods for measuring percent body fat.  
C. To measure resting energy expenditure and energy and nutrient intake in children 
with quadriplegic cerebral palsy, and to relate these measures to their body 
composition. 
D. To conduct a randomised-controlled trial of nutritional rehabilitation 
(a) to compare gastrostomy tube feeding versus oral feeding using oral 
nutritional supplementation and speech therapy, and  
(b) to determine if nutritional rehabilitation, i.e. weight gain, results in an 
increase in total body protein, fat mass, bone mineral content, and resting 
energy expenditure in children with quadriplegic cerebral palsy. 
1.2 Hypotheses to be tested 
A. That children with quadriplegic cerebral palsy have a reduced total body protein, 
fat mass, and bone mineral content, in comparison to healthy control children. 
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B. That indirect measures of body composition do not accurately predict body protein 
in children with quadriplegic cerebral palsy; and that different methods used to 
measure body fat in children with quadriplegic cerebral palsy show poor 
agreement. 
C. That children with quadriplegic cerebral palsy have a reduced resting energy 
expenditure in comparison with control children; a reduced energy intake 
compared with measured resting energy expenditure; and a reduced nutrient intake 
compared with recommended nutrient intakes for age.  
D. That gastrostomy tube feeding is more effective than oral nutritional 
supplementation with speech therapy for nutritional rehabilitation; and that 
nutritional rehabilitation results in improvements in nutritional status, including an 
increase in fat mass, total body protein, bone mineral content, and resting energy 
expenditure in children with quadriplegic cerebral palsy. 
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2 Literature Review 
2.1 Epidemiology of cerebral palsy 
2.1.1 Definition 
The term cerebral palsy (CP) is used to describe a range of permanent, non-
progressive syndromes of posture and motor impairment that result from an insult to 
the developing central nervous system (CNS) (Koman L.A. et al. 2004). CP is 
manifested early in life, generally in the first two to three years (Davis 1997), and is 
the most common serious physical disability affecting children (Colver et al. 2000; 
Maudsley et al. 1999). The prevalence of CP in Australia is approximately two to 
three per 1000 live births (Stanley and Watson 1988).  
CP is a complex of symptoms rather than a specific disease (Kuban and Leviton 
1994). There have been numerous attempts over the past century to define and 
classify CP, however the most recent consensus definition is that of Bax et al; “CP 
describes a group of disorders of the development of movement and posture, causing 
activity limitation, that are attributed to non-progressive disturbances that occurred 
in the developing foetal or infant brain. The motor disorders of cerebral palsy are 
often accompanied by disturbances of sensation, cognition, communication, 
perception, and/or behaviour, and/or by a seizure disorder” (Bax et al. 2005).  
2.1.2 History of cerebral palsy 
CP was first described in 1862 by William John Little, an orthopaedic surgeon from 
London, UK (Eicher and Batshaw 1993). He presented his observations of a group of 
children with tonal and developmental abnormalities, which he described as “spastic 
rigidity”. Many of these children had a history of prolonged labour or preterm or 
breech delivery. Because of the frequency of these perinatal problems, Little 
postulated that the motor defects resulted directly from difficulties in the birth 
5 
Chapter 2 
LITERATURE REVEIW 
process. Consequently, for over 100 years, most cases of CP were thought to be 
caused by asphyxia during either labour or the perinatal period (Blair et al. 2001; 
Paneth 1984). However, recent research has demonstrated that perinatal asphyxia is 
causative in only 6 – 8 % of CP cases (Reddihough and Collins 2003). 
2.1.3 Causes of cerebral palsy 
Known causes of CP can be divided into four categories: 
(i) antenatal causes - congenital brain malformations, vascular events (e.g. middle 
cerebral artery occlusion) and maternal infections during the first and second 
trimesters of pregnancy (e.g. rubella, cytomegalovirus, toxoplasmosis) 
(Gibson et al. 2006);  
(ii) perinatal causes - problems during labour and delivery; 
(iii) neonatal problems - neonatal encephalopathy due to severe hypoglycaemia, 
untreated jaundice, metabolic diseases and severe neonatal infection;  
(iv) post-neonatal problems – infection (e.g. meningitis, encephalitis) and head 
injuries (Reddihough and Collins 2003).  
The most commonly reported causes of CP are antenatal and perinatal insults, 
however, a large number of patients do not have a readily identifiable aetiology of the 
CP (Fishman and Bousvaros 1999). In addition, the pathophysiologic mechanisms 
that underlie most of the CP syndromes remain poorly understood (Kuban and 
Leviton 1994). There is currently neither an objective test that can be used to ‘screen’ 
for CP, nor a diagnostic test that can be used as a 'gold standard' (Mutch et al. 1992). 
2.1.4 Identification and classification of cerebral palsy 
Identification and classification of CP are often difficult. CP is a heterogeneous 
condition with various types and degrees of motor impairment. The clinical 
6 
Chapter 2 
LITERATURE REVEIW 
manifestations often differ according to the gestational age at birth, the chronological 
age, the distributions of the lesions, and the underlying disease (Kuban and Leviton 
1994). Furthermore, the expression of CP can change throughout the first few years 
giving the impression of a progressive neurological disorder (Davis 1997). In 
addition, children may have a combination of two or more types of CP. However, in 
general, CP is classified by the Swedish system according to the extremity involved: 
monoplegia (one limb), hemiplegia (one side of the body), diplegia (legs 
predominantly affected), and quadriplegia (all four limbs affected); and the 
characteristics of the neurological dysfunction: spastic, hypotonic, dystonic, athetotic, 
or a combination thereof (Kuban and Leviton 1994).  
Palisano et al (Palisano et al. 1997) recently developed the Gross Motor Function 
Classification System (GMFCS) to standardise the classification system of children 
with CP. The GMFCS consists of five levels: level I children have a very mild motor 
disorder, whilst level V children have the most severe motor disabilities. The GMFCS 
has been widely adopted in Australia and elsewhere. 
Regardless of the classification system used, spastic CP (including hemiplegic, 
diplegic and quadriplegic) is the most common type, occurring in 70 to 80 % of the 
CP population (Davis 1997). Spastic quadriplegic CP alone lies at the severe end of 
the spectrum of CP (GMFCS level IV and V), and is found in approximately one-third 
of all cases (Stanley and Watson 1988). 
2.1.5 Incidence and prevalence of cerebral palsy 
Several researchers from various developed countries have studied the incidence and 
prevalence rates of CP from the 1960s to 1980s (Colver et al. 2000; Pharoah et al. 
1987; Pharoah et al. 1996; Pharoah et al. 1998; Stanley and Watson 1988). Most 
studies agree on the current incidence of CP at around two to three per 1000 live 
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births (Winter et al. 2002). These studies also report recent rises in the prevalence 
among live births of the condition and its severity, particularly among preterm infants.  
Stanley & Watson analysed the trends in stillbirths, neonatal deaths and CP in all 
infants born in Western Australia from 1967 – 1985 (Stanley and Watson 1992). 
During this period death rates fell particularly in low birth weight (LBW) infants (< 
2500 g), and CP rates remained steady at 2 - 2.5 per 1000 live births. In contrast, CP 
rates in infants weighing under 1500 g rose significantly as evidenced by an increase 
of 53 % in those weighing < 1000 g, and by 77 % in those weighing 1000 – 1499 g. 
However, this was balanced by a fall of 36 % in the 1500 – 1999 g birth weight group. 
The main types contributing to the rise in LBW CP were spastic hemiplegia and 
quadriplegia. Over the total cohort studied there was a 22 % increase per period 
(grouped years) in the rate of quadriplegic CP. The most significant increases with 
time in quadriplegic CP were in the < 1000 g birth weight group (70 % increase) and 
in the 1000 – 1499 g birth weight group (150 % increase), with a non-significant fall 
in the other categories. 
In several developed countries there is a reported negative correlation between birth 
weight and rates of CP, i.e. as birth weight falls, rates of CP increase. Also reported in 
these countries in the LBW populations is a trend to higher rates of CP as mortality 
falls (Mutch et al. 1992; Stanley and Watson 1992). The LBW populations reported 
include preterm infants and those infants born small for gestational age. 
The reported rise in the prevalence of CP seems to be accounted for largely by 
improvements in the survival rate of LBW babies, i.e. the incidence has not changed 
but improved survival rates, particularly among LBW infants, have increased 
prevalence (Mutch et al. 1992; Pharoah et al. 1987). Survival rates of LBW infants 
has improved over the last two decades due to dramatic changes in obstetric and 
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perinatal care, including the increasing availability of foetal heart monitoring and 
foetal ultrasonography, an increase in caesarean sections (4 % in 1970 to 18 % in 
1985), the establishment of neonatal intensive care units, and the use of surfactant and 
antenatal steroids to reduce mortality and morbidity associated with hyaline 
membrane disease (Kuban and Leviton 1994; Pharoah et al. 1998; Stanley and 
Watson 1992). It appears that many babies < 2500 g who would previously have died 
in the perinatal period now survive with severe CP (Colver et al. 2000). Stanley & 
Watson reported that the percentage of CP cases contributed by newborns weighing < 
2500 g increased from 33.5 % in 1975 - 1978 to 44 % in 1983 – 1985 (Stanley and 
Watson 1992). However, Blair et al reported that they did not find any evidence for 
increased duration of survival since the 1950s despite advances in medical care (Blair 
et al. 2001). Therefore, it is unknown whether modern therapy makes any difference 
to survival of LBW infants and increased cases of CP. 
2.1.6 Life expectancy 
The life expectancy of children with CP has been studied extensively by several 
groups of researchers in Australia and other developed countries (Blair et al. 2001; 
Crichton et al. 1995; Evans et al. 1990; Hutton et al. 1994; Hutton et al. 2000; Strauss 
et al. 1998). The findings of these studies has been summarised in Table 2.1 (pg 11). 
Although the studies report varying survival rates, they all agree that survival is 
inversely correlated with the severity of disability, either intellectual or physical (Blair 
et al. 2001). In addition, several of the studies found that children with CP, who were 
of higher birth weights, or those born after 32 weeks gestation, had lower survival 
rates. It has been long recognised that heavier infants tend to have more severe 
cognitive and motor disabilities than those of LBW; this is thought to be a result of 
severely damaged premature infants being less likely to survive until diagnosis than 
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full term infants (Hutton et al. 2000; Pharoah et al. 1998). However this theory has 
been difficult to prove because CP is not usually diagnosed until several months of 
age.  
In general, the studies reported in Table 2.1 have found that more than half of even 
the most severely disabled individuals with CP live to adulthood; therefore CP must 
be regarded as a disability of which people live with rather than a disability of which 
they die from. It is therefore appropriate to plan for their survival and continue to 
research to improve the health and well-being of individuals with CP. 
2.1.7 Causes of death 
Blair et al described the trends, predictors, and causes of mortality in people with CP 
in Western Australia who were born between 1956 and 1994 (Blair et al. 2001). They 
obtained the cause of death from death certificates, hospital medical records, and post-
mortem reports. Death by respiratory causes accounted for 59 % of all deaths; with 
aspiration pneumonia and pneumonia accounting for 16.6 % and 37.1 % of all deaths 
respectively, and other respiratory causes 5.3 %. Further analysis of the data revealed 
that aspiration pneumonia was strongly associated with profound intellectual deficit 
and the proportion attributed to this cause was found to be increasing with time. 
Epilepsy was reported to be the second most common cause of death. 
In a similar study to that of Blair et al, Reddihough and colleagues extensively 
reviewed the medical records of children with CP who had died over a 25-year period 
(1970 - 1995) in Victoria, Australia in order to establish the cause of death 
(Reddihough et al. 2001). The average age at death was 6.8 years (range 2 months to 
21.8 years), and the majority of the deceased children had severe spastic quadriplegic 
CP, intellectual disability and epilepsy. The predominant cause of death was 
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 Table 2.1 Studies of survival rates in children and adults with cerebral palsy 
Author Country & 
Region 
Time 
period 
Survival rate Summary of findings 
(Evans et 
al. 1990) 
UK 
SE Thames 
region 
1970 - 
1979 
90 % 
to 10 years 
▪ 67% of those that died had more 
severe CP 
(Hutton 
et al. 
1994) 
UK 
Mersey region 
1966 – 
1984 
89.3 % for 
females  
86.9 % for 
males 
to 20 years 
▪ For severely disabled children survival 
rate was 50% 
▪ BW >2500g survival 86.4%; BW 
<2500g survival rate 91.6% 
▪ Level of ambulation found to be most 
predictive of survival 
(Crichton 
et al. 
1995) 
Canada 
British 
Columbia 
1952 - 
1989 
90 % 
to 30 years 
▪ Those with severe ID and epilepsy, 
survival rate was 66.6% 
(Strauss 
et al. 
1998) 
USA 
California 
1980 - 
1995 
N/A1 
to 15 years 
▪ Study preferentially included more 
severe CP, therefore results may not 
be representative of general CP 
population 
▪ Those with fair motor and eating skills 
had a 90% survival rate to 15y 
▪ Children unable to lift their heads and 
those who were tube fed, or fed by 
others, had poorer survival rates (7 to 
14 years). 
▪ LBW infants had better survival rates 
(Hutton 
et al. 
2000) 
UK 
North England 
1960 - 
1990 
82.8 % for 
females 
83.5 % for 
males 
to 35 years 
▪ LBW infants had better survival rates 
than those weighing >3000g; 84.2% 
versus 76% respectively. 
▪ Those with severe manual or 
ambulatory disability had a survival 
rate of 55 – 59%. 
(Blair et 
al. 2001) 
Australia 
Western 
Australia 
1956 - 
1994 
85 %2
to 40 years 
▪ 6% died before age of 5 years, and a 
further 11% between 5 and 40 years 
▪ Strongest single predictor of mortality 
was ID; of those with profound ID, 
22% died by 5y, and 50% by 18y. 
▪ Those infants born >32 weeks 
gestation were at higher risk of 
mortality 
(Hutton 
and 
Pharoah 
2006) 
UK 
Mersey region 
Not stated 25 % 
to 30 years 
▪ Data are only for children classified as 
severe CP in terms of ambulation, 
cognitive ability, manual dexterity, 
and visual disability. 
1 Survival rate for whole group was not reported; 2 data are an approximation, author’s state 
that data were insufficient to predict survival accurately. 
BW, birth weight; CP, cerebral palsy; ID, intellectual disability; LBW, low birth weight  
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pneumonia (39 %), sometimes described as aspiration pneumonia or severe chest 
infection. However, 41 % of the deceased children died at home and the cause of 
death was unknown.  
Two studies from the UK of causes of death in people with CP report similar findings 
to the two aforementioned Australian studies (Evans et al. 1990; Maudsley et al. 
1999). The UK studies reported the most common cause of death was respiratory 
failure due to pneumonia and other causes, followed by epilepsy and intellectual 
disability. However, the authors of these two studies point out that if death certificates 
alone are studied, many cases may not be identified because the terminal illness may 
only be recorded rather than the pre-existing condition. CP was not mentioned on a 
large percentage of the death certificates, which therefore questions the accuracy of 
studying death certificates alone for causes of death in CP. 
Nonetheless, all studies agreed that the predominant cause of death in people with CP 
was pneumonia and other respiratory causes. However, Reddihough et al commented 
that while pneumonia was the most frequent terminal event, there were often other 
contributing factors, such as malnutrition, scoliosis, immobility, poor cough reflex 
and aspiration both from impaired swallowing mechanisms and gastro-oesophageal 
reflux (GOR) (Reddihough et al. 2001). 
2.2 Complications associated with cerebral palsy 
Although CP is defined in terms of a motor system impairment, many children with 
CP also have other handicaps such as impaired cognition, sensory deficits, seizure 
disorders, feeding problems, behavioural dysfunction, and emotional problems. In 
general, the more limbs involved, the greater the degree of disability and the higher 
the likelihood of associated deficits and cognitive impairment (Eicher and Batshaw 
1993).  
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Intellectual disability has been reported in 50 to 66 % of children with CP (Davis 
1997; Eicher and Batshaw 1993). Approximately one-third to a half of children with 
CP are reported to have a seizure disorder. Sensory deficits in the form of hearing loss 
and vision problems (strabismus, refractive errors, retinopathy of prematurity, field 
deficits, nystagmus, and amblyopia) are also common (Davis 1997; Eicher and 
Batshaw 1993). Communication disorders in children with CP include speech motor 
deficits and central processing problems. Feeding problems may result from various 
motor problems including hypotonia, weak suck, poor coordination of the swallow 
mechanism, tonic bite reflex, hyperactive gag reflex, and exaggerated tongue thrust. 
There may be drooling or aspiration resulting from the oral motor problems. GOR 
may also be present and, together with aspiration, can cause recurrent chest infections. 
In addition, due to poor communication skills and the inability to independently 
access food, children with CP are unable to express hunger. These problems are 
contributors to failure to thrive and poor growth. In fact, one of the first signs that a 
child might have CP is poor feeding skills, and subsequent failure to thrive (Davis 
1997). Each of these problems will be discussed in more detail in the following 
sections. 
2.2.1 Gastrointestinal complications 
2.2.1.1 Gastro-oesophageal reflux 
GOR is defined as a dysfunction of the lower oesophageal sphincter mechanism with 
regurgitation of gastric contents into the oesophagus (Hebra and Hoffman 1993). The 
prevalence of GOR is reportedly higher in neurologically impaired children, including 
those with CP, than in the general population. Using barium studies, Abrahams & 
Burkitt reported a high prevalence (12 / 16) of GOR occurring in a group of children 
and adolescents with severe spastic CP who were experiencing symptoms of reflux, 
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yet in a similarly disabled group without symptoms, the prevalence of GOR was 
significantly lower (17 / 63) (Abrahams and Burkitt 1970). Halpern et al conducted a 
retrospective review of 613 consecutive children who underwent an evaluation for 
GOR by 18 to 24 hour oesophageal pH monitoring (Halpern et al. 1991). Of the 613 
children studied, 132 had documented CNS disease, including CP, prior to the 
evaluation. The authors reported that in patients older than one year there was an 
increased incidence of GOR in those with CNS disease (31 / 45) compared with those 
without CNS disease (38 / 81). In the most recent study, Reyes et al used 24-hour 
ambulatory oesophageal pH monitoring to study a small group (n = 23) of children 
with CP, all of whom had one or more symptoms suggestive of reflux (Reyes et al. 
1993). The average age of the children was 2.3 years, and approximately half had 
severe spastic CP. Significant GOR was detected in 16 of 23 patients. However, the 
latter two studies do not represent all infants and children with GOR and CP, but 
rather those children with suspected GOR who did not respond to conventional 
antireflux therapy or who manifested significant complications associated with GOR. 
Therefore, the reported prevalence of GOR may be higher than in the general CP 
population.  
2.2.1.1.1 Causes of gastro-oesophageal reflux 
GOR in neurologically impaired children is thought to be primarily related to 
abnormal CNS control mechanisms. In addition contributing factors of GOR in 
children with CP include prolonged supine positioning, liquid feeds, gastrostomy tube 
placement, slow gastric emptying, impaired oesophageal motility, and increased 
abdominal pressure due to spasticity or seizures (Fishman and Bousvaros 1999; Hebra 
and Hoffman 1993). Reflux in this group of patients can cause vomiting, oesophagitis 
leading to bleeding and iron deficiency, haematemesis, protein-losing enteropathy, 
14 
Chapter 2 
LITERATURE REVIEW 
irritability, pain, poor growth and failure to thrive (Fishman and Bousvaros 1999; 
Hebra and Hoffman 1993). Failure to thrive can result from GOR because of loss of 
ingested calories (Hebra and Hoffman 1993). Local complications within the 
oesophagus, in addition to ulceration and bleeding, include strictures and development 
of Barrett’s oesophagus and Sandifers syndrome (Hebra and Hoffman 1993). 
Extragastrointestinal symptoms of GOR are most commonly respiratory in nature and 
include pulmonary aspiration, cough, cyanosis, apnoea, reactive airway disease, 
pneumonitis, and bronchiectasis. Respiratory tract infections (RTIs) have been shown 
to be a major cause of death in children with CP, as discussed in section 2.1.7 (pg 10). 
RTIs in children with severe neurodisability are usually caused by aspiration of 
stomach contents from GOR or direct aspiration of solids or liquids from the mouth 
and pharynx due to oral and pharyngeal motor problems (Morton et al. 1999). 
2.2.1.1.2 Treatment of gastro-oesophageal reflux 
Treatment for GOR can begin with conservative measures such as formula changes, 
thickening of feeds, giving smaller more frequent feeds, avoidance of overfeeding, 
refeeding after emesis, and burping techniques (Fishman and Bousvaros 1999; Hebra 
and Hoffman 1993). If the conservative measures fail, the next step is pharmacologic 
therapy which consists of acid suppressing agents and prokinetic agents. Surgical 
treatment is available for children who fail pharmacological management, or who 
have serious complications such as oesophagitis or an oesophageal stricture, that 
warrant surgical correction of the reflux. Nissen fundoplication, which involves a 
complete wrap of the gastric fundus around the intra-abdominal oesophagus, is the 
most widely used procedure for the surgical treatment of GOR (Fishman and 
Bousvaros 1999; Hebra and Hoffman 1993).  
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2.2.1.2 Other gastrointestinal complications 
Other gastrointestinal complications of CP include gastritis and constipation. Gastritis 
can be caused by Helicobacter pylori infection. Up to 80 % of institutionalised people 
with a disability are reported to be infected with Helicobacter pylori (Fishman and 
Bousvaros 1999). Gastritis can lead to abdominal pain and vomiting which in turn can 
lead to a decreased food intake. Constipation may be caused by diminished colonic 
motility, but contributing factors include immobility, low fibre intake, low fluid 
intake, and the effects of medications. Constipation may cause early satiety, poor 
feeding, gassiness, abdominal pain, and vomiting, again leading to a decreased oral 
intake and possibly malnutrition (Fishman and Bousvaros 1999). In a survey of 271 
children with CP and neurological impairment, Sullivan et al found that 
gastrointestinal complications were prevalent with 59 % suffering from constipation, 
and 22 % with significant vomiting (Sullivan et al. 2000).  
2.2.2 Oral-motor dysfunction 
The development of oral-motor skills parallel and are closely tied to overall physical 
development (Ottenbacher et al. 1983a). Abnormal oral patterns and reflexes occur in 
conjunction with many disabilities, including intellectual disability and CP. Although 
wide individual differences exist among children, predictable deficits are commonly 
associated with abnormal oral-motor development. These are poorly co-ordinated 
breathing, difficulties with sucking and swallowing, persistence of the bite reflex or 
tonic biting, jaw instability or thrusting, tongue thrusting, decreased tongue 
movements, decreased lip closure, drooling, and hypo- or hypersensitive gag 
response. Each of these deficits is frequently associated with, and may be triggered 
by, other sensory or motor dysfunctions, particularly abnormal muscle tone and tactile 
hypersensitivity. These abnormal reactions make food intake extremely difficult, and 
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increase the risk of choking. In addition, duration of meal times is often lengthened, 
and both the children and the carers become frustrated and anxious.  
2.2.2.1 Dysphagia 
Dysphagia, defined as difficulty with swallowing and associated with feeding 
difficulties, is common in children with CP, and in many cases, may be the first sign 
of a developmental problem. Dysphagia is often the result of abnormal neuromuscular 
control. Swallowing is a complex process involving both autonomic and voluntary 
musculature. The oral phase of the swallow depends heavily on voluntary movement 
and, in CP, oral phase abnormalities are most common. Several nerves control the 
sensory and motor components of swallowing. In CP, neurological control of oral-
motor functions by these nerves is impaired, resulting in poorly coordinated mandible 
and tongue movements, tongue weakness, delay in swallow initiation, and prominent 
reflexes including jaw jerk, tonic bite and suckle. There are several consequences of 
these impaired oral-motor functions: (1) slow oral transit time, which causes slow 
feeding and poor nutrition; (2) poor bolus formation, with food escaping into the 
pharynx before the swallow reflex and larynx closure; this causes aspiration and 
gagging; (3) slow pharyngeal transit with pharyngeal residue, allowing aspiration and 
causing discomfort and irritation (Jones 1989). Symptoms of dysphagia include food 
spillage, coughing, choking, regurgitation and spitting (Jones 1989).  
2.2.2.2 Prevalence of dysphagia in cerebral palsy 
Sullivan et al conducted a questionnaire to estimate the prevalence and severity of 
feeding and nutritional problems in children with neurological impairment (n = 271), 
93 % of who had CP (Sullivan et al. 2000). Feeding problems were prevalent: 89 % 
needed help with feeding, and 56 % choked with food. In addition, 38 % of carers 
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considered their child to be underweight; yet, despite these concerns, 64 % had never 
had their feeding and nutrition assessed. In a smaller (n = 35) but similar study, Dahl 
et al interviewed the parents of children with moderate to severe CP regarding feeding 
practices and problems and found that 21 of 35 children were reported as having daily 
feeding problems (Dahl et al. 1996). The most common problems reported were 
protracted meal times and difficulty in chewing and swallowing. Reilly at al 
conducted a similar survey in 49 children aged between 12 to 72 months with varying 
degrees of CP. They found that 45 children had clinically significant oral-motor 
dysfunction, 27 had sucking and 18 swallowing problems in the first 12 months of 
life, and 39 of 49 children had been fed non-orally on at least one occasion (Reilly et 
al. 1996).  
The feeding problems reported in these studies were not directly observed or 
examined by the researchers, but reported by the parents which might be a reflection 
of parental stress and anxiety. In addition, the latter two studies preferentially 
included children with more severe CP. Therefore the prevalence of feeding problems 
reported may be higher than in the general CP population. Nevertheless, these studies 
demonstrate that feeding problems in children with CP are common, under-
recognised, and a cause of significant distress to affected children and their carers. 
2.2.2.3 Dysphagia and respiratory problems 
Children with dysphagia often cannot adequately protect their airway while feeding 
and direct aspiration of food and liquid into the lungs may result in recurrent 
pneumonia, chronic lung disease, chronic obstructive pulmonary disease, adult 
respiratory distress syndrome, lung abscess formation and pulmonary fibrosis 
(Fishman and Bousvaros 1999). Furthermore, aspiration can aggravate GOR, which, 
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as discussed in section 2.2.1.1 (pg 13), causes discomfort and may itself result in 
aspiration of stomach contents and further lung damage (Jones 1989). 
The principal test to evaluate dysphagia and aspiration is the videofluoroscopic 
evaluation of swallowing, also known as the modified barium swallow (Griggs et al. 
1989; Morton et al. 1993). Using videofluoroscopy, Griggs et al investigated 10 
children with multiple handicaps aged between nine months and 24 years, all but one 
of whom had spastic quadriplegic CP (Griggs et al. 1989). Seven of the 10 children 
were found to aspirate food or liquid. However, most of these children were referred 
due to concerns with coughing, choking, and gagging during feeding and therefore the 
sample was biased. In a similar study using videofluoroscopy, Morton et al found that 
11 out of 14 children aspirated and often it was silent, i.e. aspiration occurred without 
coughing or choking. All except one child had spastic quadriplegic CP, and all had 
severe feeding difficulty and most had frequent RTIs (Morton et al. 1993). Similar 
findings were reported by Rogers et al who conducted a retrospective review of 90 
patients with CP who had undergone videofluoroscopy for investigation of dysphagia; 
aspiration was found in 87 of the patients, and often it was silent (Rogers et al. 1994). 
However, in all three aforementioned studies, most of the children were severely 
disabled and referred for concerns regarding airway protection during oral feeding; 
therefore the cohorts were highly selective and the prevalence of aspiration reported is 
likely to be higher than in the general CP population.  
Using videofluoroscopy as well as 24-hour oesophageal pH analysis, Morton et al 
investigated both GOR and aspiration in 34 children with severe neurodisability due 
to various causes (Morton et al. 1999). The majority of children studied had spastic 
quadriplegic CP and all children had some degree of feeding problems. The children 
were divided into three groups for analysis depending on their history of RTIs (none, 
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minor or severe). Almost half of the children were found to have GOR, and more than 
half aspiration. Of the children with severe recurrent RTIs, half had GOR and almost 
all had aspiration, whereas in the group with no history of RTIs, half had GOR and 
none had aspiration. The results suggest that dysphagia is a major cause of RTIs in 
children with severe neurodisability.  
2.2.2.4 Effect of dysphagia on food intake 
In addition to aspiration and recurrent RTIs, dysphagia can result in malnutrition 
because of inefficiency of food intake and spillage. Gisel & Patrick compared the 
eating efficiency of seven children with severe CP and growth failure with healthy 
children of the same weight (Gisel and Patrick 1988). They found that the children 
with CP took two to 12 times longer to chew and swallow a standard amount of 
pureed food and one to 15 times longer for solid food than healthy children. In a 
similar study, Reilly & Skuse observed and video-recorded children with CP and age 
and sex matched healthy controls feeding in their own homes (Reilly and Skuse 
1992). The authors found that there was no significant difference in the duration of the 
meal times for the CP and control children. The children with CP were both offered 
less and consumed less food than the control children during the observed mealtime. 
In addition, they were reported to consume significantly less food over a 24-hour 
period than the control group; 804 kcal versus 1283 kcal, respectively. Furthermore, 
only two out of the 12 children with CP were fed family foods, the rest being fed 
powdered baby foods, which are low in taste, texture and calories. Considering these 
findings, it is not surprising that failure to thrive was common in the CP group.  
These two studies show that despite most of the children having significant oral motor 
dysfunction, their mealtimes were relatively brief usually because they were just 
offered less and consumed less food. The authors state that long meal times do not 
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compensate for the severity of these children's feeding impairment and, to compensate 
for inefficiencies of the order reported in these studies, feeding time would need to be 
in excess of normal waking hours. A study of length of meal times found that mothers 
of dsiabled children spend on average 3.5 hours, and some up to 7.7 hours, a day 
feeding their child compared to 0.8 hours for mothers of non-disabled children 
(Johnson and Deitz 1985). In a similar study, Reilly et al surveyed the parents of 
children with CP on how long they spent feeding their child at each meal time and 
then video recorded a meal time in the home (Reilly et al. 1996). There was a 
substantial discrepancy between the lengthy duration of mealtimes reported by 
mothers and those actually observed in the home: 27 minutes versus 18 minutes, 
respectively. Interestingly, children with the most severe oral-motor dysfunction 
tended to have shorter mealtimes than those with no or mild oral-motor dysfunction 
(19 versus 24 minutes respectively), possibly indicating that with the children with 
more severe oral-motor dysfunction, both child and parent quickly tired and gave up. 
2.2.2.5 Effect of dysphagia on growth 
Several researchers have found that children with CP who have significant oral-motor 
dysfunction tend to grow poorly, and that the prevalence is higher in children with 
more severe CP. These studies are discussed in more detail below. Most researchers 
agree that the poor growth seems to be predominantly due to the reduced food intake 
as discussed in the previous section (2.2.2.4, pg 20). In addition, aside from oral-
motor dysfunction, further reasons why children with CP have difficulty in achieving 
an adequate nutritional intake include communication difficulties; impaired 
expression of hunger or food preferences; lack of self-feeding skills; and the inability 
to forage for food (Horton 1990). 
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Krick & Van Duyn conducted a retrospective pilot study comparing the growth of 
children with CP and oral-motor dysfunction to controls with CP and no oral-motor 
dysfunction (Krick and Van Duyn 1984). They found that children with oral-motor 
dysfunction had a significantly decreased weight and height for age in comparison 
with the control group. The results suggest a relationship between oral-motor 
dysfunction and growth retardation. However, the study had small numbers of 
participants (n = 12) and the age range of the participants (eight to 34 months) is 
younger than the usual age of clinical diagnosis of CP (often 24 to 36 months); 
therefore the results may not be representative of the CP population. In addition, in 
order to assess linear growth, this study used anthropometric techniques that were 
designed for healthy children and consequently subject to error in children with 
significant contractures and skeletal deformities. 
In another retrospective study, Thommessen et al collected cross-sectional data on 
growth (height and weight) and energy intake from four-day food records in children 
with CP, half of whom were classed as severely disabled (Thommessen et al. 1991). 
Overall, half of the children had feeding problems and half had growth retardation, 
with many regarded as undernourished. In addition, low height for age and feeding 
problems were significantly more frequent in the most severely disabled children than 
in the mildly disabled. The children were then split into two groups for further 
analysis depending on the presence or absence of feeding problems. Children with 
feeding problems had a significantly lower height for age, weight-for-height, triceps 
skinfold thickness, and mid-upper arm circumference (MUAC) than children without 
feeding problems. These findings were substantiated by Troughton & Hill who also 
found that undernourished children with CP had poorer feeding skills compared to 
adequately nourished children with CP, and that feeding skills were inversely 
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correlated with the severity of CP, i.e. children with quadriplegic CP had significantly 
poorer feeding skills compared to children with milder CP (Troughton and Hill 2001). 
Thommessen et al reported that children with feeding problems also tended to have a 
lower energy intake, but the differences were not statistically significant 
(Thommessen et al. 1991). The authors concluded that the presence of feeding 
problems was a predictor of poor growth in children with CP. However, as with the 
study by Krick & Van Duyn this study used anthropometric techniques that may not 
be accurate in children with CP (Krick and Van Duyn 1984).  
Motion et al also reported that feeding problems might be a predictor of poor growth 
in children with CP (Motion et al. 2002). The authors prospectively studied the 
prevalence of feeding difficulties at four weeks and six months of age in children 
subsequently diagnosed with CP in order to determine whether early feeding 
difficulties could be predictive of functional and growth outcomes at eight years of 
age. They found that feeding difficulties at four weeks of age were associated with 
being underweight and having speech and swallowing difficulties at eight years of 
age. The authors concluded that early, persistent and severe feeding difficulties are a 
marker for subsequent poor growth, feeding and developmental outcomes.  
In addition to nutritional status, Fung et al described parent-reported feeding 
dysfunction and its association with health in a large group of children with moderate 
to severe CP (Fung et al. 2002). In agreement with previous studies they reported that 
feeding dysfunction was associated with poor nutritional status: lower weight, height, 
upper arm muscle area, and skinfold thicknesses in comparison to reference data. 
However, they also found that severity of feeding dysfunction was strongly associated 
with indicators of poor health and nutritional status. Those children with more severe 
feeding dysfunction spent more days in bed due to illness, were more likely to miss 
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their regular day program due to illness and experienced more respiratory illness than 
those with no feeding problems.  
In summary, oral-motor dysfunction is present in a significant proportion of children 
with CP. Oral-motor dysfunction can result in an inadequate nutritional intake, which 
in turn leads to poor growth and malnutrition. Malnutrition increases the risk of 
infection, poor wound healing and osteopenia (which is discussed in more detail in 
section 2.4.4.2, pg 68). Furthermore, children with oral-motor dysfunction often 
cannot adequately protect their airway while feeding and aspiration may result in 
recurrent pneumonia or chronic lung disease. Poor feeding also results in long meal 
times, depriving the children of time for other activities and causing stress for the 
parents or carers. As demonstrated in the study by the Fung et al all of these factors 
combined can greatly detract from the child’s quality of life (Fung et al. 2002).  
2.2.3 Energy and micronutrient intakes of children with cerebral palsy 
There have been many studies investigating the energy and nutrient intakes of oral-fed 
children with CP. Most of these studies are summarised in Table 2.2 (pg 26). In 
general, the studies agreed that the energy and micronutrient intakes of most children 
with CP were below that recommended for age, and that energy intakes tended to 
decrease with increasing severity of CP. However, the studies used various 
methodologies, some of which are invalid for measuring dietary intake accurately. 
Furthermore, accurately estimating energy and nutrient intakes in oral-fed children 
with CP is difficult due to losses from spillage, vomiting and regurgitation. 
Alternatively, gastrostomy tube feeding allows a more accurate estimate of dietary 
intake because there are no, or minimal, losses from spillage, and the exact energy and 
nutrient composition of the formula are known. Fried & Pencharz retrospectively 
examined the energy and nutrient intakes of exclusively gastrostomy tube-fed children 
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with CP and found that the average energy intake of the group was 61 % of the 
recommended dietary intake (RDI) for age (range 43 – 98 %) (Fried and Pencharz 
1991). Their dietary intake was adequate for protein, and for vitamins A, E, and C, 
BB12, folate, zinc, and iron but below the RDI for vitamin D (62 % of RDI), calcium 
(74 % of RDI), and phosphorus (64 % of RDI). In addition, although the children 
appeared to have insufficient intakes of micronutrients in comparison to 
recommended values, the blood levels of most micronutrients were within normal 
ranges, suggesting that their intakes were in fact biochemically adequate. However, 
the authors did not state the methodology used to measure the serum levels of the 
micronutrients, and it is therefore unknown if valid methods were used. 
Gisel & Patrick, on the basis of their experience with feeding neurologically impaired 
children, suggested that nutritional problems are caused primarily by energy deficits 
rather than by deficits of protein, vitamins or minerals (Gisel and Patrick 1988). They 
maintain that it is because the diet given to people with disabilities is qualitatively 
good but deficient in volume that malnutrition found in individuals with disabilities is 
rarely associated with either skin changes or hair or mucosal changes; and is also very 
different from the clinical picture of malnutrition seen in the developing world. The 
qualitative (micronutrient) adequacy but quantitative (energy) deficiency of the diets 
provided for children with disabilities might also be one of the reasons that such 
individuals can survive in a moderately malnourished state for many years. This raises 
the issue of using recommendations based on healthy children. Is the nutrient intake 
of children with CP appropriate for their size as distinct from their chronological age? 
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 Table 2.2 Studies of nutritional adequacy in children with cerebral palsy 
Author Participants Methods Findings 
(Peeks and 
Lamb 1951) 
N = 29 
Mostly 
athetoid CP 
One-week 
estimated food 
record 
Up to a half of the children were consuming less 
than 90% of the American RDI for energy, 
protein, vitamin C, iron, and calcium, possibly 
due to low intakes of milk and citrus fruits. 
(Leamy 
1953) 
N = 21 
Various types 
of spastic CP 
48-hour weighed 
and estimated food 
records 
The majority of children were consuming 
inadequate energy, iron, vitamin C, and niacin, 
and approximately half were consuming 
inadequate protein, calcium and thiamine. When 
comparing energy intake based on skeletal age 
rather than actual age, they found that energy 
intake was closer to that recommended based on 
skeletal age, but two-thirds were still below 
recommended. The authors also noted that the 
athetoid children had a higher energy intake 
than the spastic children. 
(Karle et al. 
1961) 
N = 12 
Mostly spastic 
quadriplegic 
CP 
Estimated 2-3 day 
food records 
Serum levels of 
micronutrients 
All children had energy intakes below 
recommended, but only two children had protein 
intakes which were less than recommended. All 
except one child had low iron intake, yet their 
haemoglobin values were within the normal 
range. Blood levels of vitamin A, carotene, and 
vitamin C were also within the normal range; 
however, all of the children routinely received a 
multivitamin and mineral supplement. 
(Hammond 
et al. 1966) 
N = 31 
Mostly spastic 
CP 
Combination of 24-
hour recall and 6-
day estimated food 
record. 
Serum levels of 
micronutrients 
In over half of the children, intakes of energy, 
calcium, iron, and thiamine failed to reach 100% 
of recommended, however, most nutrient intakes 
were higher than two-thirds of recommended. 
Serum levels of haemoglobin, vitamin A, 
carotene, protein and albumin were all within the 
normal range. They also observed that energy 
intakes of children with athetoid CP were higher 
than those with spastic CP. Energy intakes were 
inversely correlated with the severity of CP. 
(Berg and 
Isaksson 
1970) 
N = 23 
All types of 
CP 
Estimated by 
observation 
Energy and nutrient intakes were lower than 
recommended, however protein intakes were 
adequate. 
(Sullivan et 
al. 2002) 
N = 94 
All types of 
CP 
Combination of diet 
history, 24-hour 
recall and 3-day 
estimated food 
record 
Only 20% of children had energy intakes above 
recommended for their age, and more than half 
of the group with severe disabilities consumed 
less than 80% of recommended. All except four 
of the children achieved the recommended 
protein intake. All children met the 
recommended intake for sodium, potassium, 
magnesium, phosphorus, and B vitamins. Iron 
intake was below recommended for almost half 
of the children. Those children with more severe 
disability had lower energy and nutrient intakes 
and poorer growth than those with milder 
disability, suggesting that inadequate dietary 
intakes may contribute to their stunted growth. 
CP, cerebral palsy; RDI, recommended dietary intake 
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2.3 Growth and cerebral palsy 
Human growth follows a predictable pattern. Normal growth is a marker for health, 
while growth retardation suggests a psychosocial problem, malnutrition or a medical 
illness. Aside from feeding difficulties, growth deviation may be the first, or only, 
signal of a more serious underlying health problem that requires investigation (Krick 
et al. 1996).  
2.3.1 Early studies on growth 
The growth failure of children with CP was first recognised and studied in the 1950s 
and 1960s. Several groups of researchers observed that many children with CP were 
shorter and lighter than their age-matched peers (Hammond et al. 1966; Pryor and 
Thelander 1967; Ruby and Matheny 1962; Sterling 1960; Tobis 1961). In addition, 
they found that the degree of severity of CP correlated with the degree of stunting and 
wasting. One group also noted that the incidence of fevers and infection tended to be 
greater in children with CP than in the normal population (Sterling 1960).  
Different theories were postulated as to the cause of the poor growth. One group 
believed that the growth failure might be explained by an increase in metabolic 
demands whereas another believed that children with athetoid type CP had greater 
energy expenditure than children with spastic type CP (Ruby and Matheny 1962; 
Sterling 1960). Others questioned whether the lack of physical activity was the major 
factor in impairing linear growth, or whether the CNS impairment somehow affects 
growth with no relation to mobility (Tobis 1961). A summary of these studies in 
chronological order is presented in Table 2.4 on page 66. 
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2.3.2 Assessing growth in children with cerebral palsy 
All of the early studies on growth in CP used standard measures of height to assess 
linear growth. While an index of linear growth is essential in the assessment of 
nutrition and growth of children, it is difficult to obtain in children with CP, mainly 
because of fixed joint contractures, involuntary muscle spasms and scoliosis (Spender 
et al. 1989; Stevenson et al. 1994; Stevenson 1995a). Alternate measures to standing 
height or length are available and include the measurement of arm span and segmental 
measurements of upper arm length (UAL), lower leg length (LLL) and knee height 
(KH). The measurement of arm span requires the subject to outstretch their arms in 
the horizontal position and to hold this position while the distance from fingertip to 
fingertip on opposing hands is measured. Due to joint contractures and involuntary 
muscle spasms in children with severe CP, arm span would be difficult to measure 
and has therefore not been investigated as an alternative to standing height in this 
population. Segmental lengths of UAL, LLL, and KH require minimal subject co-
operation, involve the measurement of only one segment of the limb, thereby 
minimising the effects of contracted joints, and have been investigated for use in 
children with CP (Chumlea et al. 1994; Johnson and Ferrara 1991; Spender et al. 
1989; Stevenson 1995b).  
Stevenson et al developed a set of equations to convert UAL, LLL, and KH to 
standing height in children with CP aged less than 12 years (Stevenson 1995b). The 
equations were derived from measurements performed on a group of children with 
varying degrees of CP. A different set of equations, based on KH only, for use in 
children aged 12 to 18 years were developed and validated in a group of healthy 
children by Chumlea et al from the 1960-1970 National Health Examination Surveys 
of Healthy Individuals (Chumlea et al. 1994). Both sets of equations (i.e. those of 
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Stevenson and Chumlea), were developed by regression analysis using standing 
height as the dependent variable and either KH, UAL or LLL as the independent 
variable. Therefore, in order to develop and validate the equations each individual in 
the test populations had to have both the segmental length and standing height 
measured, or in the case of the Stevenson population, recumbent length if the 
individual was unable to stand. In fact of the 211 sets of measurements from the 172 
individuals of the CP population of Stevenson, only 27 were able to stand for a height 
measurement, the remaining 184 sets of measurements used recumbent length. 
Recumbent length is known to be greater than stature by up to 2 cm (Moore and 
Roche 1986). In addition, the database of Stevenson included only seven (4 %) 
individuals with quadriplegic CP. Furthermore, although they showed that the 
measurements of segmental length were highly correlated with standing height or 
recumbent length, they did not compare height estimated by conversion of KH, UAL, 
or LLL with actual standing height or recumbent length, nor did they cross-validate 
their equations.  
2.3.2.1 Validation of alternate measures for standing height 
Johnson et al attempted to validate the equations developed by Chumlea in a 
population of 31 children with varying degrees of CP (Chumlea et al. 1994; Johnson 
and Ferrara 1991). The authors measured standing height in all of the study 
participants, yet approximately one-third of the population had involvement of the 
lower extremities, and therefore the measurements of standing height are of 
questionable validity. Although the authors found that KH alone was highly correlated 
with standing height, they found that the difference between actual measured height 
and estimated height using KH was too great to make the equations useful in a clinic 
setting. However, there were only 31 participants in the study with one-third having 
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lower extremity involvement, which can make standing height difficult to measure 
and most likely unreliable.  
Spender et al also attempted to validate UAL and LLL as a proxy for standing height 
in 98 children with varying severities of CP and in a control population (Spender et al. 
1989). The authors found that they were unable to evaluate the validity of using UAL 
and LLL to estimate height in children with CP because of the lack of reliable 
measures of height or length in this group. In the control population, they found that 
UAL and LLL correlated reasonably well with standing height with correlation 
coefficients between 0.60 and 0.85. However, the measures of UAL and LLL were 
not converted to height for comparison and therefore it is difficult to determine from 
this study if segmental measures are in fact valid proxies for standing height. There 
are reference charts available for UAL and LLL and the authors recommend using 
these charts to assess linear growth when it is not possible to measure height or length 
(Cole 1998).  
Therefore, due to the inability to validate the equations to estimate height in 
populations with severe CP, the equations are of questionable utility. Nonetheless, 
even with an estimate of standing height, the interpretation of growth in children with 
CP is unclear. This is mostly because the available reference growth charts are based 
on healthy physically active children with normal muscle and bone mass which may 
not be appropriate to compare to children with CP.  
2.3.3 Development of growth standards for use in cerebral palsy 
In order to overcome the problem and uncertainty of comparing the growth of 
children with CP with normal standards, Krick et al developed growth charts 
specifically for children with quadriplegic CP (Krick et al. 1996). On comparing the 
CP and normal reference growth charts, it was found that the 50th centile of the CP 
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growth chart was below the 10th centile for normal standards for weight for age and 
length for age, and was roughly equal to the 10th centile for weight for length. As the 
children aged, the differences between the CP population and the reference population 
increased. The authors concluded that the 10th centile for weight (on the normal 
growth charts) would be an appropriate healthy weight for children with CP. 
Unfortunately, these growth charts are not recommended for use because the 
methodology used was flawed in several areas: the authors used measures of weight 
and length that were collected both prospectively and retrospectively from medical 
records; in some of the study participants who were unable to stand, part body lengths 
were measured and summed to give total length which is of unknown reliability; and 
the data included single observations of some children, but multiple observations of 
others. Moreover, malnourished children were not excluded from the sample and thus 
the results were skewed by stunted, chronically undernourished children. Finally, the 
development of these growth charts suggest that children with CP cannot be expected 
to grow at normal rates, and that growth failure is an accepted and irremediable 
consequence of the disease. Currently, evidence for either of these concepts is not 
available. However, considering that a large proportion of children with CP who can 
eat normally maintain normal growth, one could question their validity.  
As an alternate method to using height growth charts, Samson-Fang & Stevenson 
evaluated the use of standard reference weight-for-height centile (WHC) charts to 
screen 276 children with CP for depleted body fat, defined as a mid-upper arm fat 
area (UAFA) less than the 5th centile (Samson-Fang and Stevenson 2000). A cut-off 
of WHC <10th centile failed to identify 45 % of children with severely depleted fat 
stores (UAFA <5th centile). The authors claimed that this was because WHC is a 
better indicator of acute rather than chronic malnutrition. Furthermore, WHC may 
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have performed poorly as an indicator of fat stores because of excess “artificial” 
weight from clothing, braces, and faecal mass due to constipation. In addition, the 
authors claimed that using LLL to estimate height could result in false elevation of 
WHC if a child has undergrowth of the lower extremities in association with motor 
impairment. MUAC, body mass index (BMI), and subscapular skinfold thickness also 
performed poorly as screening tools. The authors found that the best indicator of 
suboptimal fat stores and malnutrition was using triceps skinfold cut-off value of 
<10th centile for age and sex. 
Due to the poor performance of weight-for-height in identifying malnutrition in 
children with CP, Lark et al sought to find reliable biochemical indicators of 
malnutrition (Lark et al. 2005). They evaluated serum prealbumin and albumin as 
markers of undernutrition in 107 children with moderate to severe CP. They found 
that prealbumin and albumin were rarely below normal reference ranges and showed 
little to no correlation with anthropometric measures, growth, severity of CP or 
general health, and therefore these biochemical tests appear to be of little value in the 
clinical setting in identifying children with CP and malnutrition. 
2.3.4 Nutritional and non-nutritional causes of growth failure 
Following the studies from the 1960s which identified significant growth failure in 
children with CP, several researchers have sought to determine the cause/s of the 
growth failure. Most researchers agree that the cause is multifactorial and is a 
combination of both nutritional and neurological, or non-nutritional, factors. 
Nutritional factors are primarily protein-energy malnutrition due to inadequate intake, 
excess losses from vomiting and spillage, and possibly altered energy requirements 
(Stevenson et al. 1994). Neurological or non-nutritional factors that have been 
postulated to effect growth include (i) that the CNS injury somehow inhibits growth; 
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(ii) that a trophic influence from the brain is disrupted causing poor growth; (iii) that 
the abnormal muscle tone and activity created by damage to the CNS, and the 
consequent disuse and decreased blood flow to the affected limbs, causes dwarfing of 
the limbs; and (iv) that parietal lobe defects associated with sensory deficits somehow 
inhibit growth (Stevenson et al. 1995) (Rempel et al. 1988; Shapiro et al. 1986). 
Stallings et al studied the growth patterns of a large group (n = 142) of children with 
spastic quadriplegic CP to test the hypothesis that poor nutritional status, as indicated 
by depleted subcutaneous fat stores and muscle stores, is an identifiable cause of 
growth failure in children with spastic quadriplegic CP (Stallings et al. 1993a). They 
confirmed the findings of previous researchers that height and weight were 
significantly reduced, and these measures dropped further below the median as the 
children aged. In addition, they found that on average the triceps and subscapular 
skinfold thicknesses, and to a lesser extent upper arm muscle area (UAMA), were 
significantly reduced. Using regression analysis, the authors sought to determine the 
relative contribution of various non-disease (age, sex, race, pubertal status) and 
disease (type of CP, cognitive status, ambulatory status, oromotor status) factors to 
nutritional status (UAMA and percent body fat) and linear growth failure of the 
children with CP. The non-disease and disease severity variables explained about 70 
to 75 % of the variation in linear growth. After controlling for the non-disease and 
disease severity factors, nutritional status explained 10 to 15 % of the remaining 
variation in linear growth. The authors concluded that both nutritional and non-
nutritional factors influence the growth of children with CP. 
Stevenson et al conducted a similar study to that of Stallings et al in order to 
investigate the causes and mechanisms of growth failure in children with various 
severities of CP (Stevenson et al. 1994). They also found greatly reduced height, 
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weight, and triceps skinfold thickness, and that height standard deviation (SD) score 
was negatively correlated with age. In addition, their results indicated that children 
with seizures, spastic quadriplegic CP and those who were non-ambulatory had 
significantly lower height and weight SD scores. The authors attempted to explore the 
associations between nutritional (weight, triceps skinfold thickness) and non-
nutritional factors (age, type of CP, seizures, non-ambulation) and growth (height), 
and the contribution which each makes towards growth. Only weight (nutritional) and 
age (non-nutritional) contributed significantly to height SD score. Therefore, these 
results support the hypothesis, and the findings of Stallings et al, that both nutritional 
and non-nutritional factors influence linear growth in children with CP.  
However, the two aforementioned studies involved patient populations with a high 
prevalence of malnutrition, which may have confounded the effects of non-nutritional 
factors on growth (Stallings et al. 1993a; Stevenson et al. 1994). Therefore, Stevenson 
et al attempted to further determine the contributions of the various factors by 
studying children with hemiplegic CP (Stevenson et al. 1995). The authors claimed 
that children with hemiplegic CP offer a natural model for the study of non-nutritional 
factors on growth without the confounding effects of malnutrition or endocrinopathy. 
Furthermore, each child can be used as its own control. They measured breadth, 
circumference, length and skinfold thicknesses on the limbs of both the affected and 
unaffected side in a small group of children with spastic hemiplegic CP and normal 
stature. They found that all measures were significantly shorter or lower on the 
affected side compared with the unaffected side and, on average, the skinfold 
measures tended to be larger on the affected side. This study suggests that CP affects 
growth negatively, even in the absence of malnutrition. The authors claim that a 
significant portion of the growth failure observed in children with CP is unrelated to 
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malnutrition, and therefore would be unaffected by nutritional treatments. There have 
been some studies of the effects of nutritional rehabilitation on growth in children 
with CP. These studies are summarised and discussed in section 2.6.3.1 (pg 84). 
Samson-Fang & Stevenson argued that the previous studies investigating influences 
on growth in children with CP were cross-sectional only and therefore were unable to 
accurately identify the factors associated with suboptimal linear growth (Samson-
Fang and Stevenson 1998). Therefore, they retrospectively studied linear growth 
velocity and the factors associated with poor linear growth in a large group (n = 81) of 
children with varying degrees of CP. Lower growth velocity was seen in children 
aged less than two years, males, non-ambulatory children, malnourished children 
(triceps <5th centile), and those with cognitive impairment. However, the authors 
acknowledged that the use of linear growth velocity to study growth patterns in 
children with CP was hampered by the difficulty in obtaining accurate measurements 
of height in this population. Therefore, the authors were only able to study children in 
whom an accurate measure of height could be obtained, and therefore preferentially 
excluded those children with more severe CP. A summary of the studies in this 
section are presented in chronological order in Table 2.4 (pg 66). 
2.3.5 Hormones and growth in children with cerebral palsy 
Growth is controlled by, and dependent upon, many factors including prenatal growth 
and development, genetic factors, nutrition and hormones. This sub-section focuses on 
the hormones that influence and control growth.  
Growth hormone (GH, or somatotropin) is necessary for normal linear growth. GH 
deficiency causes short stature while GH excess leads to gigantism (Jameson and 
Weetman 1998). In the total absence of GH, linear growth occurs at about half to a 
third of the normal rate. However, GH does not appear to be the principal direct 
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stimulator of growth but rather acts indirectly by stimulating the formation of other 
hormones or factors. These factors, known as somatomedins (SMs, or somatotropin-
mediating hormones) or insulin-like growth factors (IGFs), are GH-dependent and are 
responsible for growth stimulation. IGF-I (formerly SM-C), the most important SM 
for post-natal growth, is produced mainly in the liver, with other sources including 
chondrocytes, kidney, muscle, pituitary, and gastrointestinal tract.  
GH is controlled by a dual hypothalamic regulation (Figure 2.1, pg 38). Secretion is 
stimulated by GH-releasing hormone (GHRH) and inhibited by somatostatin (GH-
release inhibiting hormone or somatotropin release-inhibiting factor, SRIF). GH 
deficiency is often a consequence of hypothalamic GHRH deficiency. In addition, the 
levels of GH and IGF-I depend on nutritional status; IGF-I levels decline, while GH 
levels increase in states of malnutrition (Jameson and Weetman 1998)(Robinson and 
Picou 1977) (Hintz et al. 1978; Soliman et al. 1986). It has been hypothesised that the 
reduced levels of IGF-I found in malnourished children could be due to a general 
impairment of protein synthesis by the liver, which as mentioned previously is the 
main source of IGF-I production (Hintz et al. 1978). Thus without the inhibitory 
effects of IGF-I on GHRH, GH levels increase. Furthermore, it is suggested that high 
GH and possibly low IGF-I levels mediate lipolysis which is an important adaptive 
mechanism to assure fuel (fatty acids) supply for metabolism of brain and peripheral 
tissues during nutritional deprivation (Soliman et al. 1986). 
Thyroid hormones also influence growth; however, unlike the pattern of growth with 
GH deficiency, the total absence of thyroid hormone causes an almost complete 
cessation of linear growth. Thus adequate thyroid hormone appears to be an absolute 
prerequisite for normal growth. Thyroid hormones exert direct effects on cell 
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metabolism, and thyroid deficiency also results in diminished GH secretion in 
response to stimulation.  
Other hormones that influence growth include the gonadal steroids (androgen and 
oestrogens) during puberty, insulin, and other factors such as nerve growth factor, 
epidermal growth factor, and platelet-derived growth factor.  
Despite the high incidence of growth failure and malnutrition in children with CP, 
there have been only two small studies and three case reports of GH levels in this 
population. Hayashi et al reported subnormal GH responses following clonidine (a 
stimulator of GHRH and GH) administration in four boys with athetoid CP and 
following GHRH administration in seven boys with spastic CP (Hayashi et al. 1989). 
The authors suggested that athetoid CP was associated with hypothalamic GHRH 
deficiency and spastic CP with reduced pituitary reserve of GH.  
Another study of children with severe CP reported that six of the 10 children studied 
had subnormal GH secretion, four of whom also had low IGF-I levels (Coniglio et al. 
1996). A further three children in the study who had normal GH levels had low IGF-I 
levels. In addition it was found that normal growth velocity was strongly predictive of 
adequate GH secretion; only one of five children with normal growth velocity had 
subnormal GH secretion, whereas all five children with subnormal growth velocity 
had subnormal GH secretion. All children in the study had normal thyroid function 
tests. However, the authors used recumbent lengths as a measure of height which may 
not have provided an accurate estimate of growth velocity, and the study involved 
only a small number of participants with varying degrees of malnutrition. 
Furthermore, their findings are in contradiction with a number of other studies on 
severely malnourished infants and children that have found significantly elevated 
basal levels of GH and reduced levels of IGF-I (Soliman et al. 1986). 
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GH
SM
GHRH Somatostatin 
Figure 2.1 Feedback control of growth hormone secretion 
Figure adapted from (Jameson and Weetman 1998). GH, growth hormone; GHRH, growth 
hormone-releasing hormone; SM, somatomedins (insulin-like growth factors). Stimulating 
influences are shown by solid lines. Inhibitory influences are shown by dotted lines. 
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(Hintz et al. 1978; Robinson and Picou 1977). The three case reports found the 
following: 
 Case 1 – a child with moderate CP, short stature and mild malnutrition, found to 
have low GH levels, low IGF-I levels, normal thyroid functions, showed increased 
growth velocity with daily GH injections (Coniglio and Stevenson 1995); 
 Case 2 – a child with moderate CP, short stature and mild malnutrition, found to 
have subnormal GH levels, however refused treatment with GH (Coniglio and 
Stevenson 1995); 
  Case 3 – a child with hemiplegic CP, short stature, found to have normal GH 
levels, however exhibited increased growth during treatment with GH (Shim et al. 
2004). 
In summary, the studies that have been done involved only small numbers of 
participants and reported conflicting results. However, they do provide some evidence 
to suggest that endocrinological factors may play a role in causing growth failure in 
children with CP. The reasons for the GH abnormalities found in these studies are 
unclear, but may include anatomic defects of the hypothalamus or pituitary gland or 
an interaction between malnutrition and a damaged CNS. Further studies are needed 
to investigate the possible interactions between CNS damage, malnutrition and GH in 
children with CP, and whether GH therapy might be beneficial in this population. 
2.4 Body composition in children 
Weight and height are often used as a screening tool to assess nutritional status in 
children. Abnormal growth can be an indicator that the child has an underlying illness 
or disease that requires further investigation. Waterlow devised a classification system 
for malnutrition based on weight and height, where the terms wasting and stunting 
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were used to describe acute and chronic malnutrition, respectively. Acute 
malnutrition, or wasting, was defined as having a normal height, but a weight that was 
less than 80 % of expected for age (Waterlow 1972). Chronic malnutrition, or 
stunting, was defined as having a reduced weight-for-age as well as a reduced height-
for-age (Waterlow 1972). Chronic malnutrition was further categorised into mild (80 
to 90 % of expected weight-for-height), moderate (70 to 79 % of expected weight-for-
height) and severe (less than 70 % of expected weight-for-height). 
However, weight and height measurements do not describe the composition of the 
body, i.e. fat, muscle mass, water, or bone; or which of these components are 
abnormal. Precise and accurate measurement of body composition is important to the 
understanding of the disease process so that deficits or excesses can be defined and 
corrected. Body composition is also important to measure in healthy children so that it 
can be used as reference data. 
2.4.1 Body composition components 
The body consists of essentially six “compartments” – fat, water, protein, glycogen, 
bone mineral and non-bone mineral (Figure 2.2, pg 44). Often, for simplification, 
some of the compartments are combined to give either a two compartment (2C) 
model, where body weight is divided into fat mass (FM) and fat-free mass (FFM), or a 
four compartment (4C) model, which may consist of fat, water, protein and bone, for 
example. There are also three, five and six compartment models, however the 2C and 
4C are the most commonly used. Several methods exist to measure each compartment 
or to measure a combination of compartments. Some of these methods are outlined in 
section 2.4.2. At present there are no methods available for quantifying total body 
glycogen in vivo. Glycogen constitutes about only 1 % of body weight, and depending 
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on the technique used and the compartment measured, glycogen is incorporated into 
one of the other compartments (Heymsfield et al. 1993).  
Critical to the use of most indirect methods utilised to estimate body composition is 
the assumption that the content of the FFM is relatively constant. Studies based on 
animals suggested that many species reach a relatively constant FFM composition 
(chemical maturity) by 4.5 % of the lifespan (Boileau et al. 1984; Moulton 1923). 
When these observations were extended to humans it was suggested that chemical 
maturity was achieved by three to four years of age (Moulton 1923). However, the 
data used were limited to foetuses, infant and adults (Boileau et al. 1984). More recent 
studies have shown that the proportion of water, protein and minerals in FFM change 
during maturation, and that chemical maturity is reached after puberty, or around 16 
years in girls and 18 years in boys (Boileau et al. 1984; Lohman 1986). Protein and 
mineral contents of FFM increase with chemical maturity, as water content decreases. 
The changes are similar for both sexes, but females have a slightly higher water 
content than males (Boileau et al. 1984). Unfortunately all indirect methods to assess 
body composition have been developed with the assumption of chemical maturity. 
This and other assumptions are discussed in more detail in the following section, 
2.4.2. 
2.4.2 Techniques to measure body composition 
2.4.2.1 Densitometry 
The term “densitometry” refers to the general procedure of estimating body 
composition from body density. This method assumes that the body is composed of 
two distinct components (FM and FFM) and that it is possible to determine each of 
these components from the measured whole body density (Lukaski 1987). Although 
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several methods can be used to estimate body density, densitometry has become 
virtually synonymous with underwater weighing (also known as hydrodensitometry) 
(Going 1996). Underwater weighing has long been considered the gold standard and 
has been often used as the criterion method in validation studies of new body 
composition assessment methods. Underwater weighing essentially measures the 
volume of the body – when a subject is submerged in water, body volume is equal to 
the weight of displaced water. Like any material, the density of the human body (Db) 
is equivalent to the ratio of its mass (MA) and volume (V): 
Db = MA/V 
Furthermore, the density of any material is a function of the proportions and densities 
of its components. In the 2C model, body weight is divided into FM and FFM, thus: 
1/ Db = FM / dF + FFM / dFFM 
where 1/ Db equals body mass divided by body density, and FM / dF and FFM / dFFM 
are the proportion of fat and fat-free mass divided by their respective densities. 
Densitometry is based on several assumptions (Going 1996): 
1. that the density of fat is 0.9007 g/ml and that of FFM is 1.100 g/ml, 
2. that the separate densities of the body components are additive, 
3. the densities of the constituents of the body are relatively constant from person 
to person, 
4. that the proportions of the constituents other than fat are relatively constant 
from person to person, i.e. the water content of FFM is constant at 73.2 %, and  
the proportion of bone mineral to muscle in the FFM is constant, 
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5. that the person being measured differs from a standard reference body only in 
the amount of body fat. 
However, a number of studies based on chemical and anatomical models have 
demonstrated considerable variation in FFM composition and density due to growth 
and maturation, specialised training, aging, and sex, which challenge the assumption 
of FFM constancy. Furthermore, the technique of underwater weighing requires 
complete submersion of the subject in water, and for several reasons is technically 
difficult, and is therefore not appropriate for all subject groups, particularly children. 
2.4.2.2 Air displacement plethysmography 
An alternative approach to underwater weighing is air displacement plethysmography 
(ADP). ADP uses pressure-volume relationships to estimate the volume and density 
of the body (Going 2005). Although ADP avoids many of the challenges of 
underwater weighing, past applications in humans have been limited due to the 
technical difficulties in adjusting for irregularities in temperature and humidity of the 
air next to the skin and hair (Going 2005). A new system, the Bod Pod (Life 
Measurement, Inc, Concord, CA), has improved precision and accuracy compared 
with past techniques. The device consists of a single structure with two 
complementary chambers: a test chamber of approximately 450 L where the subject is 
seated and a reference chamber of approximately 300 L. A moulded fibreglass seat 
forms a common wall separating the chambers. A diaphragm oscillates between the 
chambers, producing sinusoidal volume perturbations that are equal in magnitude but 
opposite in sign. The perturbations result in very small pressure changes within the 
chambers, which are monitored by transducers and analysed for pressure at the 
frequency of oscillation. The ratio of the pressures is a measure of the test chamber 
volume (Fields et al. 2002), which is determined by the application of Poisson’s law:
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Figure 2.2 Body composition model 
Adapted from Pietrobelli et al (Pietrobelli et al. 1996) 
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P1 / P2 = (V2 / V1)γ 
where P1 and V1 represent one paired condition of pressure and volume,  P2 and V2 
represent a second condition, and γ is the ratio of the specific heat of the gas at 
constant pressure to that at constant volume (Going 2005). 
When a subject is placed inside the test chamber air is displaced from the test chamber 
and is added to the reference chamber. The volume of air displaced is equal to the 
volume of the body inside the test chamber (Fields et al. 2002). Body volume is 
calculated indirectly by subtracting the volume of air remaining inside the test 
chamber when the subject is inside from the volume of air inside the test chamber 
when it is empty (Fields et al. 2002). The body volume measured by the Bod Pod is 
then corrected for isothermal properties of the air contained in the lungs, near the skin 
or hair, and in clothing (Ellis 2001). Body density is then calculated from body 
volume using the same method as for underwater weighing and then converted to 
percent body fat using the Siri, or other similar, equation (Fields et al. 2002; Siri 
1993). 
Because the Bod Pod technique uses the same equations as underwater weighing for 
translating body volume into body density and subsequently body composition, the 
technique is limited by the validity of the assumptions of these equations described in 
the previous section.  
Studies in adults and children have revealed good precision (< 0.11 L) for the 
measurement of body volume by the Bod Pod (Fields et al. 2002). However, there 
have been only a limited number of studies validating the accuracy of the Bod Pod 
against 4C models of body composition, and therefore further studies are required to 
determine the accuracy of this technique (Fields et al. 2002).  
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In summary, ADP offers several advantages over established reference methods, 
including a quick, comfortable, automated, non-invasive, and safe measurement 
process, and accommodation of various subject types (e.g. children, obese, elderly and 
disabled persons) (Fields et al. 2002). However, both underwater weighing and ADP 
are limited by the validity of the assumptions that underlie conversion of body density 
to composition, and thus both methods are best used in combination with other 
methods in 3C or 4C models (Fields et al. 2002; Going 2005).  
2.4.2.3 Anthropometry 
Anthropometry, the measurement of body size, weight, and proportions, is one of the 
most commonly used methods available to assess nutrition. Anthropometry has the 
advantages of being simple to use, inexpensive, non-invasive and portable. However, 
the precision of the technique is variable and dependent upon the skill of the 
anthropometrist. Values derived from the measurement of skinfold thicknesses at two 
or more sites on the body as well as limb circumferences can be used in various 
multiple regression equations to predict body density and to calculate FM. FFM is 
then calculated by subtracting FM from body weight, thereby providing a 2C model 
of body composition Because FM estimated from skinfold anthropometry is derived 
using body density, it also relies on the same assumptions as for measuring body 
density. In addition, skinfold anthropometry itself is based on two main assumptions: 
that the thickness of the subcutaneous adipose tissue reflects a constant proportion of 
the total body fat and the sites selected for measurement represent the average 
thickness of the subcutaneous adipose tissue. Neither of these assumptions has been 
proven to be true, and therefore the validity of using skinfold equations to predict 
body composition is restricted to populations from whom the equations were derived 
(Lukaski 1987; Roche 1996).  
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2.4.2.4 Dual-energy x-ray absorptiometry 
Dual energy x-ray absorptiometry (DXA) was originally designed to measure only 
bone mineral content (BMC) and bone mineral density (BMD), and is considered a 
gold standard technique for this purpose (Lohman 1996). However due to the 
increasing popularity, availability and advantages of this technique, DXA was further 
developed and can now also measure other compartments of the body, namely lean 
tissue mass (LTM) and body fat. This method uses a whole-body rectilinear scanner 
and a high activity gadolinium-153 source that emits energy (photons) at two distinct 
peaks (44 and 100 keV). The source is mounted beneath a table and is opposite to a 
scintillation detector above the table. The source and detector are passed across the 
body at a traverse speed of 1 cm/s with data collected at 0.5 cm intervals (Lukaski 
1987). As the photons traverse the subject’s tissues, physical interactions take place 
that reduce the beam intensity. This process is generally referred to as attenuation 
(Pietrobelli et al. 1996). When photons at two different energies are passed through 
the subject, attenuation at the lower energy can be expressed as a ratio (R) to 
attenuation observed at the higher energy. This process produces an image of the body 
made up of thousands of pixels which is then analysed by a computer.  
The DXA body composition approach assumes that the body consists of three 
components that are distinguishable by their x-ray attenuation properties: fat, bone 
mineral, and residual or lean soft tissue (see Figure 2.2 pg 44). However, in practice, 
DXA can only resolve the fractional masses of a two-component mixture, bone 
mineral and soft tissue (Pietrobelli et al. 1996). The DXA method for estimating three 
components is to separate pixels into those with soft tissue only (fat plus lean) and 
those with soft tissue plus bone mineral. Because the R value for bone mineral is 
much higher than for soft tissue, bone-containing pixels will be those with the higher 
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composite R values. The composition of bone mineral is essentially invariable and is 
therefore accurate in its estimation; however, soft tissue is composed of varying 
amounts of fat and lean tissue. Variations in fat and lean tissue composition produce 
differences in R values. Therefore, the fat and lean components of each soft tissue 
pixel can be established from the measured and assumed R values for the two 
respective components, using the following equations: 
f1 = (R – R2) / (R1 - R2) and f2 = (R1 – R) / (R1 - R2) 
Where f1 and f2 represent fat and lean tissue, respectively; R is the measured ratio of 
attenuation at the two different energy levels; and R1 and R2 are the assumed or 
theoretical R values established by measuring “pure” fat (R1) and lean soft tissue (R2) 
samples. The theoretical R value for lean tissue is based on the assumption that the 
hydration of lean tissue is constant at 73.2 % (Pietrobelli et al. 1996). 
DXA has the advantages of being quick and precise with a low radiation dose (~ 0.2 
μSv), and is therefore ideal for use in paediatric populations. However, the cost and 
availability of the instrumentation may be a limiting factor for its use. Furthermore, 
the accuracy of the estimation of the soft tissue components by DXA has been 
questioned, mainly because, like the methods already discussed, it also relies on the 
assumption that the hydration of LTM is constant at 73.2 %. The hydration of LTM or 
FFM may vary in some disease states and also during growth and maturation, and the 
degree to which DXA measurements are sensitive to variation in hydration levels is 
unknown. 
2.4.2.5 Neutron activation analysis 
The development of in-vivo total body neutron activation analysis (NAA) has 
provided the only technique currently available for the direct measurement of several 
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compartments of the body. Absolute content of calcium, sodium, chlorine, hydrogen, 
phosphorus, and nitrogen can be determined using this technique (Ellis 1996). Of 
particular value, is the measurement of total body nitrogen (TBN). By measuring 
TBN, total body protein (TBP) can then be calculated using the following assumed 
relationship: mass of protein = 6.25 x mass of nitrogen (Baur et al. 1991a).  
The basis of this technique is that the subject is bilaterally irradiated with neutrons 
produced from the decay of two 252Cf sources, which results in the conversion of 14N 
to 15N with the emission of a 10.83 MeV gamma ray which is specific for nitrogen 
(Baur et al. 1991a). The absolute mass of nitrogen (MAN) can be determined by using 
hydrogen (2.23 MeV gamma ray emission) as an internal standard and the following 
equation: 
MAN = (YN / YH) KMAH C(W) 
Where YN and YH are the net nitrogen and hydrogen yields, respectively, K is the 
calibration factor determined from a phantom with known hydrogen and nitrogen 
masses, C(W) is the nitrogen-to-hydrogen gamma ray attenuation correction factor 
which is dependent on subject width, and MAH is the mass of hydrogen determined 
from fat mass, as per the following equation, where fat mass (MAf) is estimated from 
skinfold anthropometry using the equations of Brook (Brook 1971), or Durnin & 
Rahaman (Durnin and Rahaman 1967), and body mass (MA) using the following 
equation of Vartsky et al (Baur et al. 2001; Vartsky et al. 1979): 
MAH = 0.097MA + 0.0219MAf 
The main advantage of this technique over others is that it directly measures the 
component of interest while avoiding assumptions. Other advantages include its high 
precision and accuracy. However, the radiation dose that the subject receives from the 
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measurement can vary between machines, with most adult units delivering a dose of 
up to 0.8 mSv. The Children’s Hospital at Westmead (CHW) is fortunate to have its 
own machine which was purpose built for use in children and delivers a much lower 
radiation dose than the adult machines (< 0.15 mSv) (Baur et al. 1991a). Nonetheless, 
the equipment is expensive and requires highly skilled operators to use it, and 
therefore NAA is of only limited availability.  
2.4.2.6 Total body water 
Water is by far the most abundant of the components of the body. Body water is 
almost exclusively associated with FFM, of which it is the largest single component 
(Boileau et al. 1984). Approximately 57 % of body water is intracellular and 43 % 
extracellular (Schoeller 1996). The total volume of water in the body can readily be 
measured by isotope dilution using tritium, deuterium, or 18O-labelled water. The 
typical procedure for this technique is that the subject ingests, or is administered 
intravenously, a specified quantity of the labelled isotope. After an equilibration 
period, samples of serum, saliva or urine are collected and analysed for amounts of 
the labelled isotope.  
There are four assumptions in the measurement of total body water (TBW) by dilution 
(Schoeller 1996): 
1. that the labelled isotope is distributed only in body water, 
2. that the labelled isotope is equally distributed in all anatomical water 
compartments, 
3. that the rate of equilibrium of the labelled isotope is rapid, and 
4. that neither the labelled isotope nor body water is metabolised during the time 
of tracer equilibrium, nor lost in the urine. 
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The precision of the technique is dependent on the analytical method as well as the 
dose of the labelled isotope administered to the subject. Nonetheless, studies have 
shown that the accuracy and precision of the isotope dilution method for the 
measurement of TBW is very good (Schoeller 1996). However, due to the laborious 
procedures and specialised equipment required for this technique, direct measurement 
of TBW is limited to those units with the appropriate facilities. 
By measuring TBW, a 2C model of body composition can also be estimated, i.e. FM 
and FFM. This model is based on the fact that fat is hydrophobic and thus free of 
water, which is therefore restricted to the fat-free component. However, the 
calculation of FFM from TBW depends on the assumption of constant hydration of 
FFM, i.e. 73.2 %, which as discussed previously may not hold true in all subjects.  
2.4.2.6.1 Intracellular and extracellular water 
TBW can be divided into intracellular and extracellular water. Although intracellular 
water (ICW) is quite difficult to measure directly, extracellular water (ECW) can be 
measured by dilution and ICW calculated as the difference from TBW. The volume of 
ECW can be measured in vivo using the dilution principle, a method similar to the 
measurement of TBW (Schoeller 1996). The assumptions underlying the 
measurement of TBW by dilution are the same assumptions underlying the 
measurement of ECW (please refer to the previous page). A number of tracers exist 
that can be used for the measurement of ECW including bromide, chloride, 
thiocyanate, thiosulphate, sulphate, inulin-sucrose, and mannitol (Schoeller 1996). 
Each of these behaves differently with respect to the four assumptions, however 
bromide and isotopic chloride dilution come closest to approximating ECW, with 
bromide being the most commonly used tracer due to the advent of improved 
analytical techniques (Schoeller 1996). The relative precision of measuring ECW by 
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dilution is not as well characterised as that of TBW (Schoeller 1996). As with TBW, 
the precision of bromide dilution depends on the dose of the tracer and the analytical 
methods, however it has been reported that a relative precision of 1 % should be 
attainable if the doses are carefully chosen for the particular analytical method 
(Schoeller 1996). The precision for the determination of ICW, when calculated by the 
difference between TBW and ECW, is worse because errors in both variables 
propagate through the calculation (Schoeller 1996). The accuracy of the determination 
of ECW and ICW is unknown because direct chemical methods are not available to 
determine criterion values for these components of the body, but is thought to be 
probably accurate to 1 % in healthy subjects and around 2 – 5 % in subjects with an 
atypical ECW space (Schoeller 1996). 
2.4.2.7 Total body potassium 
The measurement of total body potassium (TBK) can be used to derive a 2C model of 
body composition, i.e. FFM and FM. The measurement of  TBK is based on two facts, 
firstly, that 90 % of the body’s potassium is located intracellularly and is not present 
in body fat and secondly, that potassium-40 (40K), which emits a characteristic gamma 
ray at 1.46 MeV, exists in the body at a known natural abundance (0.012 % of total 
potassium) (Lukaski 1987). These facts have allowed investigators to estimate FFM in 
humans by external counting of 40K (Lukaski 1987). The measurement technique 
involves placing the subject in a specially constructed shielded room (to reduce 
background radiation sources) with counters that consist of a gamma ray detection 
system connected to a suitable recording device (Lukaski 1987). The precision and 
accuracy of TBK measurements has been reported to be within ± 3 % in healthy 
adults (Lukaski 1987). Once an accurate measurement of TBK is obtained, the data 
can be translated into an estimate of body composition by assuming that potassium is 
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contained only in FFM, at a known and constant concentration (Lukaski 1996). The 
potassium content of FFM has been reported to be quite consistent, with chemical 
analyses of human cadavers yielding values of 2.66 and 2.50 g potassium / kg FFM in 
men and women, respectively (Lukaski 1987; Lukaski 1996). However, the 
assumption that potassium is at a constant concentration in FFM does not apply to 
children and adolescents due to their chemical immaturity (Fomon et al. 1982; 
Lohman 1986), and hence the measurement of TBK in children is less precise than in 
adults. Finally, the cost of the equipment and the need for specially trained technicians 
prevents the wider use of this technique. 
2.4.2.8 Electrical conductance 
In recent times, the use of techniques based on the electrical conductivity of the 
body’s tissues for the determination of body composition has rapidly grown 
(Baumgartner 1996). Two of these techniques, bioelectrical impedance analysis (BIA) 
and total body electrical conductivity (TOBEC) are described below. 
2.4.2.8.1 Bioelectrical impedance analysis 
BIA is another method that can be used to measure a 2C model of body composition. 
BIA provides an estimate of TBW, which is then transformed into FFM and 
subsequently FM (Pietrobelli and Tato 2005). Like skinfold anthropometry, this 
technique is quick, non-invasive, portable and relatively inexpensive. This technique 
is based on the principle that in living organisms electrical conductance is related to 
the water and electrolyte distribution in the biological conductor. Because FFM 
contains virtually all of the water and conducting electrolytes in the body, 
conductivity is far greater in the FFM than in the FM of the body. BIA gives a 
measure of the body’s resistance and reactance to an applied current. The current 
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(usually 50 kHz) is applied to the body through one pair of electrodes placed distally 
on the dorsal surfaces of the hand and foot on one side of the body, while a second 
pair located proximally on the same hand and foot measures the electrical potential 
providing a measure of resistance and reactance. These values are then placed into 
one of several available multiple regression equations that convert measurements of 
bioelectrical impedance to FFM and FM. In fact the main limitation to this technique 
is the choice or availability of appropriately calibrated, cross-validated predictive 
equations. It is essential to make a careful selection of equations that were developed 
from a sample that is similar in age, sex, ethnicity, and health status to the subjects 
being studied (Baumgartner 1996). There are no validated equations for use in 
children with CP. A second limitation is that, as with other indirect measurements of 
body composition discussed in this section, the estimation of FFM from BIA relies on 
the assumption that the hydration of FFM is known. While the precision of 
measurements of impedance, resistance, and reactance by BIA is reported to be very 
good (< 0.5 %), the accuracy is dependent upon the appropriateness of the equation 
selected for the study population and is therefore variable (Baumgartner 1996). 
Furthermore, several studies have examined the accuracy of estimated changes in 
body composition from BIA and found that BIA was best suited for quantifying group 
changes and could only detect relatively large changes in individuals (Baumgartner 
1996).  
2.4.2.8.2 Total body electrical conductivity 
As with the BIA method, this technique relies upon the differences in electrical 
conductivity properties of FFM and FM to estimate body composition (Lukaski 
1987). The TOBEC instrument consists of a long, uniform, solenoidal coil driven by a 
5 MHz oscillating radiofrequency current. The oscillating field will induce an 
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electrical current in any conductive material placed within the coil (Lukaski 1987). 
When a body is placed within the coil an electric current is induced in the conductive 
portion of the FFM, that is, energy is absorbed and more current is put into the coil to 
maintain the electromagnetic field. The energy absorbed is proportional to the current 
and the length and conductivity of the conductor, and hence the volume of FFM 
(Baumgartner 1996). The actual measurement consists of the difference between the 
coil impedance when empty and that when the subject is inside, which is proportional 
to the FFM of the subject (Baumgartner 1996). TOBEC measurements are highly 
precise (< 2 %); however multiple factors affect the accuracy of TOBEC predictions 
of body compositions (Baumgartner 1996). One of the greatest sources of error is the 
method of calibration of predictive equations used to convert the TOBEC 
measurement into body composition. Most TOBEC equations for predicting percent 
body fat or FFM have been calibrated against estimates of body density by underwater 
weighing. The technical error of measurement of body density by underwater 
weighing can result in an error of about ± 2.5 % body fat or about ± 1 kg FFM in 
healthy young adults, and is likely to be greater in children, the elderly and sick 
patients (Baumgartner 1996). Therefore, for these groups it is best to use predictive 
equations that have been calibrated against estimates from multi-compartment models 
(Baumgartner 1996). Currently, few such equations are available for either BIA or 
TOBEC. In conclusion, TOBEC is precise, safe, easy to perform, quick, and well-
tolerated by most subjects, however its use is limited due to its lack of appropriate 
predictive equations in certain groups, including children, as well as its high cost and 
cumbersome equipment.  
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2.4.2.9 Imaging techniques 
Computed tomography (CT) is a modern radiographic method that can be used to 
determine regional body composition. This approach relates small differences in x-ray 
attenuation to differences in the physical density of tissues to construct a two-
dimensional image of the underlying anatomy in the scanned area, which allows 
separate recognition of bone, fat tissue, and lean tissue (Despres et al. 1996; Lukaski 
1987). Using sophisticated software programs, the cross-sectional area of fat, bone, 
muscle or organ can then be determined for each image. However, because of the 
exposure to relatively high levels of ionizing radiation (dose equivalent of 1.5 to 3.0 
mSv), routine whole-body scans, particularly in children, are not recommended 
(Lukaski 1987). Furthermore, the high cost of the scanners prohibits its use for this 
purpose.  
Magnetic resonance imaging (MRI) is a relatively new method with great potential for 
safe, radiation-free, non-invasive, direct assessment of human body composition. This 
approach is based on the fact that atomic nuclei can behave like magnets (Despres et 
al. 1996). When an external magnetic field is applied across a part of the body, each 
nucleus attempts to align with the external magnetic field. Having aligned the protons 
in a known direction, a pulsed radio frequency (RF) field is applied to the body tissues 
causing many protons to flip, or absorb energy (Despres et al. 1996). When the RF 
field is turned off, the protons gradually return to their original positions, and they 
release the energy they absorbed in the form of an RF signal. This signal is used to 
generate the MRI images by computer. Like CT, the MRI produces a cross-sectional 
image that allows distinction between bone, muscle and fat. This technique is in its 
early stages of development and validation to assess body composition. Several 
studies have shown wide variability of precision in measuring fat tissue, particularly 
56 
Chapter 2 
LITERATURE REVIEW 
in the abdominal region (Despres et al. 1996). There is little evidence regarding the 
precision of MRI measures of lean tissue. However, because multiple images can be 
obtained without any known health risks to the subject, MRI, unlike CT, is suitable 
for assessment of whole body composition analysis. Yet its high cost, limited 
availability and lack of validation studies limits its use for this purpose at this stage.  
In summary, the technique of choice depends on many factors:  
▪ The test population - if it is to be used with children, the technique needs to be 
suitable for children, for example minimal or no exposure to radiation, minimal 
co-operation required from the child, and preferably non-invasive and painless. In 
addition, the technique must have been validated on children or have reference 
data available for children. 
▪ The compartment of interest - the technique of choice will depend upon which 
compartment or compartment model is to be tested. 
▪ The precision and accuracy - precision and accuracy vary with the different 
techniques. The level of precision and accuracy required will depend upon what 
the aim of the study is. For longitudinal studies, where change is being measured, 
precise techniques are required. If the technique is being used for a validation 
study, both precision and accuracy are important.  
▪ The cost - the cost of many of the sophisticated techniques inhibits their use. 
▪ The availability and practicability - some of the sophisticated techniques, such as 
those used to measure TBW and TBN, may not be widely available, and/or are 
limited to a laboratory setting, and are therefore not practical for use in a clinic or 
community setting. 
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▪ Assumptions - nearly all techniques include some assumptions. These 
assumptions need to be considered and whether they hold true in the test 
population. 
All of these factors need to be taken into account when choosing a method, or 
methods, to measure body composition, particularly in children. Many of the simpler 
methods, such as skinfold anthropometry and BIA, are cheaper, portable, safe, and 
require minimal co-operation from the subject, but include many assumptions, and 
therefore may lack in precision and/or accuracy. Whereas the more sophisticated 
methods, such as DXA, dilution techniques to measure TBW, imaging techniques, 
and NAA, may be more precise and accurate, but are expensive, not widely available 
or portable, require highly trained personnel, and may involve exposure to radiation. 
The investigator must therefore weigh up the advantages and disadvantages of each 
method. 
2.4.3 Methods suitable for measuring body composition in children with 
cerebral palsy 
Measuring the body composition of children with CP can be difficult due to their 
limited ability to co-operate because of involuntary muscle spasms and musculo-
skeletal deformities. Furthermore, none of the techniques available have been 
properly validated in children with CP, and hence rely on the assumption that the 
proportions of the components of FFM do not differ significantly to that of healthy 
children. These factors were taken into consideration when choosing appropriate 
methods for the studies in this thesis. Other factors that were taken into account 
included the suitability of the technique for children, availability of reference data, 
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Table 2.3 Summary of advantages and disadvantages of body composition techniques 
Technique Compartment 
Measured 
Advantages Disadvantages 
Air displacement 
plethysmography 
Body density 
FM & FFM 
 Quick, comfortable, non-invasive 
 Precise 
 Suitable for children 
 Contains several assumptions in the conversion of body density to body 
composition 
 Questionable accuracy 
 Expensive, limited availability, requires skilled operators 
 Not validated in children with CP 
Bio-electrical impedance 
analysis & 
Total body electrical 
conductivity 
TBW 
FM & FFM 
 Quick & non-invasive 
 BIA is portable & inexpensive 
 Precise 
 Minimal subject co-operation required 
 Suitable for children 
 Indirect measure 
 Accuracy dependent on choice of equation to convert measures to body 
composition 
 TOBEC is expensive & non-portable 
 Not validated in children with CP 
Computed tomography Bone 
FM & LTM 
 Non-invasive 
 Direct assessment 
 Involves high level of radiation, therefore not suitable for children 
 Expensive, non-portable, requires skilled operators 
 Limited availability 
 Measures cross-sectional, not whole body, body composition 
 Requires further validation studies to determine accuracy & precision 
Densitometry Body density 
FM & FFM 
 Gold standard technique for measuring 
body density 
 Accurate & precise in healthy adults 
 Requires high level of subject co-operation 
 Contains several assumptions in the conversion of body density to body 
composition 
 Not suitable for children 
Dual-energy x-ray 
absorptiometry 
BMC & BMD 
PBF & LTM 
 Gold standard technique for measuring 
BMC & BMD 
 Quick, low radiation dose 
 Precise 
 Suitable for children 
 Requires a certain level of subject co-operation 
 Expensive, limited availability, requires skilled operators 
 Contains assumptions in the measurement of PBF & LTM 
 Not validated to measure PBF & LTM in children with CP 
Table continued on next page……………………………..
 
 
 
 
Technique Compartment 
Measured 
Advantages Disadvantages 
Isotope dilution TBW 
FM & FFM 
 Gold standard technique for measuring 
TBW 
 Good accuracy & precision 
 Suitable for children who have good 
oral skills 
 Minimal subject co-operation required 
 Expensive & time consuming 
 Requires specialised laboratory equipment & skilled technicians 
 Limited to a laboratory setting 
 Conversion of TBW to FFM assumes normal hydration 
 Not validated to measure FM & FFM in children with CP 
Magnetic resonance 
imaging 
Bone 
FM & LTM 
 Safe, radiation-free 
 Non-invasive 
 Direct assessment 
 Expensive, non-portable equipment & limited availability 
 Requires highly trained operators 
 Measures cross-sectional, not whole, body composition 
 Requires further validation studies to determine accuracy & precision 
Neutron activation 
analysis 
TBP  Directly measures TBP 
 High precision & accuracy 
 Machines with low radiation dose are 
suitable for children 
 Minimal subject co-operation required 
 Variable radiation dose with different machines 
 Expensive, non-portable, limited availability 
 Requires skilled operators 
Skinfold anthropometry Skinfolds 
thicknesses 
Body density 
FM & FFM 
 Simple to use, inexpensive, non-
invasive, portable 
 Suitable for children 
 Minimal subject co-operation required 
 Variable precision & questionable accuracy 
 Contains several assumptions in the measurement of skinfolds & in the 
conversion of body density to body composition 
 Not validated in children with CP 
Total body potassium FM & FFM  Good precision & accuracy  Requires expensive equipment & highly trained operators 
 Limited availability 
 Assumes potassium is in constant concentration in FFM – invalid 
assumption in children due to chemical immaturity 
 Not validated in children with CP 
BIA, bioelectrical impedance analysis; BMC, bone mineral content; BMD, bone mineral density; CP, cerebral palsy; FFM, fat-free mass; FM, fat mass; LTM, 
lean tissue mass; PBF, percent body fat; TBW, total body water; TOBEC, total body electrical conductivity  
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exposure to radiation, invasiveness, accessibility of the equipment and trained 
operators, precision and accuracy, and the compartment of interest. The methods used 
in the studies described in this thesis included anthropometry to measure FM and 
FFM, NAA to measure TBP, and DXA to measure BMC, thereby providing a three-
compartment (3C) model of body composition, with TBW being the only component 
missing. Each of the methods is discussed in more detail in Chapter 3. 
2.4.4 Studies of body composition in children with cerebral palsy  
There have been limited studies of body composition in children with CP. Most of 
these studies have focused on measures of growth (height and weight) and fat stores, 
with very little or no investigation of the other compartments of the body, e.g. water, 
bone, and protein. However the studies that have been done in children with CP 
suggest that their body composition is significantly different from that of physically 
active children (see Table 2.4, pg 66). This presents a problem when using many of 
the simpler techniques, such as skinfold anthropometry, to assess body composition. 
Most techniques are derived, or validated, from studies of healthy physically active 
children and/or are based on the assumption that the different compartments of the 
body are in the same proportion to that of the population from which the technique 
was validated, e.g. that the hydration of FFM is 73.2 %, and/or that the ratio of protein 
to bone is fixed. If these assumptions do not hold true in the test population, e.g. 
children with CP, then the method may not provide an accurate assessment of body 
composition. 
Body composition is particularly important to measure in children with CP, not only 
because of the above-mentioned problems but also, because of the difficulties in 
assessing and interpreting growth parameters (weight and height) in this population. 
Studies have shown that many children with CP are stunted and wasted, yet there has 
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been little investigation into which compartments of the body are altered (Ruby and 
Matheny 1962; Samson-Fang and Stevenson 2000; Stallings et al. 1993a; Stallings et 
al. 1995; Sterling 1960; Tobis 1961). There have been limited studies on body water 
and bone mineral in children with CP, which are described below, but none measuring 
body protein. 
2.4.4.1 Body water in children with cerebral palsy 
Berg & Isaksson conducted the first study of body water in children with CP using 
tritiated water in 23 children with mild CP (Berg and Isaksson 1970). The authors 
used the measurement of TBW to estimate FM and FFM, using an assumed hydration 
factor of FFM of 78 %. In agreement with earlier studies, the growth data showed that 
the children were shorter and lighter for age; however, they had a normal or increased 
weight-for-height. In addition, the children had a lower FFM than predicted for 
height; a mean of 86 % of predicted. The authors stated that in normal subjects muscle 
mass comprises 70 % of FFM, therefore the reduced FFM found in these subjects was 
hypothesised to be due to a reduced muscle mass from low physical activity and 
malnutrition. Interestingly, the mean measured TBW was higher than predicted (115.9 
%) from reference data based on measurements of healthy children. Furthermore, 
when expressed per kilogram of FFM, the measured TBW was also higher than 
predicted (1.85 kg versus 1.34 kg respectively). The authors reported that the 
increased TBW appeared to be due to an increase in the extracellular water which was 
estimated from total exchangeable potassium measurements. Body fat was increased 
in only seven of the participants, reduced in five, with no difference in 11, compared 
with predicted values. Therefore, the authors concluded that the apparent overweight 
seen in this population was due to the increased extracellular water, not body fat. Low 
serum albumin levels have been associated with malnutrition and increased 
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extracellular water; however, serum albumin levels were not measured in this study. 
Although the authors did report that the amount of protein consumed was lower than 
recommended in four of the 19 participants in whom dietary intake was observed. 
The next detailed study of body composition was not conducted until around 20 years 
later (Bandini et al. 1991). The authors used deuterium oxide (D2O) to measure TBW, 
and to derive FFM, and FM in 13 adolescents with mild to severe CP, as well as a 
control group. Again in agreement with previous studies, all of the participants with 
CP had a low height, and most had a low weight, for age. In the children with CP, the 
ratio of ECW (measured by bromide) to TBW (49.5 %) was slightly higher than 
reported in the literature, indicating an increase in ECW (Shizgal 1987). In contrast to 
the findings of Berg & Isaksson, TBW as a percentage of body weight was not 
increased, although the values were not reported. Total FFM in the children with CP 
was significantly lower than in the control group, but the children with CP were 
shorter and lighter than the control group, and no adjustments were made for body 
size. In contrast, in most of the children with CP body fat exceeded the 90th centile for 
age, and on average was higher than the control group, suggesting that this group of 
children were not representative of the general CP population. In this study, the 
authors used an assumed hydration constant of FFM of 73.2 %, an assumption which 
has not been proven to hold true in children with CP. It has been suggested that the 
hydration of FFM may in fact be higher in children with CP, as increases in body 
water have been found in association with malnutrition (Shizgal 1987). The reduced 
height and weight found in this group is suggestive of chronic malnutrition. An 
increased hydration of FFM would diminish calculated FFM resulting in an increased 
body fat. Therefore, the high percentage of body fat, and reduced FFM, found in the 
CP group could be due to an error from using an assumed hydration constant of FFM.  
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In a similar study, Azcue at al measured TBW using D2O in 13 children with spastic 
quadriplegic CP and four control children (Azcue et al. 1996). Body FM and FFM 
were determined by both skinfold anthropometry and by TBW measurements using 
73.2 % as the assumed hydration factor of FFM. The authors did not report the values 
obtained for FM and FFM by TBW, but stated that they were similar to those obtained 
by skinfold anthropometry, which were lower than the control group. Furthermore, 
the results for TBW were not expressed as a percentage of body weight, or compared 
with control children, so the results are difficult to compare with previous studies. 
However, they did report that the ICW space as a percentage of body weight was 
significantly decreased in the children with CP (27 %) compared with control children 
(47 %). It was not elucidated whether this was due to a decrease in TBW or an 
increase in ECW as was found in the two previous studies. In the study by Azcue et al 
ICW was calculated by subtracting the measured ECW from the measured TBW.  
Van den Berg-Emons et al hypothesized that the available skinfold equations derived 
for healthy children to predict FM might overestimate FM in children with CP as the 
density of FFM may be lower in children with CP (van den Berg-Emons et al. 1998). 
They used anthropometry and D2O dilution to compare measures of FM and FFM in 
22 children with moderate to severe CP and 10 control children. They chose two 
equations that are commonly used to derive FM from skinfold thicknesses; that of 
Durnin & Rahaman, which uses the triceps, biceps, suprailiac and subscapular 
skinfold thicknesses, and that of Slaughter which uses the triceps and subscapular 
skinfold thicknesses only (Durnin and Rahaman 1967; Slaughter et al. 1988). In the 
children with CP, the average percentage body fat (PBF) determined by TBW was 
28.6 %, by Durnin & Rahaman was 22.5 %, and by Slaughter was 20.2 %, which was 
significantly higher than in the control group, 15.9 %, 17.4 %, and 13.7 %, 
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respectively. Therefore, in contrast to what was hypothesised, and in contrast to the 
findings of Bandini, in the children with CP, PBF predicted from skinfold 
anthropometry was considerably lower than that determined by the TBW method. 
Stallings et al found the same result using similar methodology in their study of 
children with spastic quadriplegic CP (Stallings et al. 1995). The authors hypothesised 
that this may be explained by a proportionally large internal fat deposit, possibly due 
to higher levels of body fat, which would not be measured using skinfold 
anthropometry. Furthermore, in the study by van den Berg-Emons, TBW as a 
percentage of body weight was significantly lower in the children with CP than in the 
controls (54 % versus 64 % respectively), which contrasts with the studies by Berg & 
Isaksson and Bandini et al. The authors suggest that this discrepancy of a lower 
amount of water per kg of body weight might be explained by the increased body fat 
in the children with CP compared with the control group. As with the previous TBW 
studies, the authors also used assumed hydration factors for the estimation of FFM, 
but in contrast to the other studies the authors used hydration factors specifically for 
children, which are higher than 73.2 % used for adults; 76 % and 77 % for healthy 
boys and girls respectively, and 75 % and 77 % for boys and girls with CP, 
respectively.  
In summary, these studies concentrated on estimating FM more accurately in children 
with CP, rather than studying FFM or body protein. In addition, their method of 
estimating FM and FFM from TBW is of questionable validity due to the use of 
various assumed hydration factors, and therefore it is not possible to draw any 
conclusions from these studies. One way to determine the hydration of FFM is to 
measure both TBW and TBP. However, the direct measurement of body protein has 
never been performed in children with CP. 
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Table 2.4 Studies of growth and body composition in children with cerebral palsy in chronological order 
Author/s Participants Methods Findings 
(Leamy 1953) N = 21; 4 – 20y 
All types of CP 
Bone age  The average skeletal age of the group was 107 months compared with 119 months of chronological age 
(Sterling 1960) N = 100; 6mo – 19y 
All types of CP 
Height & weight  Average shorter & lighter than similar aged children without CP 
(Tobis 1961) N = 86; 5 – 18y 
All types of CP 
Height & weight  Average significantly shorter and lighter compared with American school children 
 Growth deviation correlated with degree of disability & intelligence 
(Ruby and 
Matheny 1962) 
N = 137; 2 – 18y 
Moderate-severe CP 
Height & weight  For height & weight, males were approximately 12-15 months below, and females 18 months below 16th 
percentile with athetotic children smaller than spastic children 
(Hammond et al. 
1966) 
N = 31; 7 – 16y 
All types of CP 
Height & weight 
Bone age 
 Average shorter & lighter than similar aged children without CP 
 Bone ages lagged up to 35 months behind standards for age 
(McIvor and 
Samilson 1966) 
N = 1232; 0 - >40y 
All types of CP 
Observation  Children with CP have an increased fracture rate 
 In 52% the cause of fracture was undetermined 
(Pryor and 
Thelander 1967) 
N = 179; 1 – 15y 
All types of CP 
Height  Height was within the normal range until 10y, then declined perhaps reflecting failure of the adolescent 
growth spurt 
(Berg and Isaksson 
1970) 
N = 23; 7 – 20y 
All types of CP 
Height & weight 
TBK, TBW 
 Average shorter & lighter for age, but normal or increased weight-for-height 
 Lower FFM than predicted for height, and higher TBW than predicted 
(Bandini et al. 
1991) 
N = 13; 15 – 20y 
All types of CP 
Height & weight 
TBW 
 Average low weight and height for age 
 Increased ECW & FM, normal TBW, low FFM for age 
(Stallings et al. 
1993b) 
N = 154; 2 – 18y 
Diplegic- & 
hemiplegic CP 
Weight 
UAL, LLL, 
SA 
 On average reduced weight, LLL, UAL & triceps skinfold, normal subscapular skinfold, increased UAMA 
 Feeding problems were associated with a lower triceps skinfold 
(Stallings et al. 
1993a) 
N = 142; 2 – 18y 
Quadriplegic CP 
Weight 
UAL, LLL 
SA 
 Greater reduction in LLL than UAL, average weight & triceps skinfold reduced to 60%, subscapular 80%, 
and UAMA 90% of normal 
 Both disease & nutrition contribute to linear growth 
(Stevenson et al. 
1994) 
N = 171; 10mo – 16y 
Mostly severe CP 
Weight 
Height/length 
UAL, LLL, SA 
 On average, significantly reduced height & weight, & triceps skinfold 
 Height declined with advancing age 
 Conclusion – both nutrition & disease contribute to linear growth  
 
 
 
(Lingam and 
Joester 1994) 
N = 5; 10 – 19y 
All types of CP 
Observation  Children with CP have a tendency to sustain spontaneous fractures due to poor muscle support of the 
long bones 
(Henderson et al. 
1995) 
N = 139; 3 – 15y 
Moderate-severe CP 
SA, DXA  BMD severely diminished in distal femur, and to a lesser extent in lumbar spine 
 Fractures had occurred in ¼ of children >10y 
(Stallings et al. 
1995) 
N = 136; 2 – 12y 
Quadriplegic CP 
Height & weight 
SA, TBW 
 Significantly reduced height & weight, average triceps skinfold 61% and subscapular skinfold 88% of 
normal; reduced rate of accretion of FFM, lower PBF by SA than by TBW 
(Stevenson et al. 
1995) 
N = 20; 3 – 18y 
Spastic hemiplegia 
Height & weight 
SA, bone age 
 All measures of breadth, circumference & length were significantly smaller, except for skinfold 
thicknesses, on the affected side of the body concluding that CP impacts on growth independently of 
nutrition 
(Stevenson 1995b) N = 172; < 12y 
All types of CP 
Height 
UAL, LLL, KH 
 Developed set of equations to convert UAL, LLL & KH to standing height 
 
(Krick et al. 1996) N = 360; 1mo – 10y 
Quadriplegic CP 
Weight & length  Sought to develop growth charts for children with CP 
 Due to flawed methodology these charts are not recommended for use 
(Azcue et al. 1996) N = 13; 2 – 16y 
Quadriplegic CP 
Height & weight 
SA, TBW 
 Reduced height & weight compared with control group, but normal weight-for-height 
 Reduced FM, FFM & ICW 
(Henderson 1997) N = 43; 2 – 5y 
Quadriplegic CP 
Weight 
DXA, vitamin D 
 BMD fell further below normal with increasing age 
 Vitamin D levels & weight were not predictive of fracture 
(van den Berg-
Emons et al. 1998) 
N = 22; 7 – 13y 
Moderate-severe CP 
Height & Weight 
SA, TBW 
 Higher PBF than control group 
 TBW produced higher PBF than SA 
(Samson-Fang and 
Stevenson 1998) 
N = 81; 1 – 12y 
All types of CP 
Growth velocity  Lower growth velocity was seen in children <2y, males, non-ambulatory children, malnourished children 
& those with cognitive impairment 
(Samson-Fang and 
Stevenson 2000) 
N = 276; 3 – 12y 
All types of CP 
Height & weight 
SA 
 Weight-for-height was not a good indicator of malnutrition in children with CP 
 Best indicator of suboptimal fat stores was triceps skinfold thickness 
(Henderson et al. 
2005) 
N = 69; 2 – 18y 
Moderate-severe CP 
DXA  First longitudinal study of BMD; overall BMD increased, but at a slower rate than normal children 
 Children with a higher triceps skinfold experienced greater increases in BMD 
BMD, bone mineral density; CP, cerebral palsy; DXA, dual-energy x-ray absorptiometry; ECW, extracellular water; FFM, fat-free mass; FM, fat mass; ICW, 
intracellular water; KH, knee height; LLL, lower leg length; PBF, percent body fat; pQCT, peripheral quantitative computed tomography; SA, skinfold 
anthropometry; TBW, total body water; UAL, upper arm length; UAMA, upper arm muscle area 
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2.4.4.2 Bone mineralisation in children with cerebral palsy 
Although delayed bone age in children with CP has been recognised since the early 
1950s, the first hint that bone mineralisation was decreased came with the report by 
McIvor et al in 1966 who found an increased fracture rate in children with CP 
(Hammond et al. 1966; Leamy 1953; McIvor and Samilson 1966). They reported that 
of the 134 fractures (in 92 children) over a 10-year period, the majority of the children 
had spastic quadriplegic CP, and in 70 of the fractures, the mechanism of injury was 
unknown. Almost 30 years later, Lingam & Joester reported that children and 
adolescents with CP have a tendency to sustain spontaneous fractures (Lingam and 
Joester 1994). They hypothesised that spontaneous fractures are due to poor muscle 
support to the long bones. Henderson found that most fractures in children with CP 
involved the femur, and agreed with Lingam & Joester that most resulted from 
minimal trauma or without any specific traumatic event recognised (Henderson 1997). 
They also found that the occurrence of fractures correlated with history of long 
periods of immobilisation after surgery. 
A small study (n = 13) of children with severe CP showed that one reason this 
population has an increased fracture rate is because they have smaller and thinner 
bones thereby compromising bone strength (Binkley et al. 2005). Further reasons for 
increased fracture rates and poor bone mineralisation in children with CP are 
discussed in the following section. 
2.4.4.3 Causes of poor bone mineralisation 
Hypotheses for the poor bone mineralisation found in children with CP can again be 
divided in to nutritional and non-nutritional factors. Non-nutritional contributing 
factors are lack of weight bearing activity; periods of immobilisation after multiple 
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operative procedures; anticonvulsant medication interfering with vitamin D 
metabolism; lack of exposure to sunlight; and metabolic bone disease associated with 
prematurity. Nutritional factors include oral motor dysfunction resulting in poor 
nutrition and low calcium intake (Henderson et al. 1995). 
2.4.4.3.1 Studies investigating causes of poor bone mineralisation 
Roberts et al and Lin & Henderson attempted to investigate whether the poor bone 
mineralisation found in children with CP was related to the underlying brain injury or 
to concomitant malnutrition (Lin and Henderson 1996; Roberts et al. 1994). The 
authors chose to study children with spastic hemiplegic CP in order to use their 
unaffected side as the control. All of the children chosen for the study had normal 
growth, that is, height and weight for age between the 5th and 95th, and “normal” 
triceps skinfold thickness. These criteria were chosen in order to better characterise 
the influence of non-nutritional factors on skeletal maturation. The results showed that 
the skeletal age, BMC, BMD, bone size, and LTM of the affected side was less than 
that of the unaffected side in all patients, however there was no difference in fat 
content. The authors found a significant correlation between the skeletal age and the 
severity of disability which supports an association between functional use of the 
extremity and bone maturation. However, the authors commented that relative disuse 
and lack of purposeful activity may have contributed to the diminished muscle mass 
and BMC in the affected limb. These findings support the hypothesis that at least 
some of the poor bone mineralisation seen in children with CP is unrelated to 
malnutrition.  
Henderson et al also sought to analyse the effects of a variety of factors on lumbar and 
femoral BMD in a large group of children with various severities of spastic CP 
(Henderson et al. 1995). The authors found that current functional level of walking 
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and nutritional status correlated highly with both femoral and lumbar BMD measured 
by DXA. In addition, those children with low calcium intakes (< 500 mg/day) had a 
significantly lower BMD than those children with high calcium intakes (> 500 
mg/day). Multiple regression analysis showed that the best predictor of BMD was 
ambulatory status followed by nutritional status; again supporting the hypothesis that 
bone mineralisation in children with CP is influenced by several factors.  
A more recent study by Henderson et al found that BMD measured by DXA was 
severely diminished in the distal femur, and to a lesser extent in the lumbar spine in a 
large group (n = 117) of children with moderate to severe CP (Henderson et al. 
2002a). Fractures had occurred in one-quarter of the children older than 10 years of 
age, and were more common in non-ambulatory children. There was a relation 
between advancing age and declining BMD SD scores in the distal femur, but not the 
lumbar spine. Osteopenia, defined as a BMD SD score of less than -2, was found in 
97 % of all study participants who were unable to stand and were older than 9 years. 
In addition, there was a negative correlation between severity of disability and BMD 
SD score of the distal femur. Height, weight and triceps skinfold thickness SD scores 
correlated with BMD SD scores of the distal femur, suggesting that an improved 
nutritional status could improve bone mineralisation. However, in contrast with their 
earlier study, calcium intake did not correlate with BMD SD scores (Henderson et al. 
1995). Overall they found that the severity of CP, increasing difficulty in feeding, use 
of anti-epileptic medications and lower triceps skinfold thickness (in decreasing order 
of importance) all independently contributed to lower BMD SD scores in the distal 
femur. 
All of the previous studies compared the bone mineralisation of children with CP with 
healthy age-matched controls, and therefore the presence of growth stunting may have 
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influenced the interpretation of the results. So it may be plausible that the children 
with CP had a lower bone mineralisation than healthy age-matched peers. Therefore, 
Chad et al compared the BMC and BMD, measured by DXA, of children with CP 
with healthy controls of similar development (measured by pubertal status) rather than 
chronological age (Chad et al. 2000). The mean BMC and BMD of children with CP 
was -0.5 SD score compared with developmental age-matched controls, in 
comparison to -1.8 SD score compared with chronological age-matched controls. 
King et al reported similar results when correcting lumbar BMD for bone age (King et 
al. 2003). However, this raises several questions. How should one interpret the bone 
mineralisation of stunted children with CP? Which interpretation is more correct? Is it 
acceptable for stunted children with CP to have a lower bone mineralisation than 
children of the same age, yet the same bone mineralisation of a younger child of the 
same developmental age or size, i.e. height? Are these children still at risk of fractures 
in later life? Only a longitudinal study measuring bone mineralisation could answer 
these questions.  
There has been only one longitudinal study of bone mineralisation in children with CP 
(Henderson et al. 2005). The authors studied the BMD of 69 children with moderate 
to severe spastic CP (44 children with quadriplegic CP). There were a total of 164 
follow-up evaluations. The time interval between the initial and second evaluations 
ranged from 1.5 to 49.7 months (median 21.5 months). Forty-six participants had a 
third evaluation, 25 a fourth, and 10 had five to nine evaluations. The authors reported 
that BMD increased by a median of 2 to 5 % per year, with a wide range of + 42 % 
per year to -31 % per year. Yet, despite the finding of an overall increase in BMD, 
BMD SD scores actually decreased which reflects that the BMD of the children with 
CP in the study did not increase at the same rate as normal children. The change in 
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BMD per year was found to be correlated with nutritional status: those children with a 
higher triceps skinfold SD score experienced the greatest change in BMD per year. 
The change in BMD per year was not statistically related to age, gender, pubertal 
stage, use of anti-epileptic medications, GMFCS level, difficulty in feeding, height, 
weight, or general health as assessed by the Child Health Questionnaire (Landgraf et 
al. 1996).  
2.4.4.3.2 Bone mineralisation and intervention studies 
It is well known that immobilisation predisposes to bone resorption and decrease in 
formation, which can reduce BMD leading to an increased risk of fractures (Shaw et 
al. 1994). However it is difficult to change the ambulation status of children with CP. 
Chad et al attempted to improve the bone density of non-ambulatory and ambulatory 
children with CP using an eight-month load-bearing physical activity intervention trial 
(Chad et al. 1999). Compared with a similarly disabled control group, statistically 
significant increases in femoral neck BMC (9.6 %), volumetric BMD (5.6 %), and 
total proximal femur BMC (11.5 %) were observed in the intervention group. Even 
though these results were statistically significant, it is questionable as to whether they 
were clinically significant. In addition, the authors did not comment if there was a 
difference in bone mineral gain between the ambulatory and non-ambulatory children. 
Of the nutritional and non-nutritional factors contributing to poor bone mineralisation 
of children with CP, theoretically it should be easier to change nutrition rather than 
ambulatory status. The only study reporting a nutritional intervention is that of 
Jekovec-Vrhovsek et al (Jekovec-Vrhovsek et al. 2000). They conducted a 
longitudinal cohort study to determine the effect of vitamin D (0.25 ug/day) and 
calcium supplementation (500 mg/day) on lumbar BMD in a group of non-ambulatory 
children with CP. After the nine-month supplementation period, they found that 
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lumbar BMD greatly increased in the treated group (n = 13) (0.383 vs. 0.476 g/cm2), 
while in the observed group (n = 7) lumbar BMD significantly decreased (0.393 vs. 
0.315 g/cm2). There was no significant change in body weight over the study period in 
either group. However, total dietary calcium intake was not assessed in either group, 
and the level of supplementation of calcium was relatively low; therefore, it is 
unknown whether the intervention group did in fact have a significantly higher 
calcium intake than the control group. In addition, as Henderson et al reported, most 
fractures in children with CP occur in the femur, and lumbar BMD correlates only 
weakly with distal femur BMD, and thus studying lumbar BMD is less clinically 
relevant in this population (Henderson et al. 2002a). 
2.4.4.3.3 Treatment with bisphosphonates  
Until recently there was limited medical treatment for children with CP with reduced 
bone mineralisation. Bisphosphonate is an analogue of pyrophosphate and acts by 
inhibiting osteoclastic mediated bone resorption (Shaw et al. 1994). However, it is not 
licensed for use in children. Two recent studies have assessed the safety and efficacy 
of bisphosphonates to treat osteopenia in children with spastic quadriplegic CP. 
Henderson et al conducted an 18-month randomised, placebo-controlled, double-
blinded trial of 12 non-ambulatory children with spastic quadriplegic CP (Henderson 
et al. 2002b). To ensure adequate calcium intakes each child was given 1000 mg/day 
of calcium, as well as a multivitamin supplement containing vitamin D. They 
measured BMD by DXA in the distal femur and lumbar spine at three-monthly 
intervals. BMD increased by 89 % over 18 months in the study group compared with 
9 % in the placebo group, and by 33 vs. 15 % in the lumbar spine. BMD age SD 
scores increased from -4.0 to -1.8 in the distal femur in the study group, but did not 
change in the placebo group. 
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Shaw et al found similar results after treating three non-ambulatory children with 
severe CP with bisphosphonates over 12 to 18 months (Shaw et al. 1994). The three 
children treated had a 20 to 40 % increase in lumbar BMD SDS for age, femur BMD 
was not measured. There was no significant change in lumbar BMD SD scores for 
two untreated children over the same period.  
However, some reservations remain about the use of bisphosphonates in growing and 
maturing bones. At present their use in children remains experimental, and therefore, 
although bisphosphonates show promising results in children with CP, the treatment is 
not readily available. Current research and treatment must therefore focus on altering 
the recognised causes of poor bone mineralisation in children with CP. The level of 
ambulation is difficult to change; however, nutritional variables can be altered. Yet 
no-one has studied the impact of nutritional rehabilitation on bone mineralisation.  
2.5 Energy expenditure in children with cerebral palsy 
Researchers from the 1950s and 1960s believed that the energy requirements of 
children with CP varied depending on the type of CP, with athetoid type CP having a 
seemingly higher energy expenditure requiring a larger number of calories to maintain 
an ideal weight, and spastic type CP having a lower energy and calorie requirement 
(Hammond et al. 1966; Leamy 1953; Phelps 1951; Ruby and Matheny 1962). Phelps 
was the first to describe the energy requirements of the different types of CP, 
observing that children with spastic CP “do not move around very much, they do not 
burn up the food; they store it, and tend to put on weight easily” (Phelps 1951). 
Therefore, it was recommended that their diet be limited in energy. In contrast, Phelps 
described children with athetoid type CP as “constantly moving, burning up energy 
and are usually too thin. It is almost impossible to keep them up to a normal weight 
on an average diet”, and recommended that the children with athetoid type CP have a 
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higher energy diet. Similarly, Karle et al noted that "spastics tend to avoid exercise 
and overweight may become a problem. Thus an intake of calories below the 
recommendations may be desirable” (Karle et al. 1961). 
Similar observations were made in a small pilot study (n = 5) of children with varying 
degrees of spastic and athetoid type CP: "some athetotic children remain extremely 
thin and emaciated; other children whose palsy will permit practically no physical 
activity become obese and grossly overweight" (Eddy et al. 1965). The authors 
weighed duplicate samples of meals over a six-day study period to determine energy 
intake. In addition, they attempted to measure basal metabolism by collecting 
expiratory air in a Douglas bag while the subject was still in bed prior to breakfast, 
and total daily energy expenditure by measuring heat expenditure during various 
activities with a Wolff integrating motor pneumotachograph. Overall they found that 
total energy requirements and energy intakes were less than that of normal children 
the same age, but comparable to children of the same size. Despite this observation, 
some researchers and clinicians still believed for many years that the poor growth 
observed in children with CP was due to increased energy expenditure (Sterling 1960; 
Stevenson et al. 1994). 
More recently Bandini et al studied the resting energy expenditure (REE) and total 
energy expenditure (TEE) of 13 adolescents with CP using a combination of indirect 
calorimetry and the doubly-labelled water method (Bandini et al. 1991). They found 
that the measured REE did not differ significantly from that predicted from the World 
Health Organisation (WHO) equations (World Health Organisation 1983); however, it 
was significantly lower when compared with the control group. The ratio TEE/REE is 
an expression of the amount of energy expended above resting and represents the 
energy spent on activity and the thermic effect of food. Overall the ratio of TEE/REE 
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was significantly lower in the non-ambulatory children with CP (n = 6) than the 
controls (1.23 versus 1.76 respectively), but not in the ambulatory children with CP (n 
= 3). The results suggested that energy requirements were lower in the non-
ambulatory children with CP because their physical activity was limited. However, 
because of the study’s small sample, the effect of the type of disability and abnormal 
muscle movements on energy expenditure could not be elucidated.  
Stallings et al studied the energy expenditure of 61 non-ambulatory children aged two 
to 18 years with spastic quadriplegic CP and in a normal control group (Stallings et al. 
1996). REE was measured by indirect calorimetry in 61 children with CP and 37 
controls, while TEE was measured by doubly-labelled water in a subset of 32 children 
with CP and in 32 controls. REE expressed as a percentage of that predicted from the 
WHO equations was significantly lower in the CP group compared to controls (91 % 
versus 105 %). Furthermore, the TEE of the children with CP was significantly lower 
than the control group when expressed as kJ/kg/day. The ratio of TEE to REE was 
similar to that reported by Bandini et al and was significantly lower in the CP group 
(1.23) than in the control group (1.57) (Bandini et al. 1991). In summary, the 
measured REE and TEE showed that energy expenditure was not excessive and was 
far less than that required for healthy children of similar size.  
Azcue et al studied the REE by indirect calorimetry of exclusively gastrostomy tube-
fed children with spastic quadriplegic CP (Azcue et al. 1996). The mean measured 
REE as a percent of predicted from the WHO equations, based on age and weight, in 
the children with spastic quadriplegic CP was 79 ± 21 % (range 50 to 112 %). Energy 
intakes were assessed by the volume of formula fed in a 24 hour period, and were on 
average 1.1 times the measured REE.  
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These studies indicate that the energy requirements of children with spastic 
quadriplegic CP are reduced. This conclusion was confirmed by a study of the energy 
intakes of a group of children and adolescents with spastic quadriplegic CP fed 
exclusively by gastrostomy tube (Fried and Pencharz 1991). These patients exhibited 
positive growth although their energy intakes were below recommendations for age. 
All of the children had weights above the 50th centile for age and sex, yet the average 
energy intake of the group was 61 % of the RDI for age (range 43 to 98 %). This 
study was interesting because it showed that even when adequate energy was 
provided to allow for growth, it was still significantly below that recommended, 
suggesting that the standard recommendations based on healthy active children are 
inappropriate for children with CP. This study also suggests that if children with CP 
have a sufficient energy intake, they can achieve adequate weight gain and growth. 
The abovementioned studies demonstrated that the standard WHO equations 
overestimate the energy requirements of children with CP. Therefore, Krick et al 
sought to develop a standardised method for estimating energy needs in children with 
CP (Krick et al. 1992). The energy needs were determined by monitoring the energy 
intake required to achieve a desired weight gain while the child was in hospital, based 
on a clinically defined ideal body weight. The formula they developed also took into 
account muscle tone, activity level, and energy for growth or catch-up growth. Thus 
the final equation was energy requirements (kcal/day) = basal metabolic rate x tone 
factor x activity factor + growth factor. The authors used height age rather than 
chronological age in the calculation. They then attempted to validate the formula by 
retrospective review of recorded body weight and formula intake from the medical 
records for 30 tube-fed hospitalised patients. To estimate actual energy needs, they 
monitored weight gain from admission to discharge. The authors then calculated 
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energy needs using their own formula and compared it with the WHO 
recommendation for age. The results showed that mean predicted energy needs from 
WHO was 90.6 kcal/kg, by the Krick formula 79.4 kcal/kg, and actual estimates while 
in hospital was 77.9 kcal/kg. However, this equation has not been properly validated 
for use in children with CP, as there was no comparison with measured energy 
expenditure by indirect calorimetry or doubly-labelled water; thus, the Krick formula 
may not be appropriate for estimating the energy requirements in children with CP. 
In summary, these studies showed that the recommended age-specific equations to 
estimate energy requirements based on neurologically intact active children, greatly 
overestimate the energy requirements of children with CP. However, despite the many 
years of research in this area, there are still no available equations to accurately 
estimate the energy requirements of children with CP. Thus the current 
recommendations are to either roughly estimate requirements using the currently 
available equations based on healthy children and adjust according to weight change, 
or to measure REE by indirect calorimetry. However, facilities for measuring REE are 
not available at all centres.  
2.6 Nutritional therapies in children with cerebral palsy 
The growth failure and undernutrition described in children with CP have often been 
accepted as inevitable and irremediable consequences of the disease (Sullivan et al. 
2000). Malnourished patients have decreased muscle strength, including respiratory 
musculature, with resultant impaired cough and predisposition to pneumonia. 
Malnutrition results in increased circulation times and diminished cardiac work 
capacity, resulting in cold and mottled peripheries. Malnutrition-related disturbances 
in immune function predispose to infection, particularly of the lungs and urinary tract 
(Chandra 1983). Healing of pressure sores is delayed. Cerebral growth, cognitive 
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development, and motor progress are impaired. Undernourished children show lower 
levels of exploratory activity and attachment behaviour which may affect social-
emotional development. Irritability and decreased activity have been described in 
undernourished children (Bax 1993; Samson-Fang et al. 2002; Samson-Fang and 
Stevenson 2000; Stallings et al. 1993a). In addition, undernourished children with CP 
have differences in body composition compared with normally developing peers. 
Alterations include increased TBW, severely depleted fat stores, depleted muscle 
mass, severe short stature and decreased bone density. The numerous untoward 
consequences of malnutrition are clinically significant, and it is now generally 
considered that malnutrition in children with CP is unacceptable and should be 
treated. 
The first line of treatment for undernutrition and dysphagia in children with CP is 
usually oral nutrition supplementation combined with speech therapy. If that fails, or 
if the dysphagia is so severe that swallowing is not safe, the next step is enteral 
feeding via a naso-gastric (NG) or gastrostomy tube. The following section describes 
each of these treatments in more detail. 
2.6.1 Oral nutritional supplementation 
If there is no risk of food aspiration, the first strategy in treating undernutrition is to 
increase the energy density of ingested food. This can be achieved by offering more 
energy-dense foods, or by adding fats and glucose polymers to food, as well as 
including specialised high energy drinks. In addition, an increase in the viscosity of 
liquids has resulted in a higher intake in some children as aspiration tends to occur 
more commonly with thin liquids (Nutrition Committee of the Canadian Paediatric 
Society 1994). In some cases, aspiration occurs with fatigue, and thus can be 
minimized by small, frequent meals or supplemental forms of nutrition. 
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Studies of nutritional rehabilitation using oral supplements in children with CP are 
limited. Hals et al studied 13 severely neurologically impaired institutionalised 
children, most with CP, to test if a fortified diet improved their nutritional status (Hals 
et al. 1996). The initial dietary assessment showed that intakes of energy and fat were 
well below the RDI, while protein was markedly above the RDI for age. They 
changed the diet based on these findings: they added more fish, meat and whole meal, 
and supplemented with 5 g of fish oil, 40 g of soya bean oil and 7 g of carbohydrate, 
yielding a total of 450 kcal energy supplementation, as well as a multi-vitamin and 
iron supplement. Prior to the intervention weight gain was approximately 200-300 
g/month; during the first month of the intervention weight gain increased to 600 
g/month; during the second month 500 g; the next seven months weight gain returned 
to approximately 250-300 g/month. Triceps skinfold thickness also increased 
significantly over the same time period. However, the authors did not report whether 
the observed weight gain was greater than would be expected for a child without 
disability, i.e. it was not elucidated if the children experienced catch-up growth or 
improved their weight centiles. 
2.6.2 Speech therapy 
Oral supplementation is usually prescribed in conjunction with speech therapy or oral 
motor exercises to overcome dysphagia and to help develop chewing and swallowing 
skills. The aims of speech therapy are to optimise oral intake by proper body 
positioning, jaw control, oral tactile preparation and proper presentation of food, in 
order to promote normal oral patterns such as jaw stability, lip closure, tongue 
movements, and co-ordinated sucking, chewing and swallowing (Ottenbacher et al. 
1983a). Children with CP eat more easily when they are well seated. Adaptive seating 
maintains an upright posture, and may improve head control, retention of food in the 
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mouth, and eating skills, and can decrease the risk of aspiration (Larnert and Ekberg 
1995). Specialised feeding utensils can improve the acceptance of food into the 
child’s mouth. In addition to these techniques, specific oral-motor programs have 
been developed; however, there is scanty evidence that oral motor therapy can 
permanently improve oral motor function and induce weight gain in children with CP 
(Fischer-Brandies et al. 1987; Ottenbacher et al. 1983a). 
The first research to evaluate the effectiveness of oral-motor treatment appeared in the 
mid 1970s. Since then relatively few studies in this area have been conducted, and 
these are highly variable, with different purposes, subject populations and 
independent and dependent variables (Ottenbacher et al. 1983a). Ottenbacher et al 
treated a group of severely and profoundly disabled children and young adults with 
oral motor exercises with the purpose of increasing their weight (Ottenbacher et al. 
1981). Analysis of the data revealed no statistically significant differences in body 
weight gain or in development of specific feeding behaviours over the nine-week 
treatment period. The authors report that two participants appeared to gain a large 
amount of weight compared to other participants, but this was masked by pooling the 
data for group analysis. A similar study by the same group of researchers showed that 
one out of the four children studied evidenced an increase in weight and improved 
oral motor evaluation as a result of the intervention (Ottenbacher et al. 1983b). 
Gisel et al treated several groups of children with moderate to severe CP with an oral 
sensorimotor programme for 10 to 20 weeks, with one study involving a randomised 
controlled trial (RCT) (Gisel et al. 1995; Gisel et al. 1996). There was no difference in 
length of mealtimes or eating duration of different textures; however a significant 
proportion of the children progressed to eating solids from mashed foods. There was 
no significant change in weight percentiles over the study period. 
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Haberfellner et al showed that functional feeding skills, as measured by spoon 
feeding, biting, chewing, cup drinking, and swallowing improved significantly after 
one year of intra-oral appliance therapy (Haberfellner et al. 2001). During the course 
of one year of treatment, children gained weight and height. This weight gain was 
sufficient for children to maintain their growth trajectory (i.e. there was no 
improvement in weight percentiles), but the weight gain could not be attributed to the 
therapy because it occurred during the control period and was the same in magnitude 
through the treatment phases. Gisel et al followed this group of children for a further 
year after cessation of the therapy (Gisel et al. 2001). No significant differences were 
found in functional feeding skills, and no significant differences in weight were 
found. 
Therefore, despite the use of intensive speech therapy programmes for long periods of 
time, many children with severe CP do not achieve minimal standards of growth with 
oral feeding alone. These children continue to spill a significant proportion of their 
food, cannot chew or swallow solids, and many have difficulty drinking or using a 
straw. As discussed in section 2.2.2.4, children with CP can take two to 18 times 
longer than controls to chew and swallow a standard amount of pureed food and one 
to 15 times longer for solid food. As a result some caregivers spend up to seven hours 
per day feeding their children and, combined with having to conduct daily speech 
therapy exercises, feeding can be an extremely time consuming process with little 
apparent gain. Furthermore, as the swallow reflex is a primarily involuntary and reflex 
activity, it is unlikely there will be much improvement with increasing age in this 
population (Jones 1989). For these children, tube feeding may become necessary to 
prevent or to treat malnutrition and to improve the quality of life for their families. 
82 
Chapter 2 
LITERATURE REVIEW 
2.6.3 Gastrostomy tube feeding 
Because of the difficulty in eating and drinking, many children with CP can achieve 
an adequate nutritional status only with tube feeding. In a cross-sectional study of 
both oral-fed and tube-fed children with CP, the presence of a gastrostomy tube was 
associated with higher fat stores and muscle mass, as assessed by anthropometry 
(Samson-Fang et al. 2002). Furthermore, each SD decrease in UAFA was associated 
with a 28 % increase in doctor visits, a 31 % increase in days missed from school, and 
a 51 % increase in missed activities for the family throughout the preceding four 
weeks, suggesting that children with a better nutritional status have an improved 
quality of life. Fung et al also reported in their cohort study of children with CP, that 
when the tube-fed children were compared with those of similar disability but who 
were fed orally, greater height, triceps, and subscapular SD scores and less respiratory 
illness were observed (Fung et al. 2002). In two other similar cross-sectional studies 
comparing oral-fed and tube-fed children with severe CP, children with a gastrostomy 
tube had a greater fat mass than those without; but interestingly, there was no 
difference in measures of muscle mass (Kong and Wong 2005; Stallings et al. 1995).  
However, apart from weight gain and an increase in fat stores, the effects of tube 
feeding for children with CP have not been clearly described. There is controversy 
about whether gastrostomy tube feeding may increase the risk of death or GOR 
(Heine et al. 1995; Lewis et al. 1994; Sleigh and Brocklehurst 2004; Smith et al. 
1999; Strauss et al. 1998). Sleigh & Brocklehurst attempted to conduct a review of 
systematic reviews and/or RCTs to determine the benefits and risks for gastrostomy 
tube feeding compared with oral feeding for children with CP, however no relevant 
studies were found (Sleigh and Brocklehurst 2004). They instead reviewed two cohort 
studies 15 case series, and eight case reports (Fung et al. 2002; Strauss et al. 1998). 
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One study reported a higher death rate for children fed by a gastrostomy tube but this 
may have merely reflected the greater disability of these compared with orally fed 
children (Strauss et al. 1998). No firm conclusions were able to be drawn about 
whether GOR was increased or decreased with gastrostomy tube feeding. They 
concluded that the benefits associated with gastrostomy tube feeding are difficult to 
assess from the available evidence and that a well conducted RCT of sufficient size is 
needed.  
2.6.3.1 Nutritional rehabilitation studies 
There have been seven previous longitudinal nutritional rehabilitation studies of 
children with CP (Isaacs et al. 1994; Naureckas and Christoffel 1994; Patrick et al. 
1986; Rempel et al. 1988; Sanders et al. 1990; Shapiro et al. 1986; Sullivan et al. 
2005). However, only three of these studies were prospective (Isaacs et al. 1994; 
Patrick et al. 1986; Sullivan et al. 2005); three were retrospective reviews of the 
medical records (Naureckas and Christoffel 1994; Rempel et al. 1988; Shapiro et al. 
1986); and one did not state how the data was collected (Sanders et al. 1990). 
Furthermore, all of the studies were based on measures of weight and/or height, with 
only three including some basic skinfold anthropometry, i.e. triceps skinfold thickness 
(Isaacs et al. 1994; Patrick et al. 1986; Sullivan et al. 2005). None of the studies 
included a measure of BMC or body protein.  
In general, the studies found that most gastrostomy tube fed children with CP gain 
significant weight, and that the gains in weight were more dramatic than the gains in 
length/stature. In the studies that included skinfold anthropometry, significant 
increases in body fat were observed (Isaacs et al. 1994; Patrick et al. 1986; Sullivan et 
al. 2005). In addition, some studies reported that the weight gain was associated with 
healing of persistent pressure sores, the correction of cold and cyanosed extremities, 
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improvement in the children’s spasticity and affect, and that some children made 
significant developmental progress post gastrostomy tube feeding (Patrick et al. 1986; 
Rempel et al. 1988; Sanders et al. 1990). However, these findings were purely 
anecdotal and not collected in a standardised way. 
In conclusion, most children with CP appear to get fatter as a result of tube feeding. 
Yet, no studies have tested the impact of nutritional rehabilitation on body protein and 
bone mineralisation in children with quadriplegic CP.  
2.7 Aims of thesis 
There have been numerous studies describing the body composition of children with 
quadriplegic CP (Henderson et al. 2002a; Ruby and Matheny 1962; Samson-Fang and 
Stevenson 2000; Stallings et al. 1993a; Stallings et al. 1995; Sterling 1960; Tobis 
1961). Most of these studies have focused on measurements of body fatness and the 
validation of various methods to predict fat stores (Hildreth et al. 1997; Stallings et al. 
1995; van den Berg-Emons et al. 1998). There are no studies directly measuring body 
protein in children with quadriplegic CP, or studies validating indirect methods of 
assessing body protein. Body protein is important to measure because immune 
function, response and recovery to disease, as well as skeletal respiratory muscle 
function, are severely impaired when body protein levels are reduced (Hill 1992). 
Thus the first aim of this thesis was to directly measure TBP in children with 
quadriplegic CP.  
Secondly, because the sophisticated technology (NAA and DXA) used in this study to 
measure body composition is not readily accessible, particularly in the clinic or 
community setting, a further aim of this thesis was to determine whether alternate 
simpler measures of body composition, such as skinfold anthropometry, can 
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accurately predict body composition (particularly TBP and body fat) in children with 
quadriplegic CP. 
Thirdly, information on dietary intake and REE were collected in order to (i) examine 
energy balance and nutrient intake in this population, and (ii) to investigate any 
relations between, or influences of, dietary intake and REE and the body composition 
parameters. 
Finally, despite the many studies reporting a high incidence of malnutrition in this 
population there have been limited studies investigating the effects of nutritional 
intervention on body composition parameters. The few studies that have been done 
have investigated changes in growth parameters (weight and height) and body fat 
only, with no exploration into the effects of weight gain on TBP and bone 
mineralisation. Therefore, the final aim of this thesis was to (i) conduct an RCT of 
gastrostomy tube feeding versus oral nutritional supplementation combined with 
speech therapy, and (ii) to investigate whether nutritional rehabilitation results in 
significant increases in TBP, bone mineralisation and REE in children with 
quadriplegic CP. 
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3 Methods 
3.1 Participants 
3.1.1 Children with cerebral palsy 
Fifty-nine children (22F, 37M), between four and 19 years of age, with a diagnosis of 
quadriplegic CP were recruited through the Dysphagia Clinic at CHW between 2000 
and 2005. All children were wheelchair-bound and totally dependent on their 
parent/carer for their everyday needs.  
The Dysphagia Clinic consists of a paediatric gastroenterologist, general 
paediatrician, nurse, speech therapist, physiotherapist and dietitian. The purpose of the 
clinic is to assess and treat children with developmental disabilities and complex 
feeding and nutritional problems. 
Children less than four years of age were excluded from this study because of the lack 
of available control data in this age range. 
3.1.2 Control population  
The data on the control children were from three separate existing control databases, 
as outlined below. All control children were healthy with no known medical 
problems, were of a similar age range to the children with CP (4-19 years), and were 
recruited through friends and relatives of CHW staff. 
1. The control group for the anthropometric and DXA measurements consisted of 
172 (84F, 88M) children from an existing DXA control database (Ogle et al. 
1995). All children from this database had undergone a DXA measurement. In 
addition, measurements of height, weight and skinfold anthropometry were 
recorded at the time of the DXA measurement. 
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2. The control group for TBP consisted of data from a group of 72 (43F, 29M) 
children who had undergone TBP measurements at CHW (Baur et al. 1993).  
3. The REE measurements of the children with CP were compared with a separate 
control database consisting of 111 (42F, 69M) children who had undergone REE 
measurements at CHW (unpublished data). In addition, measurements of height, 
weight and skinfold anthropometry were recorded at the time of the REE 
measurement. 
3.2 Study Protocol 
3.2.1 Cross-sectional study 
During an outpatient visit to CHW, the children had measurements of anthropometry, 
TBP by NAA, body composition by DXA, and REE by indirect calorimetry. 
Parents/carers were then instructed to complete a weighed food record at home for 
subsequent dietary analysis.  
A Parent Information Sheet detailing the study protocol was provided to all 
parents/carers prior to them giving written consent for their child to participate in the 
study (see Appendix A). 
3.2.2 Nutritional rehabilitation study 
An attempt was made to conduct an RCT of gastrostomy tube feeding versus oral 
feeding using oral nutritional supplementation and speech therapy. For reasons 
discussed in Chapter 7 this attempt failed and therefore a longitudinal cohort study of 
gastrostomy tube-fed versus oral-fed children was conducted.  
The measurements that were performed for the cross-sectional study were repeated in 
a subset of children from the cross-sectional study after weight gain following 
gastrostomy tube feeding. These children received a gastrostomy tube as part of their 
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routine care through the Dysphagia Clinic. Some of these children continued to eat 
orally, therefore, their feeding regimens, which were determined by the Dysphagia 
Clinic dietitian, were aimed at providing between 75 % and 100 % of their estimated 
energy requirements through gastrostomy tube feeds using a range of commercially 
available, micro-nutrient complete, formulas. The energy requirements of the 
gastrostomy-fed children were initially estimated to be 1.2 times their measured REE, 
which was measured for the cross-sectional study. Weight gain was monitored at 
regular intervals through the Dysphagia Clinic, and the feeding regimens adjusted 
according to weight gain. 
In addition, the tests were repeated in a subset of oral-fed children with CP who 
participated in the cross-sectional study. These children were to be used as a control 
group for comparison with the gastrostomy tube fed group. The oral-fed children with 
CP were recruited and monitored through the Dysphagia Clinic. They were provided 
with standard dietary and speech therapy advice by the Dysphagia Clinic dietitian and 
speech pathologist, respectively. Advice provided by the dietitian included increasing 
the energy content of their diets by the addition of energy-dense food and 
commercially available high-energy oral supplements. Advice provided by the speech 
pathologist centred on adjusting the texture of food and liquid in order to aid chewing 
and swallowing. 
The same Parent Information Sheet that was given to the parents/carers for the cross-
sectional study was re-issued to the parents/carers prior to giving consent for the tests 
to be repeated. 
3.2.3 Ethics approval 
The CHW Ethics Committee approved the study and written, informed consent was 
obtained from each parent/carer (see Appendix A).  
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3.3 Anthropometry 
Two trained observers performed all measurements using standardised techniques 
(Norton et al. 1996). Please refer to Appendix B for all of the anthropometric 
equations used in this section. 
3.3.1 Height and weight 
In the children with CP, standing height was estimated using knee height. Knee height 
(±0.1 cm) was measured with an anthropometer (Holtain Ltd, Crosswell, Crymmych, 
Dyfed, Wales) with the knee and ankle each bent to a 90o angle. The distance from the 
heel to the anterior surface of the thigh over the femoral condyles was measured 
(Stevenson 1995b). The knee height measurement was then placed into the equations 
of either Stevenson (for children ≤12 y), or Chumlea et al (for children >12 y) to give 
an approximate height (see Appendix B) (Chumlea et al. 1994; Stevenson 1995b).  
Weight measurements (± 0.1 kg) were made with electronic scales (A&D Mercury 
Pty Ltd, South Australia) with children wearing minimal clothing. Because the 
children with CP were unable to stand on the scales, the carer stood on the scales 
while holding the child, then the carer was weighed on their own and the difference 
between the two weights was calculated to give the weight of the child.  
BMI was calculated as weight (kg) divided by height (m) squared. 
Weight and height measurements were converted to SD scores and compared with the 
United States Centre for Disease Control growth reference data (Kuczmarski et al. 
2000). Weight as a percent of ideal weight-for-height was calculated by first 
estimating the height-age of the child (the age at which the child’s actual height is on 
the 50th centile), and then dividing the child’s actual weight by the weight that 
corresponds with the 50th centile for the child’s height-age, and then multiplied by 100 
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to give a percentage. Weight-for-height centile charts were not used to determine the 
ideal weight-for-height because the method described above is the most commonly 
used method in the clinic setting at our centre. 
3.3.2 Skinfold anthropometry 
Skinfold thicknesses were measured in duplicate on the right side of the body at four 
sites (triceps, biceps, subscapular, and suprailiac) with a Harpenden calliper (British 
Indicators Ltd, St Albans, Hertfordshire, UK) and compared with Frisancho reference 
data, as well as the control group (Frisancho 1981).  
MUAC was measured with a flexible steel tape at the midpoint between the acromion 
process and head of the radius on the right arm. An estimate of the UAMA was 
derived from the MUAC and triceps skinfold measurement (Frisancho 1981). UAFA 
was calculated from the total upper arm area minus the UAMA. The UAMA was 
converted to a SD score derived from the Frisancho reference data (Frisancho 1981). 
Due to the non-normal distribution of the reference data for the triceps and 
subscapular skinfold thicknesses and UAFA, these measures were converted to SD 
scores according to the methods of Davies et al (Davies et al. 1993).  
3.3.2.1 Body fat 
An estimate of FM and PBF was calculated from the four skinfold thicknesses 
(PBFSKIN) using the equations of Brook for prepubertal children, and Durnin & 
Rahaman for pubertal children (Brook 1971; Durnin and Rahaman 1967). Please refer 
to Appendix B for the equations used in this section. 
3.3.2.2 Fat-free mass 
FFM was derived from skinfold anthropometry (FFMSKIN) by subtracting FM from 
body weight. 
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3.3.2.3 Pubertal status 
For the purposes of calculating PBF from skinfold anthropometry, the pubertal status 
of each study participant was determined by asking the parent / carer to select the 
pubertal status of their child from a pictorial representation of the five Tanner stages 
of puberty (Tanner and Whitehouse 1976).  
3.3.3 Comparisons with control group and reference data 
All anthropometric measures were compared with the control group as well as to 
reference data.  
3.4 Total body protein by neutron activation analysis 
TBP was calculated from the measurement of TBN by assuming that nitrogen is 16 % 
of protein weight, i.e. mass of protein = 6.25 x mass of nitrogen. The TBN facility is 
located in the James Fairfax Institute of Paediatric Nutrition at CHW and was 
designed and built by the Australian Nuclear Science and Technology Organisation 
(Baur et al. 1991a). TBN was measured by the method of prompt gamma neutron 
capture analysis, also known as NAA. The TBN measurement involves the child lying 
supine on a motorised table (see Figure 3.1 pg 96). During the testing, the children 
with CP were kept in the supine position by carefully wrapping them in a light cotton 
bed sheet. The child is bilaterally irradiated with neutrons produced from the decay of 
two 252Cf sources, which results in the conversion of 14N to 15N with the emission of a 
10.83 MeV gamma ray which is specific for nitrogen. The absolute mass of nitrogen 
(MN) can be determined by using hydrogen (2.23 MeV gamma ray emission) as an 
internal standard and the following equation: 
MN = (YN / YH) KMH C(W) 
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Where YN and YH are the net nitrogen and hydrogen yields, respectively, K is the 
calibration factor determined from a phantom with known hydrogen and nitrogen 
masses, C(W) is the nitrogen-to-hydrogen gamma ray attenuation correction factor 
which is dependent on subject width, and MAH is the mass of hydrogen determined 
from fat mass, as per the following equation, where fat mass (MAf) is estimated from 
skinfold anthropometry using the equations of Brook, or Durnin & Rahaman, and 
body mass (MA) using the following equation of Vartsky et al (Vartsky et al. 1979): 
MAH = 0.097MA + 0.0219MAf
(Baur et al. 2001). The total exposure time is approximately 15 minutes and the 
effective dose equivalent delivered during a scan is <0.15 mSv. The technique has a 
precision and accuracy of 1.4-5.4 % and 97-101.5 % respectively, in child-sized 
phantoms (Baur et al. 1991a). All measurements were made relative to a standard 
phantom, which was measured before and after each group of subjects. In this way 
corrections were made to account for any drift or change to the equipment or 
environment (Baur et al. 1991b).  
3.4.1 Replacement of radioactive sources 
Between August 2003 and June 2004, the two 252Cf sources were replaced and the 
machine was extensively re-calibrated. The sources were replaced because the 
previous sources had decayed to the extent that the machine was beginning to read 
outside the precision allowed for the measurement. The TBP results of six children 
with CP from the cross-sectional study, and two children from the nutritional 
rehabilitation study, who were measured between June 2003 and August 2003 were 
discarded and were not included in the data analysis because of the decay of the 
sources. No control children were tested during this period. Participant testing 
recommenced in July 2004.  
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3.4.2 Comparisons with control data 
The TBP measurements of the children with CP were compared with TBP predicted 
for age, height and weight using equations based on the control data. Please see 
Appendix C for the predictive equations.  
3.5 Body composition by dual-energy x-ray absorptiometry 
All DXA measurements were performed and analysed by trained staff in the 
Department of Medical Imaging at CHW with a commercial x-ray bone densitometer 
(DPX Lunar Radiation Corp, Madison, WI). Whole body scans were performed on 
fast scan mode using adult total body software version 4.7 (Lunar Radiation Corp), 
with the child lying supine (see Figure 3.2 pg 96). The total scan time is 
approximately 10 minutes with a total radiation dose of around 0.2 μSv. Most of the 
children with CP were lightly sedated with 0.35 mg/kg of oral midazolam 30 minutes 
prior to the scan to help reduce involuntary or uncontrollable movements during the 
test. Some of the children with CP were also carefully wrapped in a light cotton bed 
sheet to keep them in the supine position during testing.  
The DXA measurement provides a three-compartment model of body composition: 
fat tissue mass (FMDXA), BMC, and lean tissue mass (LTMDXA), where the LTMDXA 
represents the non-BMC LTMDXA. Percent body fat by DXA (PBFDXA) for the total 
body was calculated by the following formula: 
PBFDXA = FMDXA / (FMDXA + LTMDXA + BMC) 
The precision of the technique in children as assessed at CHW is 1.2 % for BMC, 1.59 
% for percentage body fat and 0.82 % for lean tissue mass (Ogle et al. 1995).  
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Figure 3.1 Total body nitrogen by neutron activation analysis 
Picture reproduced with parental consent 
 
 
Figure 3.2 Dual energy x-ray absorptiometry 
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3.5.1 Comparisons with control data 
Measurements for BMC were converted to age, weight, and height SD scores based 
on data derived from the control group. In addition, following the methods of Högler 
et al, the BMC measurements of the children with CP were also adjusted for both 
height and LTMDXA and expressed as an SD score for comparison with control data 
(Hogler et al. 2003). The LTMDXA data of the children with CP were converted to a 
SD score for height for comparison with control data.  
3.6 Comparison of methods to derive body composition 
3.6.1 Total body protein 
TBP was calculated from the DXA measurement (TBPDXA) and also from skinfold 
anthropometry (TBPSKIN) following the method of Fuller et al as (Fuller et al. 2001): 
TBP  = LTM – non-osseous mineral (0.2305 x BMC) – estimated TBW [FFM x 
hydration constant of FFM (HCFFM)]. 
For TBPDXA, the FFM was calculated as the sum of the two non-fat components, 
LTMDXA and BMC. For TBPSKIN, the LTM was calculated as FFMSKIN minus BMC, 
where BMC was derived from DXA. Age and sex specific HCFFM were used for the 
estimation of TBW (see Appendix D) (Fomon et al. 1982; Lohman 1986). The 
TBPDXA and TBPSKIN were then compared with the TBP derived from the direct 
assessment method of NAA (TBPNAA).  
3.6.2 Body fat 
PBFDXA was compared with PBFSKIN using two different sets of equations: 
(1) With four skinfold thicknesses (biceps, triceps, subscapular, and supra-iliac) using 
the equations of Brook (for prepubertal children) and Durnin & Rahaman (for 
pubertal children) (PBFSKIN-A), (Brook 1971; Durnin and Rahaman 1967) and  
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(2) With two skinfold thicknesses (triceps and subscapular) using the equations of 
Slaughter (PBFSKIN-B) (Slaughter et al. 1988). 
Please refer to Appendix B for the equations used in this section. 
3.7 Resting energy expenditure by indirect calorimetry 
REE was measured in the morning for 20 minutes using an open circuit, flow through, 
ventilated hood indirect calorimeter (Datex Deltatrac II MBM-200 Metabolic 
Monitor, Datex-Engstrom Division Instrumentarium Corp., Helsinki, Finland). All 
children were fasted overnight (from midnight) and were afebrile and in a rested state. 
REE was calculated from measured gas exchange over 20 minutes and extrapolated to 
estimate REE (kJ/24h). 
The parents/carers of the children with CP were instructed to give their child their 
regular morning medications prior to the testing. The decision was made not to 
withhold medications until after testing because many of the children were on anti-
epileptic medications and therefore may have been at risk of having a seizure if the 
medication was delayed. Please see Appendix E for the list of medications taken by 
the children with CP. Four of the participants with CP who had a measurement of 
REE reported using bronchodilator medication/s when required for breathing 
difficulties. However, only one of these four participants reported using the 
bronchodilator medication the morning of the test. 
3.7.1 Comparisons with reference and control data 
Measured REE was compared with that predicted from the Schofield equations based 
on actual weight, as well as that predicted from the control data based on FFMSKIN 
(see Appendix F) (Schofield 1985). 
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3.8 Dietary intake by three-day weighed food records 
The dietary intake of the children was estimated from a three-day weighed food 
record. Parents/carers were provided with portable electronic scales (Salter 
“Selectronic 2200”, Salter Housewares Ltd, Kent, UK; accuracy ± 2 g) and detailed 
written instructions as well as given a demonstration on how to use the electronic 
scales. The parents/carers were instructed to weigh all foods, beverages and 
supplements consumed by their child over three consecutive days, including two days 
during the week and one day on the weekend. Parents/carers were asked to record the 
details of methods of food preparation, description of foods, and brand names (if 
known). For composite dishes, such as a cake or casserole, the carers were instructed 
to record the weights of all raw ingredients used in the recipe, as well as the weight of 
the portion consumed by the child and the final weight of the composite dish. All of 
the food records were checked on completion and any unweighed foods were 
quantified. The food records were analysed with a computer program (FoodWorks 
Version 2, Xyris Software, Brisbane, Australia) based on the Australian food 
composition database, NUTTAB95, as well as product information supplied by 
manufacturers (Commonwealth Department of Community Services and Health 1989; 
National Health and Medical Research Council 1991).  
3.8.1 Comparisons with reference and control data 
The food records were examined for over- and under-reporting by comparing the 
energy intake with measured REE. Micro-nutrient (vitamin and mineral) intakes were 
compared with age-appropriate Australian RDI (National Health and Medical 
Research Council 1991). 
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3.9 Statistics 
All data were analysed using the programme Statistical Package for the Social 
Sciences (SPSS) (version 11.5.1, SPSS Inc, Chicago, USA). The significance level 
was set at p < 0.05.  
3.9.1 Study 1 - Cross-sectional 
3.9.1.1 Anthropometry 
A two-factor analysis of variance (ANOVA) test was used to investigate differences 
in anthropometric characteristics and body composition from skinfold anthropometry 
between children with CP and control children (from the DXA control database), 
using sex and group (CP or control) as fixed factors.  
A two-tailed one-sample t-test was used to compare mean differences between all 
participants and reference data (test value = 0) for height and weight SD scores, 
triceps and subscapular skinfold thickness SD scores, UAMA SD score, and UAFA 
SD score.  
3.9.1.2 Total body protein 
A two-factor ANOVA test was used to investigate differences between participant 
characteristics (age, height, weight, FFMSKIN, and PBFSKIN) and TBPNAA of the 
children with CP and that of the TBP control group, using sex and group (CP or 
control) as fixed factors. 
 A two-tailed one-sample t-test was used to compare mean differences between 
TBPNAA as a percentage of that predicted for age, height, and weight based upon 
control data (test value = 100).  
100 
Chapter 3 
METHODS 
3.9.1.3 Body composition by dual-energy x-ray absorptiometry 
A two-factor ANOVA test was used to investigate differences between BMC, 
LTMDXA, FMDXA, and PBFDXA of the children with CP and that of the DXA control 
group, using sex and group (CP or control) as fixed factors. 
A two-tailed one-sample t-test was used to compare mean differences between 
children with CP and control data (test value = 0) for BMC SD scores for age, height 
and weight; BMC SD score adjusted for both height and LTMDXA; and LTMDXA SD 
score adjusted for height. 
3.9.2 Study 2 – Comparison of methods 
A paired t-test was used to test for differences between (i) TBP measured by NAA, 
DXA, and skinfold anthropometry, and (ii) PBF measured by DXA and skinfold 
anthropometry. Bland & Altman plots were used to test the agreement between 
methods to measure TBP (TBPNAA versus TBPDXA, and TBPNAA versus TBPSKIN) and 
PBF (PBFDXA versus PBFSKIN-A and PBFDXA versus PBFSKIN-B) in both children with 
CP and controls (Bland and Altman 1986). A univariate analysis of covariance 
(ANCOVA) was used to statistically analyse and compare the Bland & Altman plots 
with “difference between methods” as the dependent variable, “average of methods” 
as the covariate, and group (CP or control) as fixed factors. 
3.9.3 Study 3 – Resting energy expenditure and dietary intake 
3.9.3.1 Resting energy expenditure 
A two-factor ANOVA test was used to investigate differences between participant 
characteristics (age, height, weight, FFMSKIN, and PBFSKIN) and measured REE of the 
children with CP and that of the control group, using sex and group (CP or control) as 
fixed factors.  
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Linear regression analysis was performed on the REE data of the control group to 
develop predictive equations to allow for comparisons with the children with CP. 
Measured REE was used as the dependent variable, with age, weight, height, 
FFMSKIN, and FMSKIN, tested separately as independent variables.  
Linear regression analysis was also performed on the REE data of the children with 
CP in order to find predictors of measured REE. Measured REE was used as the 
dependent variable with age, weight, height, FFMSKIN, and FMSKIN tested separately 
as independent variables. In addition, linear regression analysis was performed to 
investigate any significant associations between anticonvulsant medication use and 
tube feeding with measured REE and measured REE as a percent of REE predicted 
from control data (anti-epileptic medications (0 = no, 1 = yes); presence of a 
gastrostomy or NG tube, 0 = no, 1 = yes)). 
A two-tailed one-sample t-test was used to test if measured REE as a percent of that 
predicted from the Schofield equation (based on weight) was significantly different to 
100 % (test value = 100) for both the children with CP and the control group. In 
addition, in the children with CP only, a two-tailed one-sample t-test was used to test 
if measured REE as a percent of that predicted from the control data (based on 
FFMSKIN) was significantly different to 100 % (test value = 100). 
3.9.3.2 Dietary intake 
Energy intake was expressed in kilojoules per day as well as a percentage of measured 
REE. Micronutrient intakes were expressed as a percentage of the RDI. The energy 
intake of the children with CP was not normally distributed and is presented as 
median with inter-quartile range (IQR).  
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A Mann-Whitney U test was used to examine differences in energy intake, expressed 
as a percentage of measured REE, between oral-fed and tube-fed children with CP. A 
two-tailed one-sample t-test was used to test if micronutrient intake, expressed as a 
percentage of RDI, was significantly different to 100 % (test value = 100). 
3.9.4 Correlations 
Pearson's product-moment correlations (r) were used to investigate relations between 
anthropometric measures of body composition and TBPNAA and DXA and between 
dietary intake of calcium and protein with BMC and TBPNAA, respectively.  
3.9.5 Study 4 - Nutritional rehabilitation 
The data for the nutritional rehabilitation study were not normally distributed and are 
presented as medians with IQR.  
A Wilcoxon Signed Ranks test was used to compare differences between the baseline 
and repeat tests of the body composition parameters within each group (gastrostomy 
tube-fed and oral-fed). 
A Mann-Whitney U test was used to compare changes in the body composition 
parameters between the two groups (gastrostomy tube-fed versus oral-fed). 
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4 Study 1 - Cross-sectional study 
4.1 Introduction 
There have been a limited number of studies measuring body composition in children 
with severe CP. There are no studies that have measured a 3C model of body 
composition using a direct measure of body protein in this population. 
4.2 Aim 
To measure a 3C model of body composition in children with quadriplegic CP, 
specifically TBP, FM and BMC. 
4.3 Participants 
4.3.1 Participant recruitment 
4.3.1.1 Children with cerebral palsy 
The parents/carers of 87 children with quadriplegic CP between the ages of four to 19 
years were invited to allow their child to participate in the cross-sectional study. Of 
these, 59 agreed to participate, and 28 declined. The main reason given for declining 
to participate was parental lack of time. No information was collected on those who 
declined to participate, so it is unknown if they differed in any way to the study 
population. However, the purpose of the Dysphagia Clinic is to assess and treat 
children with developmental disabilities and multiple feeding and nutritional 
problems, therefore it is likely that those who declined to participate did not differ 
significantly from those who participated.  
Forty-two of the 59 participants were recruited and studied by the candidate, the 
remaining 17 (8F, 9M) participants had been recruited and studied by Dr Edward 
O’Loughlin and Ms. Samantha Clarke as an earlier pilot study, but have been included 
in the total as minimal changes were made to the study design as a result of the pilot 
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study. Three additional tests were added to the study protocol that were not part of the 
pilot study: 
 Knee height as a proxy for standing height 
 REE by indirect calorimetry 
 Three-day weighed food records to assess dietary intake  
Therefore, data on these three additional tests are not available for the first 17 children 
with CP who participated in the pilot study. 
4.3.1.2 Control children 
The control children for the cross-sectional study were from two separate existing 
control databases, as outlined below. All control children were healthy with no known 
medical problems, were of a similar age range to the children with CP (4 - 19 y), and 
were recruited through friends and relatives of CHW staff. 
4. The control group for the anthropometric and DXA measurements consisted of 
172 (84F, 88M) children from an existing DXA control database (Ogle et al. 
1995). All children from this database had undergone a DXA measurement. 
Measurements of height, weight and skinfold anthropometry were recorded at the 
time of the DXA measurement. 
5. The control group for TBP consisted of data from a group of 72 (43F, 29M) 
children who had undergone TBP measurements at CHW (Baur et al. 1993).  
4.3.2 Participant description 
Twelve of the 59 study participants lived in a government-funded or privately-funded 
group care residential facility, the remainder of study participants lived at home with 
their biological or adoptive parents.  
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4.3.2.1 Type of cerebral palsy 
For each study participant the type of CP was obtained from the medical records. 
Twenty-eight of the 59 children had spastic quadriplegic CP, six had athetoid 
quadriplegic CP; and the remaining 25 did not have a type specified but were 
described as “severe” quadriplegic CP.  
4.3.2.2 Cause of cerebral palsy 
The cause of CP was obtained from the medical records of each child and recorded as 
follows: hypoxic brain injury, 17; unknown, 14; secondary to prematurity, 10; brain 
abnormalities, 8; infections in-utero, 5; and other causes, 5.  
4.3.2.3 Method of feeding 
At the time of the study, 20 of the 59 children (5F, 15M) were fed partially or 
completely by either a gastrostomy (n = 17) or NG tube (n = 3). The remainder of the 
children were fed orally. Three of the tube-fed children received their gastrostomy 
tube less than one month prior to being tested. The remainder had their tubes in place 
for a median of 3.3 years (range 0.4 to 6.5 years).  
4.3.2.4 Medications 
The majority (n = 56) of children with CP were taking at least one medication (see 
Appendix E). The most common medications were anti-epileptic medications (n = 
40), followed by medications to treat reflux (n = 27), anxiety (n = 16), movement 
disorders (n = 11), constipation (n = 10), and asthma and allergic rhinitis (n = 8).  
4.4 Study protocol 
During an outpatient visit to CHW, the children had measurements of anthropometry, 
TBP by NAA, and body composition by DXA, as outlined in Chapter 3.  
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A Parent Information Sheet detailing the study protocol was provided to all 
parents/carers prior to them giving written consent for their child to participate in the 
study (see Appendix A). 
4.5 Data analysis 
All data were analysed as outlined in Chapter 3 using the programme SPSS (version 
11.5.1, SPSS Inc, Chicago, USA). The significance level was set at p < 0.05.  
4.6 Results 
4.6.1 Anthropometry 
4.6.1.1 Anthropometric characteristics 
The anthropometric characteristics of the children with CP and control children are 
shown in Table 4.1 (pg 111). The anthropometric characteristics, except for measures 
of body fatness in the control group, were not significantly different between the male 
and female children with CP or controls and therefore the sexes were analysed 
together.  
The children with CP were on average significantly younger (by an average of 1.5 
years) than the control children; however, where possible, the data were converted to 
SD scores to adjust for age differences. The height and weight SD scores for the 
children with CP were significantly lower than both the control and reference data, 
however, the mean actual weight as a percent of ideal weight-for-height of the 
children with CP was 96.3 ± 14.9 % (n = 42) which was not significantly different 
from 100 %. In contrast, measures of body fatness were all significantly reduced. The 
UAFA and the triceps and subscapular skinfold thicknesses were converted to age and 
sex specific SD scores to account for differences in sex, and are therefore presented 
with sexes combined. The mean triceps skinfold thickness was -1.5 ± 1.5 SD score, 
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the mean subscapular skinfold thickness -1.0 ± 1.5 SD score, and the mean UAFA -
1.9 ± 1.7 SD score (n = 58), for children with CP, all of which were significantly (p < 
0.01) less than the reference values and the controls. Percent body fat for the female 
children with CP was significantly lower than the female controls; 12.5 ± 7.3 % (n = 
20) versus 22.5 ± 7.3 % (p < 0.001), respectively, and also for male children with CP 
compared with male controls, 14.2 ± 7.0 % versus 17.6 ± 4.5 % (p < 0.01), 
respectively. PBF is presented with sexes separated due to the differences between 
sexes in the control group. In addition, as shown in Table 4.1, the UAMA and 
FFMSKIN of the children with CP were significantly reduced compared with reference 
data and control data.  
Knee height was not measured in the first 17 participants enrolled in the study, and 
therefore data on height, height SD score and weight as a percent of ideal weight-for-
height are unavailable for eight females and nine males. In addition, complete sets of 
skinfold anthropometry were not obtained on three (1M, 2F) participants with CP due 
to the inability of the children to cooperate, and therefore the data on UAMA is 
unavailable for one child (1M), and on FFMSKIN and PBFSKIN for two children (2F). 
The control children were not different from the reference data for height and weight 
as indicated by their SD scores, and are therefore considered to be representative of 
the normal population.  
4.6.1.2 Correlations 
Height, weight, UAMA, and FFMSKIN were significantly positively correlated with 
age in the children with CP; r = 0.81, p < 0.001; r = 0.67, p < 0.001; r = 0.54, p < 
0.001; r = 0.80, p < 0.001, respectively. Figure 4.1 (pg 112) demonstrates the 
significant correlation between age and FFMSKIN in the children with CP and controls. 
The figure reveals that the children with CP gain FFMSKIN at a reduced rate compared 
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with the control children, and consequently, in the older children the FFMSKIN of the 
children with CP is further below the control children values. 
Height SD score, weight SD score, UAMA SD score, and subscapular skinfold SD 
score in the children with CP were all significantly negatively correlated with age; r = 
-0.37, p < 0.05; r = -0.42, p < 0.01; r = -0.38, p < 0.01; r = -0.39, p < 0.01, 
respectively.  
4.6.1.3 Tube-fed versus oral-fed children with cerebral palsy 
Twenty of the 59 children with CP who participated in the cross-sectional study were 
fed via either a naso-gastric or gastrostomy tube. When analysed separately, the tube-
fed children (n = 16, excluding those who received their gastrostomy tubes less than 
one month prior to being tested) compared with the oral-fed children (n = 43) had on 
average a significantly (p < 0.05) higher weight (23.6 vs. 19.4 kg), weight as a percent 
of ideal weight-for-height (103.9 vs. 91.1 %), UAMA (21.8 vs. 16.5 cm2), UAMA SD 
score (-0.9 vs. -2.7 SDS), UAFA (8.5 vs. 4.4 cm2), UAFA SD score (-1.1 vs. -2.7 
SDS), BMI (16.2 vs. 14.4 kg/m2), BMI SD score (-0.7 vs. -2.0 SDS) and PBFSKIN 
(17.7 vs. 11.7 %), respectively. There was no significant difference between the two 
groups for weight SD score, height, height SD score, or FFMSKIN (data not shown). 
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Table 4.1 Anthropometric characteristics of children with cerebral palsy and 
controls 
 CP 
N = 59 
(22F, 37M) 
Controls 
N = 172 
(84F, 88M) 
Age (y) 10.4 ± 4.3 1 11.9 ± 4.0 
Weight (kg) 20.7 ± 7.12 42.4 ± 17.0 
Weight for age SDS -4.8 ± 5.3 3 0.0 ± 0.9 
Height (cm) 116.7 ± 15.4 2, 4 147.2 ± 20.6 
Height for age SDS  -3.1 ± 1.6 3, 4 0.1 ± 0.9 
BMI (kg/m2) 15.1 ± 2.4 2, 4 18.6 ± 3.3 
BMI SDS -1.5 ± 2.0 3, 4 0.0 ± 0.8 
UAMA (cm2)  18.1 ± 5.7 2, 5 32.3 ± 11.6 
UAMA for age SDS -2.1 ± 2.2 3, 5 0.4 ± 1.0 
FFMSKIN (kg)  18.0 ± 5.3 2, 6 33.4 ± 12.7 
Data is mean ± SD. BMI, body mass index; CP, cerebral palsy; FFMSKIN, fat-free mass 
measured by skinfold anthropometry; SDS, standard deviation score; UAMA, upper arm 
muscle area. 
A two-factor ANOVA was used to test the difference between CP and control group, using 
gender and group (CP or control) as fixed factors. A two-tailed, one-sample t-test was used to 
test the difference between SDS and reference data (test value = 0).  
1p < 0.05; 2 p < 0.001; significantly different from controls 
3p < 0.001; significantly different from reference data 
4n = 42, 5n = 58, 6n = 57 
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Figure 4.1 Fat-free mass versus age in children with cerebral palsy and controls  
The above figure illustrates a strong positive correlation between fat-free mass measured by 
skinfold anthropometry (FFMSKIN) and age in children with cerebral palsy (CP) and controls. 
Although FFMSKIN in children with CP increases with age, it is below the rate of the control 
children. 
CP: n = 57, r = 0.80, p < 0.001.  
Controls: n = 172, r = 0.87, p < 0.001 
Statistical analysis (univariate ANCOVA) revealed a significant difference in the slopes of the 
regression lines between the two groups; p < 0.001. 
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4.6.2 Total body protein by neutron activation analysis 
Fifty-three (21F, 32M) children with CP had measurements of TBPNAA. The 
characteristics of the children with CP and controls are shown in Table 4.2 (pg 115). 
The mean TBPNAA of the children with CP was 3.0 ± 1.2 kg, while that of the controls 
was 6.4 ± 2.9 kg (43F, 29M). There was no significant difference between the females 
and males with CP or controls and therefore the data are presented and analysed with 
sexes combined. As detailed in Chapter 3, the TBPNAA results of six (1F, 5M) children 
with CP were excluded from the analysis because they were tested immediately prior 
to the radioactive sources being replaced. There was no control children tested during 
this period. 
4.6.2.1 Total body protein adjusted for age, height, and weight 
The TBPNAA results for the children with CP, expressed as a percentage of predicted 
from control data for age, height and weight were significantly reduced 56.1 ± 17.3 % 
(p < 0.001, n = 45), 81.5 ± 15.7 % (p < 0.001, n = 34), and 83.9 ± 17.2 % (p < 0.001, 
n = 45), respectively. Eight (1F, 7M) children with CP were excluded from the 
analysis of TBPNAA predicted for age, height and weight because their ages fell 
outside the range for which the predictive equations were developed from control data 
(Appendix C).  
4.6.2.2 Correlations 
TBPNAA (g) was significantly positively correlated with age in both the children with 
CP (r = 0.74, p < 0.001) and the control group (r = 0.89, p < 0.001) (Figure 4.2, pg 
116). However, the TBPNAA percentage of predicted for age was significantly 
negatively correlated with age (r = -0.58, p < 0.001, n = 45) in the children with CP 
(Figure 4.3, pg 117). These two figures demonstrate that as children with CP age they 
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gain body protein but not at the same rate as control children, and subsequently in the 
older children body protein is further below the control children. For example, in 
Figure 4.2, at age 10 years the body protein of the control children is approximately 
twice that of the children with CP (approximately 6 kg vs. 3 kg, respectively). 
Whereas at age 16 years, the body protein of the control children is approximately two 
and a half times that of the children with CP (approximately 10 kg vs. 4 kg, 
respectively). 
In the children with CP, TBPNAA was highly correlated (p < 0.001) with FFMSKIN (r = 
0.86), weight (r = 0.80), height (r = 0.75), UAMA (r = 0.69), and MUAC (r = 0.56). 
In the control group there was a significant positive correlation between TBPNAA and 
FFMSKIN (r = 0.98, p < 0.001), weight (r = 0.97, p < 0.001), and height (r = 0.93, p < 
0.001). Data on UAMA was unavailable for the control group. There was also a 
significant correlation between TBPNAA and LTMDXA in both children with CP and in 
a subset of the control group who had both TBP and DXA measurements; r = 0.88, p 
< 0.001 (n = 49), r = 0.99, p < 0.001 (n = 28), respectively. There were no significant 
correlations between TBPNAA and measures of body fatness (data not shown). 
4.6.2.3 Tube-fed versus oral-fed children with cerebral palsy 
There was no significant difference in TBPNAA, when expressed in kilograms or as 
percentage of that predicted for age or height, between those children with CP fed via 
a tube or fed orally (data not shown). 
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Table 4.2 Physical characteristics and body protein of children with cerebral 
palsy and controls 
 CP 
N = 53 (21F, 32M) 
Controls 
N = 72 (43F, 29M) 
Age (y) 10.0 ± 4.1 10.7 ± 3.3 
Height (cm) 114.8 ± 15.0 1, 2 142.4 ± 19.2 
Height SDS -3.1 ± 1.6 1, 2 0.1 ± 0.9 
Weight (kg) 20.0 ± 6.9 1 39.2 ± 17.6 
Weight SDS -4.8 ± 5.5 1 0.1 ± 1.0 
FFMSKIN (kg) 17.4 ± 5.1 1, 3 29.9 ± 11.7 
TBPNAA (kg) 3.0 ± 1.2 1 6.4 ± 2.9 
PBFSKIN (%) 12.5 ± 7.6 1, 3  21.3 ± 8.5 
Data is mean ± SD. CP, cerebral palsy; FFMSKIN, fat-free mass measured by skinfold 
anthropometry; PBFSKIN, percent body fat by skinfold anthropometry; SDS, standard deviation 
score; TBPNAA, total body protein measured by neutron activation analysis. 
A two-factor ANOVA was used to test for differences between CP and control group, using 
gender and group (CP or control) as fixed factors. 
1 p < 0.001, significantly different from controls 
2 n = 36, 3 n = 51 
115 
Chapter 4 
 STUDY 1 – Cross-sectional study 
Age (years)
2 4 6 8 10 12 14 16 18 20
To
ta
l B
od
y 
Pr
ot
ei
n 
(k
g)
0
2
4
6
8
10
12
14
16
CP
Controls
 
Figure 4.2 Total body protein versus age 
 
This figure demonstrates the correlation between total body protein measured by neutron 
activation analysis and age in both children with CP and controls. The figure shows that 
children with CP gain body protein as they age; however, it deviates further from the control 
children as they age.  
 
CP: n = 53, r = 0.74, p < 0.001  
Controls: n = 72, r = 0.89, p < 0.001 
 
Statistical analysis (univariate ANCOVA) revealed a significant difference in the slopes of the 
regression lines between the two groups; p < 0.001. 
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Figure 4.3 Total body protein as a percent of predicted from controls versus age in 
children with cerebral palsy 
 
The above figure demonstrates the relation between total body protein measured by neutron 
activation analysis (TBPNAA) for age as a percentage of predicted from control data and age in 
children with cerebral palsy (CP). This figure shows that in the older children with CP their 
body protein deviates further from the control population.  
n = 45, r = -0.58, p < 0.001. 
---------- represents the control population, or predicted TBPNAA for age (100 %). 
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4.6.3 Body composition by dual-energy x-ray absorptiometry 
The results for the DXA measurements are shown in Table 4.3 (pg 121). The 
measures of LTMDXA, FMDXA, and PBFDXA were significantly different between sexes 
for the control group only; therefore data for the males and females were analysed 
separately. The results for BMC were not significantly different between sexes for the 
children with CP or control children. Three children with CP (1F, 2M) with metallic 
implants were removed from the analysis. Another child with CP (1M) was unable to 
remain motionless for the total body DXA scan and therefore their data was not 
included in the analysis.  
4.6.3.1 Bone mineral content adjusted for age, height, weight, and lean tissue 
mass 
The BMC results of the children with CP adjusted for age, height, and weight and 
expressed as SD scores were all significantly reduced: -2.6 ± 1.5 SD score (p < 0.001, 
n = 55), -0.7 ± 1.1 SD score (p < 0.001, n = 39) and -0.5 ± 1.2 SD score (p < 0.001) 
respectively. Since LTM is a major predictor of BMC (Ogle et al. 1995), others have 
recommended adjusting the BMC value for LTM (Hogler et al. 2003). The adjusted 
BMC for LTMDXA was -1.2 ± 1.5 SD score, which was significantly reduced (p < 
0.001). Furthermore, because of the stunted growth of the children with CP, height as 
well as LTMDXA was taken into account. Hence, following the methods of Hogler et 
al, the BMC/LTMDXA ratio for height was -1.2 ± 1.7 SD score, which was 
significantly reduced (p < 0.001, n = 42).  
4.6.3.2 Lean tissue mass adjusted for height 
The LTMDXA of the children with CP adjusted for height was -0.1 ± 1.5 SD score, 
which was not significantly different from the control data (i.e. SD score of 0). 
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4.6.3.3 Correlations 
BMC was positively correlated with age in both the control group (r = 0.88, p < 
0.001) and the children with CP (r = 0.76, p < 0.001) (Figure 4.4, pg 122). However, 
BMC for age SD score was negatively correlated with age (r = -0.60, p < 0.001) in the 
children with CP (Figure 4.5, pg 122). The two figures demonstrate that although 
children with CP gain bone mineral as they age, it is slower than the gain seen in the 
control population and subsequently in the older children the BMC of the children 
with CP is further below that of the control children.  
In addition, in the children with CP and control group, BMC was highly correlated 
with LTMDXA (r = 0.89, p < 0.001 and r = 0.97, p < 0.001, respectively) and with 
FFMSKIN (r = 0.93, p < 0.001 and r = 0.97, p < 0.001, respectively). BMC was also 
highly correlated with TBPNAA in the children with CP (r = 0.86, p < 0.001, n = 49), 
and in a subset of the control group who had both TBP and DXA measurements (r = 
0.99, p < 0.001, n = 28).  
4.6.3.4 Bone mineral content and anti-epileptic medication use 
There was no significant relation between BMC and anti-epileptic medication use in 
the children with CP (data not shown), i.e. the BMC or BMC SD scores of the 
children with CP who were taking anti-epileptic medications did not differ 
significantly from those children with CP who were not taking anti-epileptic 
medications. 
4.6.3.5 Tube-fed versus oral-fed children with cerebral palsy 
Those children with CP fed via either a NG or gastrostomy tube, compared with the 
oral-fed group, had on average a significantly (p < 0.05) higher FMDXA (5.5 vs. 2.8 
kg), PBFDXA (22.4 vs. 14.1 %), and BMC for LTMDXA SD score (-0.6 vs. -1.4 SD 
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score). There was no significant difference between the two groups for BMC, BMC 
for age or height SD scores, LTMDXA, or BMC adjusted for both LTMDXA and height 
(data not shown). 
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Table 4.3 Body composition by dual-energy x-ray absorptiometry in children 
with cerebral palsy and controls 
 Females Males 
 CP 
N = 21 
Controls 
N = 84 
CP 
N = 34 
Controls 
N = 88 
BMC (g) 583 ± 246 1 1645 ± 666 706 ± 297 1 1713 ± 908 
LTMDXA (kg) 15.3 ± 4.4 1 29.4 ± 9.2 18.2 ± 6.5 1 33.6 ± 15.1 
FMDXA (kg) 3.3 ± 3.1 1 9.9 ± 6.2 3.9 ± 2.8 1 6.5 ± 4.3 
PBFDXA (%) 15.9 ± 8.4 1 23.3 ± 7.7 17.1 ± 10.8 15.8 ± 6.7 
Data is mean ± SD. BMC, bone mineral content; CP, cerebral palsy; DXA, dual-energy x-ray 
absorptiometry; FM, fat mass; LTM, lean tissue mass; PBFDXA, percent body fat by DXA. 
A two-factor ANOVA was used to test for differences between CP and control group, using 
gender and group (CP or control) as fixed factors. 
1p < 0.001, significantly different from control group. 
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Figure 4.4 Bone mineral content versus age 
The above figure shows the correlation between bone mineral content (BMC) and age in 
children with cerebral palsy (CP) and controls. Although, BMC increases with age in the 
children with CP, it deviates further from the control group as the children age. 
CP: n = 55, r = 0.78, p < 0.001 
Controls: n = 172, r = 0.88, p < 0.001 
Statistical analysis (univariate ANCOVA) revealed a significant difference in the slopes of the 
regression lines between the two groups; p < 0.001. 
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Figure 4.5 Bone mineral content for age versus age in children with cerebral palsy 
The above figure demonstrates that the bone mineral content (BMC) of children with cerebral 
palsy (CP) deviates further from normal values as the children age.  
n = 55, r = -0.60, p < 0.001 
---------- represents the control population, or predicted BMC SD score for age (i.e. SD score 
of 0). 
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4.7 Summary 
In summary, this cross-sectional study of body composition in children with 
quadriplegic CP revealed that they were markedly stunted, with greatly reduced fat 
stores, TBP and BMC. Furthermore, the height, weight, TBP and BMC of the children 
with CP deviated further from control values in the older children. In addition, in 
comparison with the oral-fed children, the tube-fed children with CP had on average a 
significantly higher weight, weight-for-height, and PBF, but did not differ 
significantly in their TBP or BMC.  
4.8 Discussion 
4.8.1 Anthropometry 
4.8.1.1 Height and weight deficits 
The deficits in height and weight are in agreement with several other studies 
conducted in similar populations (Fung et al. 2002; Hammond et al. 1966; Krick et al. 
1996; Pryor and Thelander 1967; Ruby and Matheny 1962; Samson-Fang et al. 2002; 
Samson-Fang and Stevenson 2000; Stallings et al. 1993a; Stallings et al. 1995; 
Sterling 1960; Stevenson et al. 1994; Thommessen et al. 1991; Tobis 1961; Troughton 
and Hill 2001). In addition, it has been found, in this study as well as others that the 
deficits in height and weight were greater in the older children. It has been postulated 
that this is due to the cumulative effects over time of the combination of an inadequate 
dietary intake and neurological influences on growth. Alternatively, the increasing 
deviation in height could be an effect of worsening scoliosis with age which is 
common in this population, but this would not explain the same finding for body 
weight. 
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4.8.1.2 Normal weight-for-height 
Even though the mean height and weight SD scores of the children with CP were 
significantly reduced, the mean actual weight as a percent of ideal weight-for-height 
was not significantly different from 100 %, implying that although stunted they were 
not wasted. In contrast, skinfold anthropometry revealed that the children with CP had 
reduced skinfold thicknesses (the triceps more so than the subscapular), UAFA, PBF, 
UAMA, and FFM in comparison with the reference data and a similar-aged control 
group. Furthermore, these anthropometric measures differed more from the normal 
values in the older aged children. These findings suggest that, despite their apparently 
normal weight-for-height, they were in fact wasted.  
A normal weight-for-height, despite wasting of body fat and FFM, has also been 
found in two previous studies of children with CP (Berg and Isaksson 1970; Samson-
Fang and Stevenson 2000). These studies are discussed in more detail in Chapter 2, 
sections 2.3.3 (pg 30) & 2.4.4.1 (pg 62). Samson-Fang et al concluded that the best 
indicator of suboptimal fat stores and malnutrition was using triceps skinfold cut-off 
value of <10th centile for age and sex rather than weight-for-height (Samson-Fang and 
Stevenson 2000). 
These findings suggest that the commonly used Waterlow classification system of 
weight-for-height as an indicator of malnutrition with wasting may be inappropriate 
for this group of children (Waterlow 1972). One possible explanation for this 
incongruity is that the use of knee height to estimate height could result in false 
elevation of weight-for-height because this method has not been cross-validated in 
children with CP. Another possible explanation is that malnourished children with CP 
have abnormally high TBW as increased TBW has been reported in malnutrition 
(Shetty 1995). Increased TBW could result in a falsely elevated body weight and lean 
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body mass. Others have measured TBW in children with CP using isotope dilution 
methods and reported varying results which has been discussed in Chapter 2, section 
2.4.4.1 (Bandini et al. 1991; Berg and Isaksson 1970; van den Berg-Emons et al. 
1998). Therefore, it is plausible that the normal weight-for-height seen in this 
population could be due to a falsely elevated body weight due to increased body 
water. A study of TBW in a larger and more representative group of children 
specifically with quadriplegic CP is needed to verify this hypothesis. The limitations 
of using anthropometry in this group of children are discussed further in Chapter 8. 
4.8.1.3 Irregular fat distribution 
In this study it was found that the triceps skinfold thickness was reduced to a greater 
extent than the subscapular skinfold thickness, suggesting an irregular distribution of 
fat. Other studies of children with CP that have included skinfold anthropometry have 
shown similar irregularities in fat distribution (Samson-Fang and Stevenson 2000; 
Spender et al. 1988; Stallings et al. 1993a). However, as suggested by Spender et al, 
the apparent depletion of the triceps fat in the children with CP may be related to the 
arm muscle wasting due to the neurological disease.  
4.8.1.4 Reduced fat-free mass 
The reduction of FFM in older children compared with control data has been reported 
previously in a study of children with spastic quadriplegic CP; where the authors used 
doubly-labelled water and assumed hydration factors to estimate FFM (Stallings et al. 
1995). Again this was believed to be caused by the cumulative effect over time of an 
inadequate dietary intake and muscle wasting from the neurological disease. We 
attempted to determine the effect of nutrition on growth and body composition by 
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conducting a nutritional rehabilitation study, the results of which are presented and 
discussed in Chapter 7.  
4.8.2 Total body protein 
In this study it was found that TBP for age, height and weight was significantly 
reduced in children with CP and that the body protein of children with CP differed 
more from control values in older children.  
There have been no other studies that have measured TBP in children with CP. 
However, there have been a number of other studies conducted by our centre in 
stunted children with chronic diseases, including idiopathic short stature, chronic 
renal failure, chronic liver disease, and cystic fibrosis (Allen et al. 1996; Baur et al. 
1991b; Baur et al. 1994; Baur et al. 2001). Like the children with CP, all of these 
populations had a reduced TBP for age as a percentage of that predicted from control 
data. However, in contrast to the children with CP, the children with idiopathic short 
stature and chronic renal failure had a TBP for height as a percentage of predicted 
from control data that was not significantly different to 100 %, i.e. they had 
appropriate levels of TBP for height. Thus, these children had chronic protein-energy 
malnutrition causing stunted linear growth. In the remaining groups, the children with 
CF and chronic liver disease, the mean values for TBP for height, as well as for age, 
as a percentage of that predicted from control data, were significantly reduced. This is 
a similar finding to the current study of children with CP. A reduced TBP for height is 
usually suggestive of acute malnutrition causing wasting (decreased weight-for-
height). In fact, all three groups included individuals with acute wasting. Although, 
the average weight-for-height of children with CP was not significantly different from 
100 %, the range was from 70 to 130 %. Therefore, the reduced TBP for height 
suggests acute protein-energy malnutrition, superimposed on chronic protein 
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depletion. Alternatively, in the children with CP, it could possibly result from a 
combination of protein-energy malnutrition and muscle wasting from neurological 
impairment and/or from lack of use, or from inaccuracies in estimating height from 
the knee height measurement. We attempted to determine the relative contribution of 
malnutrition to the low TBP for age and height by conducting a nutritional 
rehabilitation study, the results of which are presented and discussed in Chapter 7. 
Interestingly, in the children with CP the low TBPNAA for height is in contrast to the 
finding of a normal LTMDXA for height. One possible explanation for this discrepancy 
could be that the children with CP have increased hydration, since increases in TBW 
have been associated with malnutrition (Shetty 1995). Water is included in the 
LTMDXA measurement, but is not part of TBP. Alternatively, the discrepancy found 
between these two measures could be due to the inaccuracies in estimating height 
from the knee height measurement. These two possible explanations are expanded on 
further in Chapter 8 in the limitations to the study. 
4.8.3 Body composition by dual-energy x-ray absorptiometry 
4.8.3.1 Bone mineral content 
The BMC of the children with CP was significantly reduced in comparison with 
similar aged controls. However, this was not surprising considering that the children 
with CP were significantly reduced in body size (height and weight) in comparison 
with the controls. However when the BMC was adjusted for both height and LTM, 
following the methods of Högler et al for stunted children, it remained reduced 
(Hogler et al. 2003). 
 In addition, BMC was highly correlated with age as well as measures of muscle mass, 
i.e. LTMDXA, TBPNAA, and FFMSKIN. However, BMC SD score for age was negatively 
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correlated with age, demonstrating that in the older children with CP their BMC 
deviated further from control values than in the younger age groups.  
4.8.3.2 Lean tissue mass and body fat 
LTMDXA and FMDXA were significantly reduced in children with CP compared with 
controls. PBFDXA was significantly lower in females with CP compared to controls, 
but was not different to the controls in males with CP. In addition, LTMDXA adjusted 
for height was within normal ranges, which is in contrast to the reduced TBPNAA for 
height, as discussed in section 4.8.2. 
4.8.3.3 Comparisons with other studies 
Other studies have assessed bone mineralisation in children with CP. The two largest 
studies involved children with varying severities of CP, rather than just those with 
quadriplegic CP (Henderson et al. 1995; Henderson et al. 2002a). Using DXA, the 
researchers measured areal BMD of the femur and spine, which were both found to be 
severely diminished in comparison with age-matched controls. The results of the two 
studies are difficult to compare with the current study as the populations were not as 
severely affected, they measured areal BMD in two specific sites rather than total 
body BMC, and there was no adjustment made for height or LTM.  
Chad et al measured total body BMC by DXA in a small population of children with 
varying degrees of spastic CP, the majority of which were wheelchair-bound (Chad et 
al. 2000). The total body BMC for age SD score was -1.8 as compared to -2.6 SD 
score in the current study. They then compared the results with developmentally age-
matched controls determined by pubertal status. The mean bone mineralisation of 
children with CP was around -0.5 SD score compared with developmental age-
matched controls, but again there was no adjustment made for body size or LTM. 
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It is important to note that BMD as assessed by DXA is not a true volumetric density, 
but rather, it is the mass of bone mineral per projection area (g/cm2) and is given the 
term “areal BMD” (aBMD). Areal BMD is a size-dependent measure. Shorter 
children, such as those with CP, therefore have a reduced aBMD compared to age-
matched controls. Children with chronic illness frequently have short stature resulting 
from their primary disease or its treatment, and may have a reduction in aBMD, not 
because there is anything abnormal with the composition or structure of their bones, 
but simply because the bones are small. It is therefore important to correct for height 
when interpreting aBMD (Munns and Cowell 2005). In fact in a small study of 13 
children with CP, using peripheral quantitated CT, the authors found that children 
with CP have smaller and thinner bones, leading to an overall reduced bone strength, 
and not a lower BMD (Binkley et al. 2005). 
Nevertheless, the results of the studies support our findings of a decreased bone 
mineralisation for age which could possibly lead to an increased fracture risk. 
Hypotheses for the poor bone mineralisation found in children with CP can again be 
divided in to nutritional and non-nutritional, or neurological, factors. Nutritional 
factors include oral motor dysfunction resulting in poor nutrition including a low 
calcium intake (Henderson et al. 1995). Non-nutritional contributing factors are lack 
of weight bearing activity; periods of immobilisation after multiple operative 
procedures; anticonvulsant medication interfering with vitamin D metabolism; lack of 
exposure to sunlight and metabolic bone disease associated with prematurity. In the 
current study a relation between advancing age and declining BMC SD score was 
found. This finding is supported by Henderson et al who found the same relation in 
three studies of children with varying severities of CP (Henderson 1997; Henderson et 
al. 2002a; Henderson et al. 2004). It has been postulated that again this is due to the 
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cumulative effects over time of a combination of lack of weight bearing activity and 
poor nutrition. However, in the current study no correlation or relation was found 
between BMC and nutrition (measures of body fatness, calcium intake, method of 
feeding - tube or oral), or with anti-epileptic medication use, possibly because the 
study population was relatively homogeneous. 
4.8.3.3.1 Nutritional influences on bone mineralisation 
In contrast to our findings, Henderson et al found a positive correlation between 
nutritional status assessed by a combination of skinfold thicknesses, BMI, and caloric 
intake, and BMD SD score of the proximal and distal femur and lumbar spine 
(Henderson et al. 1995; Henderson et al. 2002a). Furthermore, in one of their studies, 
the use of a feeding tube was associated with lower BMD SD scores in the femur. 
However, their studies included children with differing severities of CP, and it was 
found in one of their studies that bone mineralisation was negatively correlated with 
the severity of CP (Henderson et al. 2002a). Also children with more severe forms of 
CP are more likely to be non-weight bearing and to have a poorer nutritional status 
because of increased oral motor dysfunction, and are therefore more likely to be tube-
fed. In addition, energy intake was determined by a food frequency questionnaire 
which is designed to obtain qualitative not quantitative data (Gibson 1990). Therefore, 
their results are possibly confounded by these factors. In the latter study the authors 
conducted a multi-factorial analysis to account for the confounders, they found that a 
lower triceps skinfold thickness SD score independently contributed to lower BMD 
SD scores in the femur (Henderson et al. 2002a). A further analysis of this data 
published in 2004 reported that weight SD score was the best single predictor of BMD 
SD score (Henderson et al. 2004). Their results suggest that a better nutritional status 
could improve bone mineralisation. Until now, this had not been investigated by a 
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longitudinal nutritional rehabilitation study. We attempted to study the influence of 
weight gain and an improved nutritional status on bone mineralisation, the results of 
which are discussed in section Chapter 7. 
4.8.3.3.1.1 Calcium intake 
In a study of children with varying degrees of CP, Henderson et al found that those 
children with low calcium intakes (<500 mg/day), determined by food frequency 
questionnaire, had a significantly lower BMD than those children with higher calcium 
intakes (at least 500 mg/day) (Henderson et al. 1995). However, they found no 
significant increase in the BMD of those children with calcium intakes of 500 to 1200 
mg/day and more than 1200 mg/day. Furthermore, in another similar study by the 
same group they found no correlation between BMD and calcium intake, also 
estimated by a food frequency questionnaire (Henderson et al. 2002a). As mentioned 
in the previous section food frequency questionnaires are designed to obtain 
qualitative not quantitative data, and this may be the reason that the authors found 
conflicting results.  
Jekovec-Vrhovsek et al conducted a study to determine the effect of vitamin D (0.25 
ug/day) and calcium supplementation (500 mg/day) on lumbar BMD in a group of 
non-ambulatory children with CP (Jekovec-Vrhovsek et al. 2000). After a nine-month 
supplementation period, they found that lumbar BMD greatly increased in the treated 
group (n = 13) (0.383 vs. 0.476 g/cm2), while in the observed group (n = 7) lumbar 
BMD significantly decreased (0.393 vs. 0.315 g/cm2). However, dietary intake of 
calcium was not assessed for either group, and the level of supplementation of 
calcium was relatively low, therefore, it is unknown whether the intervention group 
did have a significantly higher calcium intake than the control group. In addition, as 
Henderson et al reported, most fractures in children with CP occur in the femur, and 
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lumbar BMD has been found to correlate weakly with distal femur BMD, therefore 
studying lumbar BMD may be less clinically relevant in this population (Henderson et 
al. 2002a). 
4.8.3.3.2 Neurological influences on bone mineralisation 
In this study it was difficult to determine the influence of the non-nutritional or 
neurological factors on bone mineralisation because our population was relatively 
homogeneous. However, our finding of a relation between advancing age and 
declining BMD SD score is supported by Henderson et al who found the same 
relation in three studies of children with varying severities of CP. It has been 
postulated that again this is due to the cumulative effects over time of a combination 
of neurological and nutritional influences (Henderson 1997; Henderson et al. 2002a; 
Henderson et al. 2004).  
4.8.3.3.2.1 Anticonvulsant medication use 
Sixty-eight percent of our population had epilepsy and were taking at least one anti-
epileptic medication. We found no difference in BMC between those with epilepsy 
and those without. This finding is partly supported by Henderson et al who also found 
no significant difference in the BMD of the proximal femur between those children 
with and without epilepsy, but did find a significant difference between these children 
in the lumbar BMD SD score (Henderson et al. 1995). In contrast, in another similar 
study by the same group of authors, they found that use of anti-epileptic medications 
was correlated with BMD SD score of the distal femur, but not the lumbar spine 
(Henderson et al. 2002a). These contradictory findings could be because their study 
populations included children with varying degrees of CP, and the incidence of 
epilepsy is higher in those with more severe CP. In turn, the children with more severe 
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CP such as those with quadriplegic CP are likely to be non-weight bearing and have a 
poorer nutritional status and therefore the results are likely to be confounded by these 
factors. In fact, the authors reported that in their earlier study the correlation between 
BMD SD score and use of anti-epileptic medications ceased to exist when these 
confounding factors were controlled for.  
4.8.3.3.2.2 Lack of weight bearing activity 
In this study we were not able to determine the impact of a lack of weight bearing 
activity on BMC because all of our population was non-ambulatory. However, several 
other studies have shown a relationship between lack of weight bearing activity and 
poor bone mineralisation (Henderson et al. 1995; Henderson et al. 2002a; Henderson 
et al. 2004). 
Lin & Henderson attempted to investigate whether the poor bone mineralisation found 
in children with CP was related to the underlying brain injury or to malnutrition (Lin 
and Henderson 1996). The authors studied children with spastic hemiplegic CP in 
order to use their unaffected side as the control, and to control for confounding 
variables such as nutritional factors, vitamin D levels and anti-epileptic medications. 
The authors found that the total BMC in the involved limb averaged 21 % less than in 
the contralateral uninvolved limb. In addition, the average bone size (area) was 
reduced by 16.2 % and bone density by 5.6 %. LTM was also reduced by 14.8 %; 
however there was no difference in fat content. The authors proposed that relative 
disuse and lack of purposeful activity may have contributed to the diminished muscle 
mass and BMC. These findings support the hypothesis that at least some of the poor 
growth and bone mineralisation seen in children with CP is unrelated to malnutrition. 
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4.8.3.3.2.3 Relation between bone mineral content and lean tissue mass 
The relation between BMC and measures of LTM has been shown to exist in normal 
children, suggesting that peak BMC is determined by the amount of LTM (Ogle et al. 
1995). This implies that a poor muscle mass may predispose children with CP to a 
low bone mineralisation which, in turn, could minimise the attainment of peak bone 
mass, and therefore increase the risk of fractures in adulthood. However, it is difficult 
to prove this association and simply because two factors are strongly related it does 
not necessarily infer causality.  
In conclusion, the factors that contribute to a decreased bone mineralisation in 
children with CP are multi-factorial and include both nutritional and non-nutritional 
factors. 
4.8.4 Tube-fed versus oral-fed children with cerebral palsy 
In this cross-sectional study, the tube-fed children with CP, in comparison with the 
oral-fed children, had on average a significantly higher weight, weight-for-height, and 
PBF, but did not differ significantly in their TBP or BMC.  
There have been only three other cross-sectional studies that have compared the body 
composition of tube-fed and oral-fed children with quadriplegic CP (Fung et al. 2002; 
Kong and Wong 2005; Stallings et al. 1995). In one study, the authors derived FM 
and FFM from measurements of TBW and found that children with a gastrostomy 
tube had nearly twice as much FM as those without (4.2 vs. 2.4 kg, respectively), but 
they did not differ significantly in their FFM (Stallings et al. 1995). However, the 
authors did not report if there were differences in weight or height between the two 
groups. The second study also reported in their cohort study of children with CP, that 
when the tube-fed children were compared with those of similar disability but who 
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were fed orally, greater height, triceps, and subscapular SD scores and less respiratory 
illness were observed (Fung et al. 2002). In the third study, the authors compared 
weight-for-height measurements and skinfold thicknesses in tube-fed and oral-fed 
children with CP and found that the tube-fed children had greater fat stores and 
weight-for-height (Kong and Wong 2005). However, the latter two studies did not 
include a measure of muscle mass, nor did any of the studies include a direct measure 
of body protein or bone mineralisation. The effect of gastrostomy tube feeding on 
body protein and bone mineralisation was explored further in a longitudinal 
nutritional rehabilitation study, the results of which are presented in Chapter 7. 
These finding of this cross-sectional study as well as recommendations and future 
directions for study are discussed in more detail in Chapter 8. 
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5 Study 2 - Comparison of methods 
5.1 Introduction 
The sophisticated technology used in this study to measure body composition, i.e. 
NAA and DXA, is not always readily accessible, particularly in the clinic or 
community setting. Therefore we sought to determine whether alternate simpler 
measures of body composition, such as skinfold anthropometry, can accurately predict 
body composition (particularly TBP and body fat) in children with quadriplegic CP. 
5.2 Aim 
To compare methods for measuring body composition in children with quadriplegic 
CP, specifically, (i) to determine whether indirect measures of body composition can 
accurately predict TBP; and (ii) to compare methods for measuring PBF.  
5.3 Participants 
5.3.1 Children with cerebral palsy 
The data collected on the 59 (22F, 37M) children with quadriplegic CP who 
participated in the cross-sectional study (Study 1) were used for this study to compare 
methods for measuring TBP and PBF.  
5.3.2 Control children 
5.3.2.1 Total body protein 
The control children for comparing methods of measuring TBP consisted of a subset 
of 28 (17F, 11M) children from the existing DXA and TBP control databases who 
underwent measurements of both DXA and TBP. 
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5.3.2.2 Percent body fat 
The control children for comparing methods of measuring PBF consisted of 172 (84F, 
88M) children from the existing DXA database who underwent measurements of both 
DXA and skinfold anthropometry. 
5.4 Study protocol 
The children underwent measurements of skinfold anthropometry, TBP by NAA and 
DXA as described in detail in Chapter 3. 
5.4.1 Total body protein 
TBP was calculated from the DXA measurement (TBPDXA) and also from skinfold 
anthropometry (TBPSKIN) following the method of Fuller et al (Fuller et al. 2001) as: 
TBP  = LTM – non-osseous mineral (0.2305 x BMC) – estimated TBW [FFM x 
hydration constant of FFM (HCFFM)]. 
For TBPDXA, the FFM was calculated as the sum of the two non-fat components, 
LTMDXA and BMC. For TBPSKIN, the LTM was calculated as FFMSKIN minus BMC, 
where BMC was measured by DXA. Age and sex specific HCFFM were used for the 
estimation of TBW (see Appendix D) (Fomon et al. 1982; Lohman 1986). The 
TBPDXA and TBPSKIN were then compared with the TBP derived from the direct 
assessment method of NAA (TBPNAA) using Bland & Altman plot analysis.  
5.4.2 Percent body fat 
PBFDXA was compared with PBFSKIN using two different sets of equations (Appendix 
B): 
(1) With four skinfold thicknesses (biceps, triceps, subscapular, and supra-iliac) using 
the equations of Brook (for prepubertal children) and Durnin & Rahaman (for 
pubertal children) (PBFSKIN-A), and  
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(2) With two skinfold thicknesses (triceps and subscapular) using the equations of 
Slaughter (PBFSKIN-B).  
5.5 Results 
5.5.1 Comparison of methods for measuring total body protein 
TBP values derived from NAA, DXA and skinfold anthropometry are shown in Table 
5.1 (pg 141).  
5.5.1.1 Comparison of total body protein derived from neutron activation 
analysis and dual-energy x-ray absorptiometry 
For the children with CP, complete data sets of both DXA and TBP measurements 
were obtained on 49 (20F, 29M) of the 59 study participants. The TBPNAA 
measurements of six children were discarded due to the decay and subsequent 
replacement of the radioactive sources, one child did not have a DXA scan, and a 
further three children with metallic implants were removed from the DXA data set. 
There was a strong positive correlation between TBPNAA and TBPDXA in the children 
with CP, r = 0.91, p < 0.001, and the control group r = 0.99, p < 0.001 (Figure 5.1, pg 
143).  
Bland & Altman plots were constructed to test agreement between TBPNAA and 
TBPDXA (Figure 5.2, pg 144). For the children with CP, there was a mean difference 
between TBPDXA and TBPNAA of 0.1 ± 0.5 kg. As shown in Figure 5.2 and Table 5.1, 
the 95 % range of agreement was -0.9 to 1.1 kg (-2 SD to +2 SD). For the average 
child in this study, this equated to a variation of 1.0 kg, or 33.3 %. Conversely, for the 
control children, TBPDXA underestimated body protein by a mean of 1.0 ± 0.6 kg with 
a variation of ± 15.4 %. In addition, in the control group there was a significant 
negative slope for mean difference versus average in Figure 5.2 (r = 0.74, p < 0.001), 
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indicating a systematic error when estimating body protein by DXA, i.e. DXA 
increasingly underestimated TBP as body protein increased. 
Statistical analysis (univariate ANCOVA) revealed that the pattern of the Bland & 
Altman plots was significantly different between the children with CP and the 
controls (p = 0.02). 
Furthermore, as previously reported in Chapter 4, there was a significant positive 
correlation between LTMDXA and TBPNAA in both the children with CP and the 
control group; r = 0.88, p < 0.001 (n = 49), r = 0.99, p < 0.001 (n = 28), respectively. 
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 Table 5.1 Comparison of methods for measuring total body protein 
 CP 
n = 49 (20F, 29M) 
Controls 
n = 28 (17F, 11M) 
 Mean ± SD Mean 
Difference3
95% limits of 
agreement3
Mean ± SD Mean 
Difference3
95% limits of 
agreement3
TBPNAA (kg) 3.0 ± 1.2  - 7.3 ± 3.6  - 
TBPDXA (kg) 3.1 ± 1.2 0.1 ± 0.5 -0.9 to 1.1 6.2 ± 3.11 -1.0 ± 0.62 -2.2 to 0.1 
TBPSKIN (kg) 3.4 ± 1.11,4 0.3 ± 0.54 -0.7 to 1.34 6.1 ± 2.81 -0.7 ± 0.62 -1.9 to 0.5 
CP, cerebral palsy; TBPNAA, total body protein derived from neutron activation analysis; TBPDXA, total body protein 
derived from dual-energy x-ray absorptiometry; TBPSKIN, total body protein derived from skinfold anthropometry. 
1 p < 0.001, significantly different from TBPNAA, paired t-test; 2 p < 0.001; significantly different from 0, one-sample t-test. 
3 Calculated from Bland and Altman plot analysis (see Figure 5.2 & Figure 5.4). 
4 n = 47 (18F, 29M) 
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Figure 5.1 Correlation between total body protein derived from neutron activation analysis and 
dual-energy x-ray absorptiometry  
The above figure demonstrates the strong positive correlation between total body protein 
derived from neutron activation analysis (TBPNAA) and dual-energy x-ray absorptiometry 
(TBPDXA) in children with cerebral palsy (CP) and controls. 
CP: n = 49, r = 0.88, p < 0.001  
Controls: n = 28, r = 0.99, p < 0.001 
Statistical analysis revealed a significant difference in the slopes of the regression lines for 
the above figure; p < 0.001 
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Figure 5.2 Bland & Altman plot analysis for total body protein derived from neutron activation 
analysis and dual-energy x-ray absorptiometry 
For children with cerebral palsy (CP), the mean difference (MD) between total body protein 
derived from DXA (TBPDXA) and total body protein derived from neutron activation analysis 
(TBPNAA) was 0.1 ± 0.5 kg. The 95% limits of agreement (2SD = 1.1 kg, -2SD = -0.9 kg) 
equate to a variation of 1.0kg, or 33.3 % when expressed as a percentage of the mean of 
TBPNAA. (-------) r = 0.06, p = 0.69.  
For control children, TBPDXA underestimated body protein by a MD of -1.0 ± 0.6 kg. The 95% 
limits of agreement (2SD = 0.1 kg, -2SD = -2.2 kg), when expressed as a percentage of the 
mean TBPNAA, equate to a variation of ±15.4 %. (-------) r = -0.74, p < 0.001. 
Statistical analysis revealed a significant difference in the slopes of the regression lines for 
the above figures; p = 0.02. 
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5.5.1.2  Comparison of total body protein derived from neutron activation 
analysis and skinfold anthropometry 
For the children with CP, there were complete data sets of skinfold anthropometry, 
DXA (for BMC) and TBP measurements on 47 (18F, 29M) of the 59 study 
participants, as the TBPNAA measurements of six children were discarded due to 
technical problems previously described, one child did not have a DXA scan, three 
children with metallic implants were removed from the DXA data set, and a further 
two children had only two out of the four skinfold thicknesses measured due to their 
inability to cooperate. 
There was a strong positive correlation between TBPNAA and TBPSKIN in both the 
children with CP and the control group r = 0.90, p < 0.001 and r = 0.99, p < 0.001, 
respectively (Figure 5.3, pg 147). Bland & Altman plots were constructed to test 
agreement between TBPNAA and TBPSKIN (Figure 5.4, pg 148). 
On average, TBPSKIN overestimated body protein in the children with CP by 0.3 ± 0.5 
kg (see Table 5.1, pg 142; Figure 5.4, pg 148). For the average child in this study, the 
95 % limits of agreement equated to a variation of ± 1.0 kg (33.3 %). For the control 
children, TBPSKIN underestimated body protein by 0.7 ± 0.6 kg (see Table 5.1, pg 142; 
Figure 5.4, pg 148). When expressed as a percentage of the mean TBPNAA, the 95 % 
limits of agreement equated to a variation of ± 16.5 %. 
In addition, in the control group there was a significant negative slope for mean 
difference versus average in Figure 5.4 (r = -0.65, p < 0.001), indicating a systematic 
error when estimating body protein from skinfold anthropometry, i.e. skinfold 
anthropometry increasingly overestimated TBP as body protein increased. Statistical 
analysis (univariate ANCOVA) revealed that the pattern of the Bland & Altman plots 
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was not significantly different between the children with CP and the controls (p = 
0.46). Further analysis revealed that the intercepts of the regression lines on the y-axes 
were significantly different between the two groups (p < 0.001). 
5.5.1.3 Correlation between total body protein and basic skinfold 
anthropometry 
As previously reported in Chapter 4, in the children with CP there was a significant 
positive correlation between TBPNAA and FFMSKIN (r = 0.86, p < 0.001), weight (r = 
0.80, p < 0.001), height (r = 0.75, p < 0.001), UAMA (r = 0.69, p < 0.001), and 
MUAC (r = 0.56, p < 0.001). In the control group there was a significant positive 
correlation between TBPNAA and FFMSKIN (r = 0.98, p < 0.001), weight (r = 0.97, p < 
0.001), and height (r = 0.93, p < 0.001). Data on UAMA were unavailable for the 
control group. 
 
146 
Chapter 5 
STUDY 2 - Comparison of methods 
TBPNAA (kg)
0 2 4 6 8 10 12 14 16
TB
P S
K
IN
 (k
g)
0
2
4
6
8
10
12
14
CP
Controls
 
Figure 5.3 Correlation of total body protein derived from neutron activation analysis and 
skinfold anthropometry 
The above figure demonstrates the significant relation between total body protein derived 
from neutron activation analysis (TBPNAA) and skinfold anthropometry (TBPSKIN) in both 
children with cerebral palsy (CP) and controls. 
CP: n = 47, r = 0.90, p < 0.001 
Controls: n = 28, r = 0.99, p < 0.001 
Statistical analysis revealed a significant difference in the slopes of the regression lines for 
the above figure; p < 0.001 
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Figure 5.4 Bland and Altman plots for total body protein derived from neutron activation 
analysis and skinfold anthropometry 
For the children with cerebral palsy (CP), total body protein derived from skinfold anthropometry 
(TBPSKIN) overestimated body protein by a mean difference (MD) of 0.3 ± 0.5 kg. The 95% limits of 
agreement (2SD = 1.3 kg, -2SD = -0.7 kg), equated to a variation of 1.0 kg, or 33.3 %, when expressed 
as a percentage of the mean of the total body protein derived from neutron activation analysis (TBPNAA). 
(-----) regression line, r = -0.17, p = 0.24. 
For the control children, TBPSKIN underestimated body protein by a MD of -0.7 ± 0.6 kg. The 95% limits 
of agreement (2SD = 0.5 kg, -2SD = -1.9 kg), when expressed as a percentage of the mean TBPNAA, 
equated to a variation of ± 16.5 %. (-------) regression line, r = -0.65, p < 0.001. 
Statistical analysis revealed no significant difference in the slopes of the regression lines for the above 
figures; p = 0.46; however a significant difference was found in the intercepts on the y-axes of the two 
figures, p < 0.001. 
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5.5.2 Comparison of methods for measuring percent body fat 
Percent body fat values derived from DXA and skinfold anthropometry are shown in 
Table 5.2, pg 151. For the children with CP complete data sets of both skinfold 
anthropometry and DXA measurements were obtained on 53 (19F, 34M) of the 59 
children, as two children did not have two of the four skinfold thicknesses measured 
due to their inability to cooperate, one child did not have a DXA scan due to the 
inability to remain motionless, and a further three children were removed from the 
DXA data set because they had metallic implants. 
5.5.2.1 Percent fat from dual-energy x-ray absorptiometry and skinfold 
anthropometry (PBFSKIN-A) 
There was a strong positive correlation between PBFDXA and PBFSKIN-A (refer to 
definition section 5.4.2, pg 139) in both the children with CP and the control group r = 
0.87, p < 0.001 (n = 53) and r = 0.91, p < 0.001 (n = 172), respectively (Figure 5.5, 
pg 152). Bland & Altman plots were constructed to test agreement between PBFDXA 
and PBFSKIN-A (Figure 5.6, pg 153). 
For the children with CP, the Bland and Altman plots revealed a significant mean 
difference of 3.7 ± 5.3 % between PBFDXA and PBFSKIN-A, with DXA producing a 
higher percent body fat in comparison to skinfold anthropometry. For the average 
child in this study, the 95 % limits of agreement equated to a variation of ± 10.5 %. 
For the control children, the Bland and Altman plots revealed a significant mean 
difference of -2.3 ± 3.4 % between PBFDXA and PBFSKIN-A, with DXA producing a 
lower percent body fat in comparison to skinfold anthropometry. The 95 % limits of 
agreement equated to a variation of ± 6.7 %. In addition, in both the children with CP 
and the control group there was a significant positive slope in Figure 5.6 (r = 0.58, p < 
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0.001; r = -0.44, p < 0.001, respectively). Statistical analysis (univariate ANCOVA) 
revealed that the pattern of the Bland & Altman plots was significantly different 
between the children with CP and the controls (p = 0.02). 
 
150 
 Table 5.2 Percent body fat derived from dual energy x-ray absorptiometry and skinfold anthropometry 
 CP 
n = 53 (19F, 34M) 
Controls 
n = 172 (84F, 88M) 
 Mean ± SD Mean 
Difference3
95% limits of 
agreement3
Mean ± SD Mean 
Difference3
95% limits of 
agreement3
PBFDXA (%)  17.5 ± 10.3   17.7 ± 8.0   
PBFSKIN-A (%) 13.9 ± 7.21 3.7 ± 5.32 14.1, -6.8 20.0 ± 6.51 -2.3 ± 3.42 4.4, -9.0 
PBFSKIN-B (%) 11.6 ± 6.21 5.9 ± 5.42 16.5, -4.6 16.7 ± 6.11 0.9 ± 3.52 7.7, -5.9 
CP, cerebral palsy; PBFDXA, percent body fat derived from dual-energy x-ray absorptiometry; PBFSKIN-A, percent body fat 
derived from skinfold anthropometry using the equations of Brook for prepubertal children, and Durnin and Rahaman for 
pubertal children; PBFSKIN-B, percent body fat derived from skinfold anthropometry using the equations of Slaughter et al.  
1 p < 0.001, significantly different from PBFDXA, paired t-test. 
2 p < 0.001, significantly different from 0, one-sample t-test. 
3 Calculated from Bland and Altman plot analysis (see Figure 5.6 & Figure 5.8). 
 
 
Chapter 5 
STUDY 2 - Comparison of methods 
PBFSKIN-A (%)
0 10 20 30 40 50
PB
F D
XA
 (%
)
0
10
20
30
40
50
CP
Controls
 
Figure 5.5 Correlation between percent body fat derived from dual-energy x-ray absorptiometry 
and skinfold anthropometry (PBFSKIN-A) 
The above figure demonstrates the significant relation between percent body fat derived from 
dual-energy x-ray absorptiometry (PBFDXA) and skinfold anthropometry using the equations of 
Brook for prepubertal children and Durnin & Rahaman for pubertal children (PBFSKIN-A)) in 
both children with cerebral palsy (CP) and controls.  
CP: n = 53, r = 0.87, p < 0.001 
Controls: n = 172, r = 0.91, p < 0.001 
Statistical analysis revealed a significant difference in the slopes of the regression lines for 
the above figure; p < 0.001. 
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Figure 5.6 Bland and Altman plots for percent body fat derived from dual-energy x-ray 
absorptiometry and skinfold anthropometry (PBFSKIN-A) 
For the children with cerebral palsy (CP), percent body fat derived from dual-energy x-ray 
absorptiometry (PBFDXA) overestimated body fat by a mean difference (MD) of 3.7 ± 5.3 % in 
comparison with percent body fat derived from skinfold anthropometry (PBFSKIN-A) using the 
equations of Brook for prepubertal children and Durnin & Rahaman for pubertal children. The 
95 % limits of agreement (2SD = 14.1%, -2SD = -6.8 %), equated to a variation of 10.5%. (----
-) regression line, r = 0.58, p < 0.001. 
For control children, PBFDXA underestimated body fat in comparison to PBFSKIN-A by a MD of -
2.3 ± 3.4 %. The 95 % limits of agreement (2SD = 4.4 %, -2SD = -9.0 %), equated to a 
variation of ± 6.7 %. (-------) regression line, r = 0.44, p < 0.001. 
Statistical analysis revealed a significant difference in the slopes of the regression lines for 
the above figures; p = 0.02.
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5.5.2.2 Percent body fat derived from dual-energy x-ray absorptiometry and 
skinfold anthropometry (PBFSKIN-B) 
There was a strong positive correlation between PBFDXA and PBFSKIN-B (refer to 
definition in section 5.4.2, pg 139) in both the children with CP and the control group; 
r = 0.89, p < 0.001 (n = 53) and r = 0.91, p < 0.001 (n = 172), respectively (Figure 
5.7, pg 156). Bland & Altman plots were constructed to test agreement between 
PBFDXA and PBFSKIN-B (Figure 5.8, pg 157). 
For the children with CP, the Bland & Altman plots revealed a mean difference of 5.9 
± 5.4 % between PBFDXA and PBFSKIN-B, with DXA producing a higher percent body 
fat in comparison to skinfold anthropometry (see Table 5.2, pg 151). For the average 
child in this study, the 95 % limits of agreement equated to a variation of ± 10.5 %. 
For the control children, the Bland and Altman plots revealed a mean difference of 0.9 
± 3.5 % between PBFDXA and PBFSKIN-B, with DXA producing a higher percent body 
fat in comparison to skinfold anthropometry. The 95 % limits of agreement equated to 
a variation of ± 6.8 %. In addition, in both the children with CP and the control group 
there was a significant positive slope in Figure 5.8, r = 0.76, p < 0.001; r = 0.55, p < 
0.001, respectively.  Statistical analysis (univariate ANCOVA) revealed that the 
pattern of the Bland & Altman plots was significantly different between the children 
with CP and the controls (p < 0.001). 
5.5.2.3  Correlations between percent body fat and skinfold anthropometry 
Correlation analysis revealed that of the four skinfold thicknesses (triceps, biceps, 
subscapular and suprailiac) and UAFA, the triceps skinfold was most highly 
correlated with PBF derived from DXA and from skinfold anthropometry, using 
either equation, in both the children with CP and the control group. The results are as 
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follows for the triceps skinfold thickness: in the children with CP, for PBFDXA, r = 
0.87, p < 0.001; for PBFSKIN-A, r = 0.85, p < 0.001; for PBFSKIN-B, r = 0.96, p < 0.001; 
in the control children, PBFDXA, r = 0.84, p < 0.001; for PBFSKIN-A, r = 0.87, p < 
0.001; for PBFSKIN-B, r = 0.95, p < 0.001. 
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Figure 5.7 Correlation between percent body fat derived from dual-energy x-ray absorptiometry 
and skinfold anthropometry (PBFSKIN-B) 
The above figure demonstrates the significant relation between percent body fat derived from 
dual-energy x-ray absorptiometry (PBFDXA) and skinfold anthropometry using the equations of 
Slaughter (PBFSKIN-B) in both children with cerebral palsy (CP) and controls.  
CP: n = 53, r = 0.89, p < 0.001 
Controls: n = 172, r = 0.91, p < 0.001 
Statistical analysis revealed a significant difference in the slopes of the regression lines in the 
above figure, p < 0.001. 
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Figure 5.8 Bland and Altman plots for percent body fat derived from dual-energy x-ray 
absorptiometry and skinfold anthropometry (PBFSKIN-B) 
For children with cerebral palsy (CP), percent body fat derived from dual-energy x-ray 
absorptiometry (PBFDXA) overestimated body fat by a mean difference (MD) of 5.9 ± 5.4 % in 
comparison to percent body fat derived from skinfold anthropometry (PBFSKIN-B) using the 
equations of Slaughter. The 95 % limits of agreement (2SD = 16.5 %, -2SD = -4.6 %), 
equated to a variation of 10.5 %. (-----) regression line, r = 0.76, p < 0.001. 
B
For control children, PBFDXA overestimated body fat in comparison to PBFSKIN-B by a MD of -
0.9 ± 3.5 %. The 95 % limits of agreement (2SD = 7.7 %, -2SD = -5.9 %), equated to a 
variation of ± 6.8 %. (-------) regression line, r = 0.55, p < 0.001. 
Statistical analysis revealed a significant difference in the slopes of the regression lines for 
the above figures; p < 0.001. 
157 
Chapter 5 
STUDY 2 - Comparison of methods 
5.6 Summary 
Comparison of methods to measure TBP found significant correlations between 
skinfold anthropometry and NAA, and between DXA and NAA. Simple 
anthropometric measures of FFM and UAMA, as well as LTM by DXA, were also 
found to correlate well with TBP by NAA. Despite these significant correlations, 
agreement between the methods revealed that both skinfold anthropometry and DXA 
produced wide and unacceptable individual variation in the estimation of TBP in 
children with CP and in the control population.  
Comparison of methods to measure PBF found a strong positive correlation between 
PBF derived from DXA and skinfold anthropometry in both the children with CP and 
controls. Yet method agreement analysis revealed wide variation in both groups, with 
a larger variation seen in the children with CP. On average, DXA produced a higher 
PBF than skinfold anthropometry, using either equation, in the children with CP. 
However, in the control group, DXA on average produced a lower PBF than skinfold 
anthropometry using the Brook, Durnin & Rahaman equations, but a slightly higher 
PBF compared to the Slaughter equations. In addition in both groups, DXA appeared 
to underestimate PBF in the lower ranges of fat, and overestimate PBF in the higher 
ranges in comparison to skinfold anthropometry.  
5.7 Discussion 
5.7.1 Comparison of methods to measure body protein 
5.7.1.1 Significance of findings 
Comparison of methods to measure TBP revealed significant correlations between 
TBP derived from DXA and skinfold anthropometry with TBP derived from NAA. 
Furthermore, significant correlations were found between simple anthropometric 
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measures of FFM and UAMA, as well as LTM by DXA, with TBP by NAA, 
demonstrating that both of these methods can be used as indicators of body protein. 
However, method agreement analysis found that for individuals DXA and skinfold 
anthropometry do not provide accurate estimates of TBP.  
5.7.1.2 Comparisons with other studies 
There have been no other studies that have measured TBP in children with CP. 
However, Fuller et al, in healthy children, compared TBP estimated from a 4C model 
with that from DXA using the same methodology as this study (Fuller et al. 2001). In 
agreement with the findings from this study of children with CP, they reported that 
DXA provided an acceptable estimate of TBP for the group, but found considerable 
individual variation suggesting that the methods are not interchangeable for assessing 
individuals. However, in contrast to this study, the authors did not measure body 
protein directly. To derive TBP using the 4C model they combined measurements of 
body water, BMC and FM and subtracted the total from body weight. This method 
does not take into account the presence of other body components such as glycogen, 
free amino acids, nucleic acids, and urea. The authors acknowledge that such 
components were most likely to be included in the estimate of TBP. However, they 
point out that such components are also included in the DXA model for estimating 
body protein because components that are not either measured or predicted (e.g. free 
glycogen, free amino acids) are included with the estimate of TBP. Interestingly, the 
study showed that incorporating estimated rather than measured hydration factors for 
FFM in the DXA model improved its accuracy for predicting TBP and also reduced it 
variability in predicting TBP for individuals. The authors hypothesise that this may 
have occurred because when an individual’s hydration deviates further from the 
assumed population-specific constant, which could be the case in children with CP; 
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discrepant measurements of fat-free soft tissue (FFST) would be obtained. Under such 
circumstances, discrepant FFST assessments would lead to erroneous estimates of 
TBP when measured TBW is then integrated into the DXA model i.e. although TBW 
is correct, the difference between FFST and TBW is incorrect and it was by difference 
that TBP was calculated.  
Using similar methodology to this study, but in adult patients undergoing peritoneal 
dialysis, Borovnicar found that on average for the group FFM from DXA was similar 
to FFM derived from a 4C model of body composition using direct measurement of 
TBP by NAA (Borovnicar et al. 1996). However, again there was wide individual 
variation suggesting that DXA may be accurate to derive body protein for groups, but 
not for individuals. Furthermore, they reported that DXA increasingly overestimated 
FFM in individuals with increasing levels of over-hydration, and vice versa.  
5.7.2 Comparison of methods to measure percent body fat 
5.7.2.1 Significance of findings 
Comparison of methods to measure PBF revealed poor agreement between PBF 
derived from DXA and PBF derived from skinfold anthropometry, using either 
equation. However, correlation analysis revealed strong positive correlations between 
the triceps skinfold thickness and PBF derived from DXA and skinfold 
anthropometry, using either equation, indicating that the triceps skinfold thickness can 
be used in the clinic setting as an indicator of fat stores. Further studies, using a 4C 
model of body composition, need to be done in order to validate both skinfold 
anthropometry and DXA as an accurate measure of PBF. 
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5.7.2.2 Comparisons with other studies 
Van den Berg-Emons compared PBF measured by skinfold anthropometry with that 
derived from the deuterium dilution (D2O) technique in a small group of children with 
CP (n = 22) and healthy controls (n = 10) (van den Berg-Emons et al. 1998). Like the 
current study, they also compared PBF derived from the Durnin and Rahaman 
equations and with that derived from the Slaughter equations. Overall, they found that 
PBF predicted from skinfold anthropometry, using either equation, was significantly 
lower than that determined by the D2O technique in the children with CP, but not in 
the controls. Interestingly, they also found a similar correlation to this study, that D2O 
(rather than DXA) underestimated PBF in the lower ranges of fat and overestimated 
PBF in the upper ranges compared with PBF from skinfold anthropometry.  
The authors hypothesised that a proportionally large internal fat deposit and a 
different distribution of subcutaneous fat may be responsible for their finding. On the 
other hand, the D2O technique uses assumed hydration factors, and as discussed in the 
previous Chapter, these may not be applicable to children with CP. The authors do in 
fact acknowledge this, and state that in the event of a higher proportion of water in 
FFM the discrepancies found between PBF derived from skinfold anthropometry and 
D2O would be even more pronounced because, using the D2O technique, an increase 
in the hydration factor would diminish calculated FFM and body fat would appear 
increased (Bandini et al. 1991). This could account for the difference in findings 
between the children with CP and controls. Alternatively, the lack of difference in the 
control group could be due to the small number of children studied.   
In a similar study to that of van den Berg-Emons, Stallings et al also found that FM 
derived from skinfold anthropometry, using the Slaughter equations, was significantly 
lower than that derived from D2O in the children with spastic quadriplegic CP (n = 
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28), but was not significantly different in the control group (n = 39) (Stallings et al. 
1995). 
The only study to compare PBF derived from both skinfold anthropometry and DXA 
with a dilution technique (18O) in people with CP was done in adults (Hildreth et al. 
1997). The authors reported that they found no significant difference between PBF 
measured by DXA and 18O dilution (mean difference 0.06 ± 9.6 %), but found a large 
discrepancy between PBF derived from skinfold anthropometry and 18O dilution 
(mean difference -6.3 ± 12.3 %). However the limits of agreement for DXA versus 
18O dilution were wide 9.67 % to -9.56 %, and, like the current study and that of van 
den Berg-Emons, they also found a significant positive correlation between the mean 
versus the difference on the Bland and Altman plot. This suggests a bias with DXA at 
the low and high ranges of body fatness particularly in people with CP. Yet 
surprisingly the authors concluded that DXA had good agreement with the 18O 
dilution technique and is therefore an accurate measure of body composition, which 
may have been the case for the total group, but not for individuals. 
In conclusion, simple skinfold anthropometry can be used in the clinic setting as 
indicators of body protein and body fat, but they cannot be used to provide an 
accurate estimate of these body compartments. Further studies using a 4C model of 
body composition are required in order to validate the use of DXA and skinfold 
anthropometry as accurate and precise measures of body composition in children with 
CP. In the 4C model used for validation, gold standard techniques must be used, i.e. 
TBW is measured by dilution techniques, TBP by NAA, BMC by DXA, and then 
body fat is determined by subtracting the sum of TBW, TBP, and BMC from body 
weight. This recommendation as well as limitations of the study and future directions 
are discussed further in Chapter 8. 
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6 Study 3 - Resting energy expenditure and dietary 
intake 
6.1 Introduction 
There have been a limited number of studies measuring REE in children with CP, and 
only one study that has related measured REE with dietary intake and body 
composition parameters. REE and dietary intake is important to assess in this group of 
children so that dietitians and clinicians can tailor their advice and/or nutritional 
therapies to suit the specific requirements, and optimise the care, of these children.  
6.2 Aims 
To measure REE and energy and nutrient intake in children with quadriplegic CP, and 
to relate these measures to their body composition. 
6.3 Resting energy expenditure by indirect calorimetry 
6.3.1 Participants 
6.3.1.1 Children with cerebral palsy 
Forty (12F, 28M) of the 59 children with CP who participated in the cross-sectional 
study (Study 1) underwent measurements of REE by indirect calorimetry. As 
previously mentioned, the first 17 (8F, 9M) children with CP enrolled in the cross-
sectional study did not have their REE measured because it was not part of the study 
protocol at that stage. A further two (2F) children with CP declined to have their REE 
measured. In addition, one female with CP had an REE that was more than two 
standard deviations above the mean of the group and her data were removed from the 
analyses. 
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6.3.1.2 Control children 
The control children for this study was from a separate control database consisting of 
111 (42F, 69M) healthy children who had undergone REE measurements at CHW on 
the same machine (unpublished data). 
6.3.2 Study protocol 
The children with CP and the controls underwent measurements of REE and 
anthropometry as outlined in Chapter 3.  
6.3.3 Data analysis 
All data were analysed as outlined in Chapter 3 using the programme SPSS (version 
11.5.1, SPSS Inc, Chicago, USA). The significance level was set at p < 0.05.  
The measured REE of the children with CP was compared with:  
(i) predicted REE using the Schofield equations based on body weight 
(PREESCHO); and with 
(ii) predicted REE using equations developed from the control database based 
on FFMSKIN (PREECTRL).  
6.3.4 Results 
The anthropometric characteristics of the children with CP and controls are shown in 
Table 6.1 (pg 167). The children with CP were of similar age to the control group, 
however, they were significantly shorter and lighter, and had less FFM and body fat 
than the controls. 
The body composition parameters and measured REE were significantly different 
between male and female controls, but not between male and females children with 
CP; therefore the data for measured REE were analysed with sexes separated. 
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However, the data for predicted REE and percent of measured versus predicted was 
analysed with sexes combined because the predictive equations are adjusted for sex. 
6.3.4.1 Measured versus predicted resting energy expenditure from Schofield 
equations 
In the male and female children with CP, the measured REE was significantly lower 
than predicted using the Schofield equations for age and weight (Table 6.2, pg 168). 
Whereas, in the control group, the measured REE was significantly lower than 
predicted in the females and significantly higher than predicted in the males. 
Therefore, new predictive equations were developed using the control database. 
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Table 6.1 Characteristics of children with cerebral palsy and controls 
 Females Males 
 CP 
N = 11 
Controls 
N = 42 
CP 
N = 28 
Controls 
N = 69 
Age (y) 9.2 ± 2.6 9.4 ± 2.3 9.8 ± 4.1 11.1 ± 4.1 
Height (cm) 120.0 ± 18.51 137.6 ± 16.6 122.6 ± 18.31 146.5 ± 23.1 
Height SDS -3.3 ± 1.51 0.4 ± 1.0 -3.1 ± 1.71 0.4 ± 0.9 
Weight (kg) 18.7 ± 7.01 34.7 ± 12.5 22.0 ± 7.21 42.4 ± 20.7 
Weight SDS -2.6 ± 0.91 0.3 ± 0.9 -2.1 ± 1.51 0.3 ± 1.1 
FFMSKIN (kg) 16.4 ± 4.21, 3 27.2 ± 8.3 18.5 ± 5.61 34.1 ± 16.1 
PBFSKIN (%) 13.2 ± 8.72, 3 20.5 ± 6.4 14.9 ± 7.82 18.7 ± 6.4 
Data is mean ± SD. CP, cerebral palsy; FFMSKIN, fat-free mass measured by skinfold 
anthropometry; PBFSKIN, percent body fat measured by skinfold anthropometry; SDS, 
standard deviation score. 
A two-factor ANOVA was used to test for differences between CP and control group, using 
sex and group (CP or control) as fixed factors. A two-tailed, one-sample t-test was used to 
test for differences between SD scores and reference data (test value = 0).  
1 p < 0.001; 2 p < 0.05; significantly different from control group. 
3 n = 10 
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Table 6.2 Measured versus Schofield predicted resting energy expenditure 
 Females Males 
 CP 
N = 11 
Controls 
N = 42 
CP 
N = 28 
Controls 
N = 69 
MREE (kJ / 24hr) 2044 ± 6281 4315 ± 1001 2919 ± 12451 6309 ± 1729 
PREESCHO (kJ / 24hr) 3670 ± 585 4800 ± 845 4238 ± 650 5887 ± 1583 
MREE / PREESCHO (%) 57.4 ± 21.02 89.4 ± 9.62 67.8 ± 24.22 107.4 ± 9.52
Data is mean ± SD. CP, cerebral palsy; MREE, measured resting energy expenditure by 
indirect calorimetry; PREESCHO, predicted resting energy expenditure calculated from the 
Schofield equation using weight only.  
A two-factor ANOVA was used to test for differences between CP and control group, using 
gender and group (CP or control) as fixed factors. A two-tailed, one-sample t-test was used to 
test for differences between measured as a percent of predicted REE (test value = 100).  
1 p < 0.001; significantly different from control group.  
2 p < 0.001; significantly different from 100 %. 
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6.3.4.2 Regression analysis of control data 
Linear regression analysis was performed separately on the male and female control 
groups in order to develop predictive equations for REE. The most significant 
predictor of REE in both the female and male control groups was found to be 
FFMSKIN, followed by weight, height, age, and then FMSKIN (Table 6.3, pg 171). 
FFMSKIN accounted for 80 % of the variance in the measured REE for female controls 
and 90 % for male controls. 
6.3.4.3 Regression analysis of cerebral palsy data 
The REE data of the children with CP were combined for linear regression analysis 
because of the small number of females and because the body composition parameters 
did not differ significantly between sexes (Table 6.3, pg 171). In the children with CP 
the most significant predictor of REE was FFMSKIN, followed by weight, age, height, 
and then FMSKIN. FFMSKIN accounted for 34 % of the variance in the measured REE 
for the CP group with sexes combined. Figure 6.1 (pg 173) demonstrates the 
significant relation between FFMSKIN and measured REE in both the children with CP 
and controls. 
6.3.4.4 Predictive equations derived from control data 
The following predictive equations for REE were developed from linear regression 
analysis of the measured REE versus FFMSKIN in the control group: 
Females: REE (kJ / 24hr) = 1370 + 108.2 x FFMSKIN (kg) 
Males: REE (kJ / 24hr) = 2778 + 102.7 x FFMSKIN (kg)  
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6.3.4.5 Measured resting energy expenditure adjusted for fat-free mass 
The REE data of the children with CP were then re-analysed using the above 
predictive equations derived from the control data (Table 6.4, pg 172). The children 
with CP had a significantly reduced REE compared to controls.  
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Table 6.3 Regression analysis of resting energy expenditure data 
Controls CP  
Females 
N = 42 
Males 
N = 69 
Sexes combined 
(11F, 28M) 
FFMSKIN (kg) 0.801 0.901 0.341
Weight (kg) 0.791 0.881 0.222
Height (cm) 0.741 0.831 0.172
Age (y) 0.551 0.701 0.182
FMSKIN (kg) 0.551 0.491 0.01 
Data is adjusted r-squared. CP, cerebral palsy; FFMSKIN, fat-free mass measured by skinfold 
anthropometry; FMSKIN, fat mass measured by skinfold anthropometry. 
Linear regression analysis was performed using measured REE as the dependent factor with 
FFMSKIN, weight, height, age, TBPNAA and FMSKIN entered as separate independent variables. 
1 p < 0.001; 2 p < 0.01 
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 Table 6.4 Measured versus control predicted resting energy expenditure  
 Females Males 
 CP 
N = 11 
Controls 
N = 42 
CP 
N = 28 
Controls 
N = 69 
MREE (kJ/24hr) 2044 ± 6281 4315 ± 1001 2919 ± 12451 6309 ± 1729 
PREECTRL (kJ/24hr) 3091 ± 464 4315 ± 900 4677 ± 575 6309 ± 1644 
MREE/ PREECTRL (%)  68.2 ± 25.32 100.0 ± 9.4 61.2 ± 22.12 100.0 ± 9.1 
Data is mean ± SD. CP, cerebral palsy; MREE, measured resting energy expenditure by 
indirect calorimetry; PREECTRL, predicted resting energy expenditure calculated from control 
group regression equations based on fat-free mass. 
A two-factor ANOVA was used to test for differences between CP and control group, using 
sex and group (CP or control) as fixed factors. A two-tailed, one-sample t-test was used to 
test for differences between measured as a percent of predicted REE (test value = 100).  
1 p < 0.001; significantly different from control group. 
2 p < 0.001; significantly different from 100 %. 
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Figure 6.1 Fat-free mass versus measured resting energy expenditure 
The above figure demonstrates a significant relation between measured resting energy 
expenditure (REE) and fat-free mass measured by skinfold anthropometry (FFMSKIN) in both 
children with cerebral palsy (CP) and controls. The figure also demonstrates that after 
adjustment for FFMSKIN, the measured REE of children with CP is below that of controls. 
CP: n = 39, r = 0.60, p < 0.001. 
Controls: n = 111, r = 0.90, p < 0.001. 
Statistical analysis revealed a significant difference in the slopes of the regression lines in the 
above figure; p < 0.001. 
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6.3.4.6 Influence of nutritional status and anti-epileptic medication use on 
resting energy expenditure 
Due to the relatively low contribution of FFMSKIN to predict REE in children with CP, 
nutritional status, tube feeding, and anti-epileptic medication use were investigated as 
possible influences on the measured REE. Regression analysis was performed in order 
to investigate any significant associations between the aforementioned factors and 
measured REE and measured REE as a percent of REE predicted from control data. 
Fat mass (FMSKIN) was chosen as an indicator of nutritional status. No significant 
associations were found with FMSKIN, or with children who were fed via a tube (n = 
28) and those fed orally (n = 11), with measured REE or with measured REE as a 
percent of REE predicted from control data (data not shown). 
Twenty-seven of the 39 children with CP who had their REE measured were taking 
one or more anti-epileptic medications. Linear regression analysis was conducted to 
test if there was an influence of anti-epileptic medications on the measured REE or on 
the percent of measured REE versus REE predicted from control data. There was no 
significant association found (data not shown). 
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6.4 Dietary intake 
6.4.1 Participants 
6.4.1.1 Children with cerebral palsy 
Thirty-eight of the 59 children with CP who participated in the cross-sectional study 
completed a three-day weighed food record.  
The first 17 children enrolled in the study did not complete food records because it 
was not part of the study protocol at that stage. The parents/carers of a further four 
children with CP declined to keep food records due to lack of time. 
6.4.1.2 Reference data 
The energy intake of the children with CP was compared with their measured REE. 
Protein and micro-nutrient (vitamin and mineral) intakes were compared with 
Australian RDIs for age. 
6.4.2 Study protocol 
The study participants completed three-day weighed food records as outlined in 
Chapter 3. 
6.4.3 Data analysis 
All data were analysed using the programme SPSS (version 11.5.1, SPSS Inc, 
Chicago, USA). The significance level was set at p < 0.05.  
Energy intake was expressed in kilojoules per day as well as a percentage of measured 
REE. Micronutrient intakes were expressed as a percentage of the RDI. The energy 
intake of the children with CP was not normally distributed and is presented as 
median with IQR.  
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A Mann-Whitney U test was used to examine differences in energy intake, expressed 
as a percentage of measured REE, between oral-fed and tube-fed children with CP. A 
two-tailed one-sample t-test was used to test if micronutrient intake, expressed as a 
percentage of RDI, was significantly below 100 % (test value = 100). 
6.4.4 Results 
The results of the three-day weighed food records are shown in Table 6.5 (pg 179). 
6.4.4.1 Tube-fed 
Eighteen of the 38 children who completed food records were fed either partially or 
completely by a gastrostomy or naso-gastric tube. Fifteen of these children received 
100 % of their energy intake via tube feeds; the remaining three children received 13 
%, 27 % and 34 % of their energy intake from oral feeds in addition to tube feeds.  
6.4.4.2 Oral-fed 
Twenty of the children with CP who completed food records were fed orally. Of this 
oral-fed group only eight of the food records were entirely weighed. The remaining 12 
records included unweighed amounts and metric measures, e.g. “2 biscuits”, “1 slice 
of bread”, and metric measures, e.g. “1 cup of rice”, “3 tablespoons of mashed 
potato”.  
6.4.4.3 Enteral formulas and supplements 
Of the 18 children who were tube-fed, six were fed with PediaSure® (Abbott, 
Chicago, IL, USA), six with Jevity® (Abbott), two with Ensure® (Abbott), two with 
TwoCal HN® (Abbott), one with Osmolite (Abbott), and one child was on the 
ketogenic diet (a combination of MCT oil® (SHS, Liverpool, UK), Calogen® (SHS), 
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Carbohydrate-Free Mixture® (SHS), Polyjoule® (Nutricia, Zoetermeer, The 
Netherlands), and Paediatric Seravit® (SHS)). 
Three children in the oral-fed group were taking a vitamin and/or mineral supplement 
at the time of the study. One child had 300 mg/day of calcium, another 100 mg/day of 
Vitamin C plus 121 mg of calcium, and the third had 1.7 mg/day of thiamine, 1.7 
mg/day of iron, plus 33 mg/day of vitamin C. In addition, in the oral-fed group, five 
children, including one who also took a vitamin and mineral supplement, consumed 
enteral supplements orally; Ensure® (Abbott) (n = 4), PediaSure® (Abbott) (n = 1), 
and Nurture Follow-On® (Heinz, London, UK) (n = 1).  
6.4.4.4 Energy and micro-nutrient intakes of children with cerebral palsy 
The median energy intake of the children with CP was 5222 kJ (IQR 4392 to 6636 
kJ).  The energy intakes of the children with CP were widely variable and not 
normally distributed and are therefore presented in the text as medians with IQR. The 
average micro-nutrient intakes, including supplements, of the children with CP were 
not below recommended intakes (Table 6.5, pg 179). The energy intakes of the 
children with CP were compared with their measured REE, the results of which are 
presented in section 6.4.4.6 (pg 180). 
6.4.4.5 Tube-fed versus oral-fed children with cerebral palsy 
6.4.4.5.1 Energy and protein intakes 
The group was then sub-divided into tube-fed and oral-fed to compare results (Table 
6.5, pg 179). The median energy intake of the tube-fed group was 5020 kJ/day (IQR 
4055 to 6520 kJ), which was not significantly different to the oral-fed group, 5471 
kJ/day (IQR 4432 to 6794 kJ). The average protein intake of the oral-fed group was 
significantly higher than the tube-fed group. 
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6.4.4.5.2 Micro-nutrient intakes 
Intakes of thiamine, magnesium, iron and zinc were significantly lower in the oral-fed 
group compared with the tube-fed group, but were all above or close to 100 % of the 
RDI.
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Table 6.5 Protein and micro-nutrient intakes of children with cerebral palsy  
 Combined Group 
N = 38 (14F, 24M) 
% of RDI 
Tube-fed 
N = 18 (5F, 13M) 
% of RDI 
Oral-fed 
N = 20 (9F, 11M) 
% of RDI 
Protein  281 ± 118 222 ± 81 334 ± 1231
Thiamine  228 ± 122 297 ± 131 167 ± 722
Riboflavin 182 ± 64 197 ± 76 169 ± 48 
Niacin  220 ± 96 235 ± 112 206 ± 78 
Vitamin C  531 ± 340 620 ± 322 451 ± 343 
Vitamin A  228 ± 113 241 ± 72 216 ± 142 
Magnesium  152 ± 70 181 ± 74 125 ± 542
Calcium  103 ± 39 116 ± 45 93 ± 28 
Phosphorus  114 ± 40 105 ± 40 123 ± 39 
Iron  172 ± 80 221 ± 77 128 ± 542
Zinc  146 ± 80 198 ± 72 99 ± 542
Data is mean ± SD. RDI, recommended dietary intake.  
Data for the oral-fed group includes nutritional supplements. 
A two-tailed one-sample t-test was used to test if micronutrient intake, expressed as a 
percentage of RDI, was significantly different to 100 % (test value = 100). 
1 significantly higher than tube fed group; p < 0.01. 
2 significantly lower than tube fed group; p < 0.01. 
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6.4.4.6 Energy intake versus measured resting energy expenditure 
The energy intakes of the children with CP were compared with their measured REE 
by indirect calorimetry. Two children with CP who completed food records did not 
have their REE measured. For the whole group (n = 36), the median energy intake 
expressed as a percentage of measured REE was 204 % (IQR 140 - 304 %); for the 
tube-fed group (n = 17) it was 149 % (IQR 124 – 264 %) and for the oral-fed group (n 
= 19) it was 272 % (IQR 190 – 410 %). 
Of the children who received 100 % of their energy intake from tube feeds (n = 14), 
their median energy intake as a percent of measured REE was 154 % (IQR 118 – 262 
%), which was not significantly different from that of the children who received some 
oral food as well as tube feeds (n = 3) (149 %; IQR 128 – 306 %), but was 
significantly lower than the oral-fed group (p = 0.006, Mann-Whitney U Test). 
In the oral-fed group, the median energy intake as a percent of measured REE for the 
eight records that were completely weighed was 190 % (IQR 139 – 361 %) compared 
to 279 % (IQR 201 – 406 %; n = 12) for the partially unweighed records. This was not 
statistically significantly different (p = 0.20; Mann-Whitney U test). 
6.4.4.7 Correlations between energy intake and resting energy expenditure 
There were no significant correlations between energy intake and measured REE, in 
the group as a whole or when subdivided into tube-fed and oral-fed (data not shown). 
6.4.4.8 Correlations between nutrient intake and body composition 
A correlation analysis was not performed to test for associations between nutrient 
intakes and body composition parameters due to the finding that the food records were 
overestimated. 
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6.5 Summary 
The REE of the children with CP was significantly reduced in comparison with the 
Schofield equations, which are based on weight. However, the Schofield equations 
did not accurately predict the REE of the control children. The equations 
overestimated REE in female controls and underestimated in male controls. It was 
found that FFM, rather than body weight, was the most significant predictor of REE 
in the control group and in the children with CP, accounting for 80 % of the variance 
in female controls and 90 % in males, yet accounted for only 34 % in the children 
with CP. The REE data from the children with CP were reanalysed using the control 
predictive equations based on FFM, however, on average, their REE was still 
significantly reduced. There was also wide variation in the group, with REEs ranging 
from 23.5 to 125.1 % of predicted from the control data.   
Nutritional status, gastrostomy tube feeding, and use of anti-epileptic medications 
were also investigated as possible influences on the measured REE in the children 
with CP, but were found to be insignificant.  
The dietary intake data presented in this Chapter revealed that the energy intakes of 
the children with CP were grossly overestimated by the weighed food records. The 
median reported energy intakes were double the measured REE. Furthermore, the 
food records of oral-fed children were overestimated to a greater extent than the tube-
fed children.  
Furthermore, no correlation was found between energy intake and measured REE 
confirming the inaccuracy of food records in this group of children. 
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6.6 Discussion 
6.6.1 Resting energy expenditure 
The measured REE of children in this study was significantly less than that of control 
children of a similar size and FFM.  
6.6.1.1 Comparisons with other studies 
In a similar study to the current study, Stallings et al studied the body composition 
and REE by indirect calorimetry of 61 children with spastic quadriplegic CP and a 
normal control group (Stallings et al. 1996). The average age, weight and PBF of the 
group were similar to this study, and one-quarter of the group were tube-fed, 
compared to approximately one-third for this study. Despite the similarities of the 
methods and study population to the current study, the measured REE expressed as a 
percentage of that predicted from the WHO equations was 91 %. While this was 
significantly lower than 100 %, and significantly lower in comparison to their control 
group (105 %), it was not reduced to the same extent as this study. The authors did not 
report the range of results, but the SD of the measurement of the whole group was 20 
%, compared to 12 % for the control group, suggesting wide variation. Furthermore, 
the authors found that FFM, by skinfold anthropometry, was the most significant 
contributor to measured REE, however they did not report the r-squared value. They 
adjusted the measured REE for both FFM and fat stores based on the triceps skinfold 
thickness. They found that in children with low fat stores (n = 47) REE was 88 % of 
predicted, while for those with adequate fat stores (n = 14), it was 101 %. In this 
study, no significant correlation was found between REE and FM. The authors 
suggested that the lower REE found in the group with low fat stores may have been an 
adaptation to chronically low food intake, a recognised metabolic change in response 
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to a low energy intake. In the same study, the authors also measured TEE using 
doubly-labelled water. They reported that the ratio of TEE to REE, an indication of 
the amount of energy required above REE, was significantly lower for all children 
with CP (1.23), and for those with low fat stores (1.29) and those with adequate fat 
stores (1.07) than in the control group (1.57). 
In the current study, the finding of a significantly reduced measured REE in 
comparison to that predicted from the Schofield equations is in contrast to the findings 
of Bandini et al (Bandini et al. 1991). Bandini et al studied body composition and 
REE, by indirect calorimetry, of nine adolescents with CP, six of whom had 
quadriplegic CP, four were non-ambulatory. They found no significant difference 
between measured REE and that predicted from the WHO equations based on weight 
and age (range 85 to 110 %). Their methodology was similar to the current study. 
However, the number of participants in their study was small, and the average age 
was 18.6 years, compared to 10.4 years in the current study. In addition, most of their 
participants were above the 95th centile for PBF, averaging 34 %, and not all were as 
severely disabled as in the current study. Also in contrast to the current study, they 
found no significant correlation between measured REE and FFM, which may be due 
to their narrow range of data and small numbers. However, they did find that the 
measured REE was significantly lower when compared with their control group. Yet 
their control group was significantly taller and had a higher FFM than the group with 
CP and no adjustments were made for this. The authors also measured TEE by 
doubly-labelled water and, in agreement with Stallings et al, they reported a 
significantly lower TEE to REE ratio in the six non-ambulatory adolescents with CP 
compared with their control group; 1.23 versus 1.76, respectively.  
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Interestingly the same group of authors conducted another similar study a few years 
later, this time in a group of 12 adolescents with severe CNS disorders (Bandini et al. 
1995). In contrast to their previous study, all of the participants were exclusively 
gastrostomy tube-fed, and the measurement of REE was performed while non-fasted. 
This time they found that the measured REE was only 63.7 % of predicted from the 
WHO equations with a range of 37.8 – 96.8 %, which was similar to findings from the 
current study. In addition, they found that the best predictor of REE was length; 
however there was no measure of FFM, and length was measured by summing the 
lengths of five segments of the body, and therefore may be inaccurate.  
Azcue et al studied the REE by indirect calorimetry of 13 exclusively gastrostomy 
tube-fed children with spastic quadriplegic CP (Azcue et al. 1996). The results 
showed that the mean measured REE as a percent of predicted from the WHO 
equations, based on age and weight, in the children with CP was 79 ± 21 % (range 50 
to 112 %), and in the control group 104 ± 9 % (n = 21). The authors found that the 
best predictor of REE was ICW measured by dilution techniques (r = 0.35, p = 0.03), 
and reported that FFM was a poor predictor of REE.  
In summary, the current study and the aforementioned studies, indicate that the energy 
requirements of children with CP are lower than healthy children of the same size, are 
widely variable and difficult to estimate using the currently available equations. On 
average, the recommended age-specific equations to estimate energy requirements 
based on healthy, physically active children, tend to overestimate the energy 
requirements of children with CP. However, despite the many years of research in this 
area, there are still no equations available to accurately estimate the energy 
requirements of children with CP. Thus the current recommendations are to either 
measure REE by indirect calorimetry, however such sophisticated technology is not 
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available at all centres; or to roughly estimate energy requirements using the currently 
available equations and adjust energy intake according to weight change.  
6.6.2 Dietary intake 
In a similar study of 50 children with spastic quadriplegic CP, Stallings et al also 
found energy intakes from three-day weighed food records were grossly 
overestimated in comparison with measured REE by indirect calorimetry (Stallings et 
al. 1996). They reported that the average energy intake was 170 % when expressed as 
a percentage of their measured REE. Furthermore, this was not significantly different 
to their control population of physically active children (160 %). Fifteen of the 
children in their study were tube-fed, but they did not separate them for analysis. 
However, they did separate children according to their fat stores based on the triceps 
skinfold thickness and found that children with low fat stores (n = 38) overestimated 
their energy intakes to a greater extent than those with adequate fat stores (n = 12), 
180 % versus 150 %, respectively. The authors also measured TEE by doubly-labelled 
water in half of the children with CP and in most of the control group. They found 
that the ratio of reported energy intake to TEE, indicating the accuracy of the dietary 
intake data, was 0.98 in the control group, but was significantly higher in the CP 
children overall (1.51) and within the groups with low (1.54) and adequate (1.44) fat 
stores. This indicates a 44 to 54 % overestimation of reported energy intake. 
The current study, and that of Stallings et al, confirms that estimating energy and 
nutrient intake from food records in oral-fed children with CP is difficult. The 
overestimation of energy intake seen in both studies may be due to food losses from 
spillage, vomiting and regurgitation due to the poor oral skills in this population. If 
this was the reason, then it would be expected that food records from exclusively 
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tube-fed children would be more accurate because there are no or minimal losses from 
spillage. In this study we found that the ratio of energy intake to measured REE of 
exclusively tube-fed children (1.54) was significantly lower than that of the oral-fed 
group (2.72), but still appeared to be overestimated compared to reports of TEE 
discussed in section 6.6.1.1. Similar to the current study, Azcue et al assessed energy 
intakes of a group of exclusively tube-fed children with CP (n = 13) and found that 
they were on average 1.1 times their measured REE (Azcue et al. 1996).  
The verdict that the food records were overestimated is also supported by the results 
of the cross-sectional study, Chapter 4, which found that this group of children were 
severely malnourished. If the food records were an accurate estimate of their energy 
intakes then these children could not possibly be malnourished. 
In conclusion, the results from the current study demonstrated that the REE of 
children with severe CP is on average greatly reduced and widely variable and does 
not appear to be strongly influenced by any one body composition parameter. In 
addition, analysis of food records found that energy intakes in oral-fed children with 
CP are on average grossly overestimated and are therefore of limited value in this 
population. Reasons for these findings including limitations of the study, 
recommendations and future directions are discussed further in Chapter 8.  
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7 Study 4 - Nutritional rehabilitation 
7.1 Introduction 
Despite the many studies reporting a high incidence of malnutrition in children with 
severe CP there have been limited studies investigating the effects of nutritional 
intervention on body composition parameters. The few studies that have been done 
have investigated only changes in growth parameters (weight and height) and body 
fat, with no exploration into the effects of weight gain on TBP, BMC and REE. 
7.2 Aim 
To conduct a RCT of nutritional rehabilitation 
(i) to compare gastrostomy tube feeding versus oral feeding using oral nutritional 
supplementation and speech therapy, and  
(ii) to determine if nutritional rehabilitation, i.e. weight gain, results in an increase in 
TBP, FM, BMC, and REE in children with quadriplegic CP. 
7.3 Participants 
7.3.1 Recruitment of children with cerebral palsy 
The parents/carers of 19 children with quadriplegic CP were approached regarding 
participation in a six-month RCT of gastrostomy tube feeding versus oral feeding (see 
Appendix G for Parent Information Sheet). These were children without gastrostomy 
tubes who were undergoing investigations for feeding problems and undernutrition 
through the Dysphagia Clinic at CHW. None of the parents/carers consented to their 
child participating in a RCT. The parents/carers were then given the option to choose 
which arm of the study they would like their child to participate in, but none agreed to 
participate citing lack of time and the inability to commit to a six-month trial. 
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However, nine agreed to participate in the cross-sectional study only. Therefore, the 
decision was made to abandon the RCT. In place of this, the 39 children who took 
part in the cross-sectional study, who did not have a gastrostomy tube at the time of 
the study, were monitored through the Dysphagia Clinic. Any of these children who 
then received a gastrostomy tube (n = 22) as part of their routine care were monitored 
for weight gain and invited to undergo repeat measures after significant weight gain 
(defined as a 25 % increase in body weight). This included three children who 
received their gastrostomy tube less than one month prior to participating in the cross-
sectional study. In addition, a further four children who had a gastrostomy tube for at 
least six months prior to the cross-sectional study and had initially failed to gain 
weight, but then gained significant weight later, were also invited to have repeat 
measures performed. Therefore, a total of 26 children were potentially eligible to 
participate in the nutritional rehabilitation study. Please refer to Figure 7.1 (pg 193) 
for a flow chart of subject participation. 
A further 12 oral-fed children with quadriplegic CP who participated in the cross-
sectional study, who did not have a gastrostomy tube at the time of the study, and who 
did not receive a gastrostomy tube as part of their care, were invited to have repeat 
measures conducted. These children were to be used as a CP control group to compare 
with the gastrostomy tube-fed group. 
7.3.2 Study protocol 
During an outpatient visit to CHW, the children had measurements of anthropometry, 
TBP by NAA, body composition by DXA, and REE by indirect calorimetry. 
Parents/carers were then asked to complete a three-day weighed food record at home 
for subsequent dietary analysis. These tests were conducted for the cross-sectional 
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study and then repeated for this study. The methods for each test are described in 
detail in Chapter 3. 
A Parent Information Sheet detailing the study protocol was provided to all 
parents/carers prior to them giving written consent for their child to participate in both 
the cross-sectional study and the nutritional rehabilitation study (see Appendix A). 
7.3.2.1 Nutritional intervention 
The feeding regimens of the gastrostomy tube-fed children were determined by the 
Dysphagia Clinic dietitian. Some of the gastrostomy tube-fed children continued to 
eat orally, therefore their feeding regimens were designed to provide between 75 % 
and 100 % of their energy requirements through gastrostomy tube feeds using a range 
of commercially available, micro-nutrient complete, formulas. The energy 
requirements of the gastrostomy tube-fed children were initially estimated to be 1.2 
times their measured REE, which was measured at the time of the cross-sectional 
study. Weight gain was monitored at regular intervals through the Dysphagia Clinic, 
and the feeding regimens adjusted according to weight gain. 
The oral-fed children with CP were provided with standard dietary and speech therapy 
advice by the Dysphagia Clinic dietitian and speech pathologist, respectively. Advice 
provided by the dietitian included increasing the energy content of their diets by the 
addition of energy-dense food and commercially available high-energy oral 
supplements. Advice provided by the speech pathologist centred on modifying the 
texture and consistency of food and liquid in order to aid chewing and swallowing. 
7.3.3 Control group and reference data 
The data on the control children were from three separate existing control databases, 
as outlined below. All control children were healthy with no known medical 
190 
Chapter 7 
STUDY 4 – Nutritional rehabilitation 
problems, were of a similar age range to the children with CP (4 - 19 years), and were 
recruited through friends and relatives of CHW staff. 
1. The control group for the anthropometric and dual-energy x-ray absorptiometry 
(DXA) measurements consisted of 172 (84F, 88M) children from an existing 
DXA control database (Ogle et al. 1995). All children from this database had 
undergone a DXA measurement. In addition, measurements of height, weight and 
skinfold anthropometry were recorded at the time of the DXA measurement. 
2. The control group for total body protein (TBP) consisted of data from a group of 
72 (43F, 29M) children who had undergone TBP measurements at CHW (Baur et 
al. 1993).  
3. The REE measurements of the children with CP were compared with a separate 
control database consisting of 111 (42F, 69M) children who had undergone REE 
measurements at CHW (unpublished data). In addition, measurements of height, 
weight and skinfold anthropometry were recorded at the time of the REE 
measurement. 
Weight and height measurements were converted to SD scores and compared with the 
United States Centre for Disease Control growth reference data (Kuczmarski et al. 
2000). 
7.3.4 Statistics 
The data for the nutritional rehabilitation study were not normally distributed and are 
presented as medians with IQR.  
A Wilcoxon Signed Ranks test was used to compare differences between the baseline 
and repeat tests of the body composition parameters within each group (gastrostomy 
tube-fed and oral-fed). 
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A Mann-Whitney U test was used to compare changes in the body composition 
parameters between the two groups (gastrostomy tube-fed versus oral-fed). 
7.4 Results 
7.4.1 Participation of children with cerebral palsy 
7.4.1.1 Gastrostomy tube-fed children 
Of the 26 gastrostomy tube-fed children who were potentially eligible to participate in 
the nutritional rehabilitation study, the parents of 15 consented to have the tests 
repeated. The remaining 11 children either were either lost to follow-up (n = 3), failed 
to gain weight (n = 3), declined to have repeat measures conducted (n = 3), or were 
over the age of 18 years and had moved on to adult care (n = 2). Please refer to Figure 
7.1 (pg 193) for the flow chart of subject participation. 
In nine of the children in the gastrostomy tube-fed group, there was a median time 
delay of 5.0 months (IQR 3.9 to 9.2 months, min-max 0.3 to 13.7 months) between 
having the baseline measurement and insertion of a gastrostomy tube, therefore the 
median length of time of actual gastrostomy tube feeding was 10.1 months (IQR 7.1 
to 34.8; min-max 3.7 to 80.4 months). 
7.4.1.2 Oral-fed children 
The parents/carers of nine of the 12 oral-fed children agreed for their child to have 
repeat measures conducted; one declined, and two were on the waiting list to have a 
gastrostomy tube inserted and requested to delay repeat testing until after weight gain. 
Of the nine who agreed to participate, only eight children had the tests repeated 
because one (1M) failed to attend his appointment and was unable to reschedule in 
time for his data to be included in the analysis. 
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N = 59
Agreed 
N = 28 
Declined 
N = 20
Tube-fed 
N = 39
Oral-fed 
N = 19 
Later received a 
gastrostomy tube 
N = 3
Had gastrostomy 
tube < 1 month 
N = 4 
Had gastrostomy 
tube > 6 months, but 
initially failed to gain 
weight 
N = 26
Eligible for Study 4  
Nutritional Rehabilitation Study 
N = 15
Participated in  
Study 4 
N = 11 
Did not participate in 
Study 4 
N = 87
Invited to participate in: 
Study 1 - Cross-sectional study 
Study 2 - Comparison of methods 
Study 3 - REE & dietary intake 
N = 12 
Invited as a CP control 
group for Study 4 
N = 8 
Participated in 
Study 4 
 
Figure 7.1 Flow chart of subject participation 
CP, cerebral palsy; REE, resting energy expenditure 
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7.4.2 Baseline and repeat body composition results 
The baseline anthropometric characteristics of the 15 (8F, 7M) gastrostomy tube-fed 
children and eight (4F, 4M) oral-fed children with CP are shown in Table 7.1 (pg 
198). Although there was no significant difference in age between the two groups, 
there was a significant difference between weight, height, LTMDXA, and TBPNAA at 
baseline testing, with the oral-fed group being significantly higher in all of the 
aforementioned parameters than the gastrostomy tube-fed group. This was likely to be 
due to the oral-fed group having less severe disease compared with the gastrostomy 
tube-fed group. Although all of the children in this study were defined as having 
severe quadriplegic CP there was still some variation in the severity of disease and 
therefore it is possible that the oral-fed group were less severely disabled compared 
with the gastrostomy tube-fed group. Furthermore, there was a significant difference 
between the two groups in the length of time between the baseline and repeat 
measurements. In the gastrostomy tube-fed group, the median time difference 
between baseline and repeat testing was 15.8 months (IQR 9.3 to 25.1 months; min-
max 7.3 to 48.2 months), whereas in the oral-fed group the median time difference 
was 36.4 months (IQR 14.5 to 40.2 months; min-max 12.6 to 42.6 months). 
Therefore, due to the abovementioned factors, it was decided that it would be 
inappropriate to compare the two groups. Consequently, all data on the oral-fed group, 
apart from the baseline characteristics, were removed from this Chapter and are 
presented in Appendix H. Thus this Chapter presents the comparison of baseline and 
repeat measures in the gastrostomy tube-fed group only.  
7.4.3 Anthropometry 
The baseline and repeat anthropometric measures of the gastrostomy tube-fed group, 
as well as the baseline characteristics only of the oral-fed group, are shown in Table 
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7.1 (pg 198). In the gastrostomy tube-fed group, there was a significant increase in all 
body composition parameters measured by anthropometry between baseline and 
repeat testing. 
Baseline measures of height, height SD score, and weight as a percent of ideal weight-
for-height were unavailable for seven (4F, 3M) of the gastrostomy tube-fed children 
because the measurement of knee height was not part of the study protocol at the time 
of their participation in the cross-sectional study. In addition, one female did not have 
a complete set of skinfold thicknesses collected at baseline due to her inability to co-
operate, and therefore there is no baseline data for this participant for FFMSKIN, 
FMSKIN, and PBFSKIN. Furthermore, the carer of one male declined for him to have 
skinfold anthropometry collected at the repeat measure, and therefore there was no 
data for this participant for UAMA, UAFA, FFMSKIN, FMSKIN, and PBFSKIN at repeat 
testing. For each parameter in Table 7.1, only those participants with both a baseline 
and repeat measure were included. 
7.4.3.1 Comparison with reference data 
Where possible the anthropometric measures were converted to SD scores to allow for 
comparison with reference data. The gastrostomy tube-fed group showed significant 
increases in their SD scores for weight, UAMA, and UAFA, but not height. 
7.4.4 Body composition by dual-energy x-ray absorptiometry 
The baseline and repeat body composition measures by DXA are shown in Table 7.2 
(pg 199). The gastrostomy tube-fed children showed significant increases in BMC, 
PBFDXA, FMDXA and LTMDXA between baseline and repeat testing.   
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7.4.4.1 Comparison with control data 
The gastrostomy tube-fed children demonstrated no significant changes in their 
LTMDXA for height SD score, or their BMC SD scores for age or height, or BMC 
adjusted for both LTMDXA and height.  
As previously mentioned, a baseline measurement of height was unavailable for seven 
(4F, 3M) of the gastrostomy tube-fed children, therefore, for these participants 
baseline data was unavailable for BMC for height SD score, BMC for LTM & height 
SD score, and LTM for height SD score. For each parameter in Table 7.2, only those 
participants with both a baseline and repeat measure were included. 
7.4.5 Total body protein by neutron activation analysis 
The baseline and repeat measures of TBPNAA for the gastrostomy tube-fed children 
are shown in Table 7.3 (pg 200). There was a significant increase in TBPNAA between 
baseline and repeat testing. 
7.4.5.1 Comparison with control data 
The gastrostomy tube-fed children demonstrated a significant increase in TBPNAA as a 
percentage of predicted from control data for height between baseline and repeat 
testing. However, there was no significant change in TBPNAA expressed as percentage 
of predicted from control data for age.  
As previously mentioned, a baseline measurement of height was unavailable for seven 
(4F, 3M) of the gastrostomy tube-fed children, therefore, for these participants 
baseline data was unavailable for TBPNAA expressed as a percentage of predicted for 
height. In addition, the carer of one male declined for him to have a repeat measure of 
TBPNAA, and therefore there is no data available for this child at repeat testing. 
Furthermore, the repeat measurement of TBPNAA for two males had to be discarded 
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because it was conducted immediately prior to the radioactive sources being replaced 
as discussed in Chapter 3. For each parameter in Table 7.3, only those participants 
with both a baseline and repeat measure were included, and therefore data on 12 
participants is presented. 
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Table 7.1 Baseline and repeat anthropometric characteristics of gastrostomy 
tube-fed and baseline anthropometric characteristics of oral-fed children with 
cerebral palsy 
 Gastrostomy tube-fed 
(8F, 7M) 
Oral-fed 
(4F, 4M) 
 Baseline Repeat Baseline 
Age (y) 7.6 (4,9, 11.4) 10.1 (7.5, 13.1) 4 8.6 (7.4, 12.3) 
Weight (kg) 14.0 (11.6, 19.2) 20.6 (16.1, 25.2) 4 21.0 (16.6, 24.7) 
Weight SDS  -5.1 (-7.0, -3.1) -3.0 (-5.1, -1.4)5 -3.1 (-4.0, -2.1) 
Height (cm)  105.0 (95.3, 111.8)1 115.2 (111.4, 119.7)1,5 120.3 (105.0, 128.2) 
Height SDS  -4.1 (-5.4, -2.4)1 -3.4 (-4.4, -2.0)1 -3.0 (-4.3, -1.8) 
Ideal weight-for-height (%) 91.0 (82.3, 99.9) 1 100.0 (93.0, 108.3)3, 5 85.9 (75.7, 102.5) 
UAMA (cm2)  13.9 (11.0, 17.1)2 19.6 (14.9, 23.3) 2, 4 19.7 (15.5, 21.7) 
UAMA SDS  -2.1 (-3.2, -1.1) 2 -0.4 (-2.3, 0.0) 2, 4 -1.4 (-2.2, -0.9) 
UAFA (cm2)  3.4 (2.6, 6.6) 2 7.4 (3.8, 10.6) 2,5 5.3 (3.0, 6.0) 
UAFA SDS  -2.5 (-3.9, -0.9) 2 0.1 (-2.2, 0.7) 2,5 -1.9 (-2.9, -0.8) 
FFMSKIN (kg)  12.5 (10.9, 17.5) 3 17.1 (14.4, 29.5) 3, 4 18.5 (15.2, 20.2) 
FMSKIN (kg)  1.4 (0.7, 2.6) 3 3.6 (2.0, 5.6) 3,5 2.5 (0.9, 4.3) 
PBFSKIN (%) 10.2 (6.1, 17.1) 3 17.2 (9.9, 25.1) 3,5 10.7 (5.8, 17.7) 
Data is median (inter-quartile range). FFMSKIN, fat-free mass by skinfold anthropometry; FMSKIN, fat mass 
by skinfold anthropometry; PBFSKIN, percent body fat by skinfold anthropometry; SDS, standard deviation 
score; UAFA, upper arm fat area; UAMA, upper arm muscle area. 
1 n = 8, 2 n = 14, 3 n = 13; 4 p <0.001, 5 p <0.05; significantly different between baseline and repeat test; 
Wilcoxon Signed Ranks test. 
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Table 7.2 Baseline and repeat body composition measures by dual-energy x-ray 
absorptiometry  
 Gastrostomy tube-fed 
(8F, 7M) 
 Baseline Repeat 
BMC (g) 434 (365, 626) 597 (444, 698) 2
BMC for age SDS -2.6 (-3.7, -1.5) -2.7 (-3.8, -1.4) 
BMC for height SDS -0.2 (-0.6, 0.0) 1 -0.4 (-1.2, 0.1) 1
BMC for LTM & ht SDS -1.3 (-2.0, 0.4) 1 -1.2 (-1.7, -0.5) 1
LTMDXA (kg) 12.2 (10.1, 15.1) 15.6 (13.5, 17.3) 2
LTMDXA for height SDS -0.2 (-0.6, 0.5) 1 0.0 (-1.2, 0.3) 1
FMDXA (kg) 1.5 (1.1, 2.4) 3.9 (1.8, 7.1) 2
PBFDXA (%) 12.5 (7.5, 22.3) 21.8 (10.0, 31.3) 2
Data is median (inter-quartile range). BMC, bone mineral content; DXA, 
dual-energy x-ray absorptiometry; FMDXA, fat mass by DXA; LTMDXA, lean 
tissue mass by DXA; PBFDXA, percent body fat by DXA; SDS, standard 
deviation score. 
1 n = 8 
2 p < 0.01; significantly different between baseline and repeat testing; 
Wilcoxon Signed Ranks test. 
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Table 7.3 Baseline and repeat measures of total body protein  
 Gastrostomy tube-fed 
(8F, 4M) 
 Baseline Repeat 
TBPNAA (kg) 2.1 (1.5, 2.8) 3.4 (2.1, 3.9)2
TBP NAA for age (%) 51.3 (44.4, 56.4) 58.8 (38.0, 76.5) 
TBP NAA for height (%) 75.6 (67.8, 87.7)1 101.9 (96.7, 117.9)1, 2
TBP NAA for weight (%) 77.0 (70.0, 83.9) 87.0 (70.8, 101.3) 
Data is median (inter-quartile range). FFMSKIN, fat-free mass measured 
by skinfold anthropometry; NAA, neutron activation analysis; TBPNAA, 
total body protein. 
1 n = 6 
2 p < 0.05, significantly different between baseline and repeat testing; 
Wilcoxon Signed Ranks test. 
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7.4.6 Annualised changes in body composition 
Table 7.4 (pg 202) shows the annualised change in the body composition parameters 
for the gastrostomy tube-fed children. The annualised change was calculated as the 
difference between the baseline and repeat measure divided by the actual time of 
gastrostomy feeding (in years), not the time difference between the dates of the two 
measurements. This was done because, as previously mentioned, in nine of the 
children in the gastrostomy tube-fed group, there was a median time delay of 5.0 
months (IQR 3.9 to 9.2 months) between having the baseline measurement and 
insertion of a gastrostomy tube, therefore the median length of time of actual 
gastrostomy tube feeding was 10.1 months (IQR 7.1 to 34.8; min-max 3.7 to 80.4 
months). Upon review of the medical records for each gastrostomy tube-fed child it 
was found that there was no significant difference in weight between when the child 
participated in the cross-sectional study and when the gastrostomy tube was inserted. 
In addition, due to the variation in length of time that the gastrostomy tube-fed 
children were followed-up, an attempt was made to determine if these children gained 
significantly more in any of the body composition parameters in the acute phase of re-
feeding (i.e. <12 months). In the gastrostomy tube-fed children there were nine 
children who were underwent their repeat testing within 12 months of receiving a 
gastrostomy tube (median of 7.1 months). The data on these nine children are 
represented in Table 7.4 in the column labelled “<12 months”, and the data on the 
remaining six gastrostomy tube-fed children are represented in the column labelled 
“>12 months” (median of 35.9 months of gastrostomy tube feeding). Comparison of 
these two groups revealed that the children who were tube-fed for <12 months gained 
significantly more per year in weight, height, UAMA, UAFA, FMSKIN, FFMSKIN, 
PBFSKIN, and LTMDXA, than those children who were tube-fed >12 months.  
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Table 7.4 Annualised change in body composition parameters  
 Gastrostomy tube-fed 
(8F, 7M) 
 
Gastrostomy tube-fed 
(N = 9)  
< 12 months 
Gastrostomy tube-fed 
(N = 6)  
> 12 months 
Weight (kg) / y 3.9 (2.1, 7.9) 6.7 (4.9, 9.6) 1.7 (1.0, 3.2) 8
Height (cm) / y 9.7 (3.5, 14.2) 1 9.0 (5.8, 15.4) 5 2.9 (1.6, 5.4)7, 8
UAMA (cm2) / y 3.6 (2.5, 6.2) 2 5.9 (4.0, 9.3) 1 2.3 (1.0, 3.0) 8
UAFA (cm2) / y 2.2 (0.4, 3.7) 2 3.4 (2.0, 6.0) 1 0.7 (-0.2, 1.9) 8
FMSKIN (kg) / y 1.4 (0.3, 3.3) 3 2.6 (1.4, 4.0) 1 0.3 (0.0, 1.0) 5, 8
FFMSKIN (kg) / y 2.8 (1.4, 3.9) 3 3.8 (3.0, 5.0) 1 1.2 (1.0, 2.0) 5, 8
PBFSKIN (%) / y 3.9 (0.6, 10.7) 3 8.1 (3.7, 17.7) 1 0.8 (-0.6, 3.2) 5, 8
BMC (g) / y 63.9 (39.6, 111.9) 105.3 (33.0, 190.6) 46.5 (30.0, 58.1) 
LTMDXA (kg) / y 2.4 (1.1, 4.8) 4.7 (2.7, 6.4) 1.1 (0.6, 1.5) 8
FMDXA (kg) / y 1.4 (0.7, 3.0) 2.2 (1.1, 4.6) 1.1 (0.3, 1.4) 
PBFDXA (%) / y 5.0 (1.7, 10.0) 9.3 (2.7, 13.2) 2.8 (0.6, 5.9) 
TBPNAA (g) / y 382 (105, 509) 4 325 (-28.6, 2242) 6 382 (261, 416) 
Data is median (inter-quartile range). DXA, dual-energy x-ray absorptiometry; UAMA, upper 
arm muscle area; UAFA, upper arm fat area; FMSKIN, fat mass by skinfold anthropometry; 
FFMSKIN, fat-free mass by skinfold anthropometry; PBFSKIN, percent body fat by skinfold 
anthropometry; BMC, bone mineral content; LTMDXA, lean tissue mass by DXA; FMDXA, fat 
mass by DXA; LTMDXA, lean tissue mass by DXA; PBFDXA, percent body fat by DXA; TBPNAA, 
total body protein by neutron activation analysis; y, year. 
1 n = 8; 2 n = 14; 3 n = 13; 4 n = 12; 5 n = 5; 6 n = 6; 7 n = 3 
8 p < 0.05; significantly different between <12 months and >12 months, Wilcoxon Signed 
Ranks Test. 
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7.4.7 Resting energy expenditure and energy intake 
Table 7.5 (pg 204) shows the REE and energy intake of the gastrostomy tube-fed 
children at baseline and repeat testing. Eight (4F, 4M) children underwent both 
baseline and repeat testing of REE by indirect calorimetry and completed three-day 
weighed food records. There was a significant increase in their measured REE 
(kJ/24h) and their measured REE as a percent of predicted REE between baseline and 
repeat testing. Interestingly there was no significant change in their reported energy 
intake, and a significant decrease in their reported energy intake as a percentage of 
their measured REE between baseline and repeat testing. 
There were two children who had unusually high measured REEs at repeat testing 
(1F, 1M; 171 % and 141 % of predicted, respectively). The parents / carers of only 
one of these children (1F) agreed for their child to have the test repeated – it was 
equally as high when repeated. Clinic physicians were concerned that these patients 
may have unrecognised metabolic disorders causing a CP phenotype and abnormally 
high REE and thus these two children were removed from the data set and the data 
were re-analysed, the results of which are presented in Table 7.6 (pg 205). The results 
did not change significantly from when these children were included in the data set, 
i.e. there remained a significant increase in their measured REE (kJ/24h) and their 
measured REE as a percent of predicted REE, no significant change in their reported 
energy intake, and a significant decrease in their reported energy intake as a 
percentage of their measured REE between baseline and repeat testing. 
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Table 7.5 Baseline and repeat measures of resting energy expenditure and energy 
intake 
 Gastrostomy tube-fed 
(4F, 4M) 
 Baseline Repeat 
MREE (kJ / 24hr) 2040 (1792, 3342) 4245 (3540, 5950) 1
MREE / PREE (%) 67.6 (59.0, 76.4) 115.6 (90.7, 139.6) 1
Energy Intake (kJ / 24hr) 4897 (4625, 6254) 5782 (4428, 6694) 
Energy Intake / MREE (%) 244 (154, 297) 113 (106, 152) 1
Data is median (inter-quartile range). MREE, measured resting energy expenditure by indirect 
calorimetry; PREE, predicted resting energy expenditure adjusted for fat-free mass using 
equations developed from control database. 
1 p < 0.05, significantly different between baseline and repeat measurements, Wilcoxon 
Signed Ranks test. 
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Table 7.6 Baseline and repeat measures of resting energy expenditure and energy 
intake excluding REE >140% 
 Gastrostomy tube-fed 
(3F, 3M) 
 Baseline Repeat 
MREE (kJ / 24hr) 1879 (1775, 2837) 3997 (3367, 4399)1
MREE / PREE (%) 64.9 (55.7, 73.8) 103.9 (85.0, 129.0) 1
Energy Intake (kJ / 24hr) 4745 (4462, 5862) 4783 (4463, 6295) 
Energy Intake / MREE (%) 244 (181, 305) 123 (109, 169) 1
Data is median (inter-quartile range). MREE, measured resting energy 
expenditure by indirect calorimetry; PREE, predicted resting energy 
expenditure adjusted for fat-free mass using equations developed from 
control database. 
1 p < 0.05, significantly different between baseline and repeat measurements, 
Wilcoxon Signed Ranks test. 
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7.5 Summary of results 
The nutritional rehabilitation study revealed that significant weight gain in 
gastrostomy tube-fed children with CP produced significant increases in height, 
measures of fat mass, FFMSKIN, LTMDXA, TBPNAA, BMC and REE. The gastrostomy 
tube-fed children demonstrated significant improvements in their SD scores for 
weight, UAMA, and UAFA, and for TBPNAA expressed as a percentage of predicted 
for height from control data as well as their REE expressed as a percentage of 
predicted from control data. There were no significant improvements seen in height 
SD score, TBPNAA expressed as a percentage of predicted for age, or for BMC when 
expressed as an SD score for age or height. 
7.6 Discussion 
7.6.1 Anthropometric changes 
There have been seven previous longitudinal nutritional rehabilitation studies of 
children with CP (Isaacs et al. 1994; Naureckas and Christoffel 1994; Patrick et al. 
1986; Rempel et al. 1988; Sanders et al. 1990; Shapiro et al. 1986; Sullivan et al. 
2005). However, only three of these studies were prospective (Isaacs et al. 1994; 
Patrick et al. 1986; Sullivan et al. 2005); three were retrospective reviews of the 
medical records (Naureckas and Christoffel 1994; Rempel et al. 1988; Shapiro et al. 
1986); and one did not state how the data was collected (Sanders et al. 1990). 
Furthermore, all of the studies were based on measures of weight and/or height, with 
only three including some basic skinfold anthropometry, i.e. triceps skinfold thickness 
(Isaacs et al. 1994; Patrick et al. 1986; Sullivan et al. 2005). None of the studies 
included a measure of BMC or body protein.  
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Naureckas & Christoffel retrospectively collected data from the medical records on 
weight and height of 26 NG (n = 13) and gastrostomy tube-fed (n = 13) children with 
neurological disability (CP or degenerative neurological disorder) who had tube feeds 
for a mean of 23 months (Naureckas and Christoffel 1994). For all children, tube 
feeds resulted in significant improvements in their weight as a percent of ideal weight-
for-height (73.2 to 94.2 %). No significant change in height percentile for age was 
observed, although the authors did not state their method used to measure height.  
Shapiro et al conducted a retrospective review of weight and height from the medical 
records of 19 gastrostomy tube-fed children with quadriplegic CP and other severe 
neurological disorders (Shapiro et al. 1986). On average the children had been 
receiving gastrostomy tube feeds for 23 months. Prior to gastrostomy tube feeding the 
average weight-for-length of the group was -2.7 SDS. Post gastrostomy tube feeding 
this improved to -1.2 SDS. The authors reported that the gains in weight were more 
dramatic than the gains in length/stature and improvements in weight-for-length did 
not correlate with duration of follow-up. The authors reported that comments by 
parents and carers suggested that gastrostomy tube feeding decreased irritability and 
improved the quality of life for the child and family. 
Patrick et al attempted to conduct a prospective RCT of NG tube feeding versus oral 
feeding of 10 children with wasting and severe CP (Patrick et al. 1986). However, the 
children who were in the oral feeding arm of the study were studied for less than five 
weeks before switching to the NG tube feeding arm because of lack of weight gain. 
The authors reported that in all of the children weight gain ceased four to five weeks 
after it started. The children gained an average of 23 % body weight over this time, as 
well as increased their triceps skinfold thickness by an average of 83 % and UAMA 
by 14 %, which the authors reported was most likely a reflection of increased fat 
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stores rather than increased muscle mass. Furthermore, the weight gain was associated 
with healing of persistent pressure sores and the correction of cold and cyanosed 
extremities. There was also anecdotal evidence to suggest improvement in the 
children’s spasticity and affect.  
Rempel et al also reported anecdotal evidence of an improvement in the children’s 
disposition in a retrospective review of 35 gastrostomy tube-fed children with spastic 
quadriplegic CP (Rempel et al. 1988). The average length of time for gastrostomy 
tube feeding was 3.4 years. Even though weight gain was achieved in the majority of 
study participants, a large percentage of the children remained below the 5th centile 
for both height and weight. However, only a few remained below the 5th centile of 
weight-for-height, with most children reaching what the authors define as their 
“appropriate” weight-for-height (between the 25th and 75th centile). Only one quarter 
of the group showed an improvement in their height curve. Children who had received 
a gastrostomy tube prior to two years of age, and those with a gastrostomy tube for 
more than two years, showed the highest percentages in achieving appropriate weight-
for-height. This is in contrast to the finding of Shapiro et al who found no correlation 
with weight gain and duration of follow-up.  
Sanders et al conducted a relatively large study of 51 tube fed patients with severe CP 
(Sanders et al. 1990). The average length of follow-up was 2.4 years (range six 
months to 5.5 years). They found that after six months of feeding, children who 
received tube feeding soon after their CNS insult, and those who were around four 
years of age or younger, had better outcomes in terms of weight and length gain, than 
those who were older and received tube feeds more than 12 years after their CNS 
insult. The authors commented that this finding may be because the older children 
were reaching sexual maturation and therefore probably had little chance for 
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significant change in length. Overall, in agreement with Shapiro and Patrick, the gains 
in weight were more marked than the gains in length. Furthermore, parents reported 
that the children appeared more alert, less irritable and made significant 
developmental progress with weight gain. 
Isaacs et al studied 22 gastrostomy tube-fed children with neurological impairment 
(15 with CP), and followed their progress for 10 months to four years (Isaacs et al. 
1994). They found that after at least 12 months of tube feeding most children gained 
significant weight, but less than half gained length, although the authors used 
recumbent length to measure stature which does not provide an accurate measure of 
stature (Moore and Roche 1986). In addition, half of the group improved their weight-
for-age centile, with children who were initially less than the 5th centile for weight, 
showing greater improvement than those who were at the 50th centile weight for age. 
Furthermore, nearly half of the children showed an increase in their triceps skinfold 
thickness. 
Sullivan and colleagues conducted a large longitudinal, prospective, multi-centre 
study on the outcomes of gastrostomy tube feeding in 46 children with CP, the 
majority with spastic quadriplegic CP (Sullivan et al. 2005). They measured weight, 
LLL, UAL (as proxies for linear growth) and triceps and subscapular skinfold 
thicknesses, in the children at baseline, and then at six and 12 months post 
gastrostomy tube feeding. They found that on average the children increased their 
weight SD scores from -3.0 to -1.6 after 12 months. In addition, the children achieved 
some linear growth, with LLL SD scores increasing from -1.3 to -0.4, and UAL SD 
scores increasing from -0.14 to 0.58. However, the triceps SD scores increased only in 
the first six months from -0.9 to -0.5, and then dropped back to -0.7 SD score after 12 
months. Interestingly, overall the greatest rate of change, or gains, in all parameters 
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was in the first six months with a decreased rate of change between six and 12 
months. 
Generally all of the above studies support the findings from the current study. Most 
studies found that the gains in weight were greater than the gains in height and in 
those studies that measured skinfold anthropometry, significant gains in body fat were 
also observed. However two studies reported that not all children gained weight with 
gastrostomy tube feeding (Isaacs et al. 1994; Rempel et al. 1988). In the current study, 
in the gastrostomy tube-fed group, only those children who gained weight were 
remeasured, as the aim of the study was to examine what changes occur in body 
composition with weight gain. Though, as mentioned in the participant description of 
this Chapter, three children were not remeasured because they failed to gain weight. 
This suggests that not all children with CP will benefit from the insertion of a 
gastrostomy tube. This is discussed further in the limitations of the study in Chapter 8. 
The lack of improvement in height SD scores observed in the current study and other 
nutritional rehabilitation studies of children with CP is most likely due to the lack of 
weight bearing activity in these children. Immobilisation, or disuse, during growth 
results in reduced growth in bone length and subsequently a lack of growth in height 
(Bass et al. 2005). Therefore, despite the provision of adequate nutrition in the 
gastrostomy tube-fed group, no improvement in height SD scores were observed. This 
is discussed further in section 7.6.2. 
The study by Sullivan and colleagues found that the greatest gains in weight, height 
and body fat were observed in the first six months of nutritional rehabilitation with a 
plateau in change between six and 12 months (Sullivan et al. 2005). In the current 
study it was found that those children who were re-measured after < 12 months of 
gastrostomy tube feeding gained significantly more in all of the anthropometric 
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parameters than those re-measured after > 12 months of gastrostomy tube feeding. 
This suggests, in agreement with the findings of Sullivan et al, that there may have 
been short term rapid gains which then plateau with time. In future studies a more 
structured study with set follow-up appointments every six months, for example, 
would assist in characterising the pattern of change in growth and body composition 
with refeeding in children with CP. 
7.6.2 Longitudinal studies of bone mineralisation 
Aside from the current study, there has been only one other longitudinal study of bone 
mineralisation in children with CP (Henderson et al. 2005). Although the authors were 
not conducting a nutritional rehabilitation study, they did find that a better nutritional 
status, as assessed by the triceps SD score, was associated with greater change in 
BMD per year in 69 children with moderate to severe spastic CP. The study by 
Henderson et al also reported that BMD SD scores decreased over time in spite of 
overall increases in BMD, whereas in the current study it was found that there was no 
significant change in BMC SD scores for age or height in the gastrostomy tube-fed 
group. However, the results are difficult to compare with the current study because the 
authors measured rate of change in areal BMD in the distal femur and lumbar spine, 
compared with total body BMC in this study, they had larger numbers of participants, 
they studied the children over a longer period of time (40 out of the 69 were studied 
over 3 years), no adjustments were made for body size, and they conducted an 
observational rather than an interventional study.  
In the current study, despite overall increases in BMC, no improvements in BMC SD 
scores for age or height were observed. Similar to the lack of improvement in height 
SD scores discussed in the previous section, this may be because both physical 
activity and nutrition are responsible for the growth and development of bone (Bass et 
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al. 2005). Immobilisation during growth results in reduced growth in bone length and 
a loss of bone strength due to large losses in bone mass. Studies have shown that 
under adequate nutrition, physical activity has the potential to increase the muscle 
forces acting on bone and thus can lead to a proportional increase in bone strength. In 
contrast, nutrition alone, without physical activity, does not influence muscle or bone 
development (Bass et al. 2005). The intrinsic relationship between muscle and bone is 
summed up by the “mechanostat” theory, which postulates that increasing maximal 
muscle force during growth or in response to increased loading will affect bone mass, 
size and strength predictably and correspondingly. Similarly, unloading (disuse or 
immobilisation) will lead to reduced muscle development (and muscle force) and 
invariably have a negative effect on the mass, size, and strength of bone (Bass et al. 
2005). Studies of patients with a spinal cord injury have shown that adequate nutrition 
alone, without the influences of physical activity, are not enough to maintain bone 
density and strength (Bass et al. 2005). Nutrition has its most profound effect on the 
muscle and bone unit when in a state of deficiency. Energy and protein restriction 
appear to act by retarding growth in length and size, resulting in a proportionately 
smaller skeleton and reduced cortical mass. Reduced stature as a result of energy 
deficiency has been characteristic of the evolution of the human species. Energy and, 
more so, protein deficiency also reduces body weight and muscle mass, which 
diminishes the mechanical demands on bone for adaptation in bone strength. 
Therefore, both exercise and nutrition are important for the development of muscle 
and bone during growth. Adequate nutrition in the absence of physical activity will 
not maintain bone strength and vice versa. Consequently, in children with CP, it is 
unlikely that any significant improvements in BMC SD scores will be seen with 
adequate nutrition alone. In a study of both ambulant and non-ambulant children with 
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CP, weight-bearing activity was shown to significantly improve femoral neck BMC 
compared to controls although the ambulant and non-ambulant children were not 
separated for analysis (Chad et al. 1999). In another study of non-ambulant children 
only with CP, a standing frame to facilitate an upright position was shown to improve 
BMD, with the gains in BMD being proportional to the duration of standing (Caulton 
et al. 2004). Possibly future nutritional intervention studies will also need to include a 
weight-bearing activity program. However, it is important to note that in the current 
study although no significant improvements in BMC SD scores were observed, no 
significant decreases in BMC SD scores were observed either. It could be postulated 
that adequate nutrition alone, while not enabling a significant increase in BMC SD 
scores, may be enough to maintain BMC SD scores and prevent further decline. A 
nutritional intervention study including larger numbers of participants with longer 
term follow up is needed before coming to any firm conclusions on the effects of 
gastrostomy tube feeding on bone mineralisation. 
7.6.3 Longitudinal studies of total body protein 
The current study is the only study to report longitudinal data on TBP in children with 
CP; therefore there are no other studies in children with CP for comparison. However, 
our centre has measured longitudinal changes in TBP in healthy control children. 
Allen et al (Allen et al. 1996) reported that the average annual accretion of TBP of 
prepubertal healthy control children (n = 17) was 481 g/y. Compared with the healthy 
controls, the gastrostomy tube-fed children with CP gained less TBP per year, yet they 
showed significant improvements in their TBP as a percent of predicted for height, 
but not for age, although there was wide variation. Nonetheless, this study 
demonstrated that significant increases in body protein can be achieved in children 
with severe CP with gastrostomy tube feeding. 
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7.6.4 Resting energy expenditure and food records 
In the current study it was found that the measured REE of the gastrostomy tube-fed 
children with CP increased from 65 % of predicted at baseline testing to 104 % of 
predicted after significant weight gain. However the number of participants in this 
part of the study was small (n = 6).  
There have not been any other studies in children with CP that have explored the 
effects of nutritional rehabilitation on REE. However, there have been a number of 
other studies in patients with anorexia nervosa which have also demonstrated a 
significantly decreased REE which subsequently increases with refeeding (de Zwaan 
et al. 2002b; de Zwaan et al. 2002a; Krahn et al. 1993; Russell et al. 1998; Salisbury 
et al. 1995; Schebendach et al. 1997; Van Wymelbeke et al. 2004). One of the theories 
postulated for this is that during semi-starvation the body adapts by a reduction in 
REE. With refeeding there is a reversal of this adaptive function (Schebendach et al. 
1997; Vaisman et al. 1991). This is possibly what occurred in the gastrostomy tube-
fed patients with CP, however a larger number of children will need to be studied 
before and after nutritional rehabilitation before coming to any firm conclusions on 
this.  
Analysis of the food records revealed that at baseline testing, when the children with 
CP were fed orally, energy intake was grossly overestimated in comparison to 
measured REE. This was also demonstrated in the cross-sectional study and is 
discussed in more detail in Chapters 6 and 8. At repeat testing, the food records of the 
gastrostomy tube-fed children with CP appeared to be more accurate. This was most 
likely because the children were fed almost entirely through the gastrostomy tube with 
specialised formulas which are a known volume and composition and are therefore 
easy to record.  
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These findings demonstrate that nutritional rehabilitation of children with CP possibly 
results in a reversal of the adaptive response to semi-starvation, and that these 
children can gain significant weight with an energy intake that is approximately 1.1 
times their measured REE. In a cross-sectional study of 61 children with quadriplegic 
CP, Stallings et al reported that on average the children required an energy intake of 
1.23 times their measured REE, or 1.29 for those with reduced fat stores and 1.07 for 
those with higher fat stores, compared with 1.57 in a healthy control group (Stallings 
et al. 1996). In another similar, but smaller (n = 6) cross-sectional study, the authors 
reported that the children with CP, compared with a healthy control group, required 
on average an energy intake that was 1.23 versus 1.76 respectively, times their 
measured REE (Bandini et al. 1991). The finding from the current study supports the 
two aforementioned studies and provides further evidence that children with CP can 
achieve adequate weight gain on energy intakes that are only slightly higher than their 
measured REE. Finally, in agreement with the findings from the cross-sectional study, 
food records in oral-fed children with CP appear to be of limited value. 
7.6.5 Significance of findings 
The data from this nutritional rehabilitation study suggest that gastrostomy tube 
feeding in children with severe CP can induce large gains in weight in most, but not 
all, children, with significant increases in height, PBF, BMC and TBP. In addition, it 
was found that nutritional rehabilitation possibly may reverse the adaptive response of 
a reduction in REE to semi-starvation, however larger numbers of children need to be 
studied to confirm this finding.  
This longitudinal nutritional rehabilitation study needs to be continued in order to 
collect data on a larger number of children. In addition, it is suggested that future 
children included in the study have two to three repeat measures both pre- and post-
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gastrostomy tube feeding so that each child can be used as its own control. 
Furthermore, it is recommended that the repeat measurements follow a set structure 
with testing every six months, for example, in order to better compare and 
characterise the patterns of change in body composition.   
Further limitations, recommendations and future directions are discussed in the 
overall discussion of this thesis in Chapter 8. 
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8 Discussion 
8.1 Overall conclusions 
Children with quadriplegic CP in this study were stunted and wasted with greatly 
reduced body protein, fat mass, and bone mineralisation. The measurement of weight 
and height alone did not identify those children with malnutrition. A more detailed 
assessment of body composition in the clinic setting using skinfold anthropometry is 
recommended to help identify those children at risk of malnutrition. Simple 
anthropometric measures such as the triceps skinfold thickness, UAMA and FFM 
showed good correlation with more sophisticated techniques to measures body fat and 
body protein. However, as an accurate and precise measure of body protein in 
individuals, both skinfold anthropometry and DXA showed wide variability and are 
therefore not recommended in this population. Furthermore, as a measure of percent 
body fat, DXA and skinfold anthropometry showed poor agreement indicating that 
one, or both, of these techniques is inaccurate for the measurement of percent body fat 
in children with CP. Further studies using a 4C model of body composition are 
required in order to validate skinfold anthropometry and DXA before they can be 
accepted as precise measures of body composition in children with CP. 
The REE of the children with CP was significantly reduced, widely variable and 
poorly correlated with body composition parameters making it difficult to predict 
from the existing predictive equations. Thus, it is recommended to either measure 
REE by indirect calorimetry, however such sophisticated technology is not available 
at all centres; or to roughly estimate energy requirements using the currently available 
Schofield equations and adjust energy intake according to weight change (Schofield 
1985). Food records were found to grossly overestimate the energy intake of these 
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children; particularly those fed orally, and appear to be of limited value in this 
population.  
Gastrostomy tube feeding of children with CP resulted in significant increases in 
weight, height, FM, measures of muscle mass (FFM and LTM), TBP, BMC and REE. 
In addition, these children demonstrated significant improvements in their weight SD 
score and for TBPNAA when expressed as a percentage of predicted for height from 
control data. However, there were no significant improvements seen in height SD 
score, TBPNAA expressed as a percentage of predicted for age, or for BMC when 
expressed as an SD score for age or height. 
Further studies including larger numbers of participants with longer term, more 
structured follow-up pre- and post-gastrostomy tube feeding are required to confirm 
these findings and recommendations.  
These conclusions as well as limitations of the study are discussed in more detail in 
this Chapter. 
8.2 Study 1 - Cross-sectional study 
8.2.1 Limitations of using anthropometry in children with cerebral palsy 
8.2.1.1 Difficulties with measuring height 
Two different sets of equations were used in this study to convert knee height to an 
estimate of standing height. As discussed in Chapter 2 (section 2.3.2.1, pg 29) these 
equations have not been properly validated in children with quadriplegic CP, and are 
therefore of questionable accuracy in this population. However, a measure of height is 
useful to have in this population in order to adjust measures of body composition, 
such as TBP and BMC, according to body size to allow for comparisons with 
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reference data. Estimated measures of height must be used and interpreted cautiously 
with an understanding of their limitations. 
8.2.1.2 Skinfold anthropometry 
As reported in Chapter 2, skinfold anthropometry is a popular method for assessing 
body composition in the clinic setting because the instruments are portable and 
relatively cheap and minimal training is required. However, estimating body fat and 
FFM by skinfold anthropometry is based on several assumptions, none of which have 
been proven to be true in the normal population, let alone in children with CP. 
Furthermore, the precision of the measurement of a skinfold thickness is dependent 
upon the skill of the anthropometrist and the site measured. In general, the error of 
precision can increase if the skinfold thickness gets very large (>15 mm) or small (<5 
mm) (Roche 1996). Skinfold thicknesses less than 5 mm were common in this study. 
Also, the bony landmarks that are required to determine the site of measurement are 
difficult to locate in children with quadriplegic CP because of joint contractures and 
scoliosis, and the inability of the participant to cooperate. Finally, the skinfold 
thickness should be taken while the participant is standing and with their muscles 
relaxed. Children with severe CP are usually unable to stand and suffer from 
involuntary muscle contractions making the measurement of skinfold thicknesses 
possibly unreliable. 
Furthermore, apart from assuming a normal hydration of FFM, skinfold 
anthropometry is also based on the assumptions that 
 the participant has a normal bone size and density (Roche 1996). As this study and 
others have shown, children with severe CP have a reduced bone mineralisation. 
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 for the calculation of the UAFA and UAMA include: the mid-arm is circular; the 
triceps skinfold is twice the average fat rim diameter; the mid-arm muscle 
compartment is circular; and bone, which is included in the anthropometric 
UAMA, atrophies in proportion to muscle protein-energy malnutrition, none of 
these assumptions have been proven to hold true in children with CP (Lukaski 
1987). 
Further work, using a 4C model of body composition, needs to be done to validate this 
potentially useful technique in patients with CP. This is discussed further at the end of 
this Chapter. 
8.2.2 Limitations of neutron activation analysis to measure total body protein 
The advantage of this technique over the conventional method of analysis is that 
errors in counting resulting from differences in irradiation and detection conditions 
from differences in size and shape of subjects are reduced considerably. This 
reduction in error makes sequential nitrogen measurements more reliable, particularly 
when subject weight has changed significantly, which was the case in the nutritional 
rehabilitation study of this thesis (Lukaski 1987). However, some may argue that one 
potential source of error in the equation used to calculate TBP is in the estimation of 
FM by skinfold anthropometry. Calculations have shown that an uncertainty of ± 30 
% in the FM will produce an acceptable uncertainty in the hydrogen content of up to 
2.5 %, for fat masses ranging from 5 to 40 % of body mass (Baur et al. 1991a), and 
therefore NAA is considered to be the most accurate and precise method available to 
measure TBP. In addition, compared with skinfold anthropometry and DXA, minimal 
subject cooperation is required. The main disadvantages that limit the wide use of this 
method is its high cost, the need for highly skilled operators, lack of mobility, and the 
use of ionizing radiation. However, the current study found that basic skinfold 
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anthropometry can be used in the clinic setting to provide an indicator of TBP, but 
further work needs to be done to validate skinfold anthropometry as an accurate and 
precise measure of TBP in individuals. 
8.2.3 Methodological limitations of dual-energy x-ray absorptiometry to assess 
soft tissue 
DXA was originally designed to measure bone mineralisation and has been well 
validated for this purpose. However, using DXA to measure the soft tissue 
components of the body, i.e. LTM and FM, is less well validated; it incorporates 
several assumptions as discussed in Chapter 2 (section 2.4.2.4, pg 47) and is therefore 
of questionable accuracy (Lohman 1996; Pietrobelli et al. 1998).  
The estimation of FM and LTM by DXA is derived from assumed attenuation 
coefficients which are based on a hydration of LTM of 73.2 %. As discussed 
previously, the hydration of the LTM in children with CP is unknown, and could in 
fact be greater than 73.2 %. The degree to which DXA measurements are sensitive to 
variation in hydration levels is unknown (Roubenoff et al. 1993).  
Another assumption of DXA is related to the area of the body analysed to obtain body 
composition data. DXA does not include any soft tissue that is directly above or 
below bone, therefore DXA makes assumptions about the associations between the 
soft tissue content of the area analysed with the soft tissue content of the area that is 
not analysed. It has been estimated that 40 to 45 % of the 21,000 pixels in a typical 
whole body scan contain bone in addition to soft tissue, and these pixels are therefore 
excluded from the calculation of values for soft tissue (Lohman 1996). Thus, the 
extent to which the composition in the excluded area differs from the considered area 
in a given population is a source of systematic error for that population (Lohman 
1996). Furthermore, the influence of the arm and thorax on the total body composition 
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estimates may be under-represented because of the relatively large areas of bone in 
these regions. As a result, proportionately fewer pixels are used to estimate soft tissue 
composition in these regions than in the lower extremities and the abdomen. In the 
current study, the anthropometric measures showed that the children with CP had an 
irregular distribution of fat, with more fat on the thorax than on the extremities. As 
mentioned previously the thorax contains large areas of bones and consequently 
proportionately fewer pixels are included in the estimate of soft tissue composition in 
this region. It is unknown what impact this has on the estimation of body composition 
of the children in this study, but it can be speculated that DXA may therefore 
underestimate fat in this group. This will be discussed further in the next section. 
Comparison with a 4C model of body composition in children with CP is required to 
validate the accuracy of the soft tissue estimates by DXA. 
8.3 Study 2 - Comparison of methods to measure protein and fat 
8.3.1 Limitations of DXA and skinfold anthropometry to measure body protein 
In addition to the limitations and assumptions involved in using skinfold 
anthropometry and DXA to derive body composition of soft tissue discussed in 
previous sections of this Chapter, the method used in this study to estimate body 
protein from these two measures was based on two assumptions. Firstly, that the 
hydration of the LTM was estimated; and secondly, that the non-osseous mineral to 
bone mineral ratio was 0.18:0.82 such that the mass of non-osseous mineral was 0.23 
x BMC. The applicability of these assumptions to the current study population is 
questionable because it is unknown if malnourished children with severe CP have a 
normal hydration and furthermore the children in this study were found to have a 
significantly reduced BMC. 
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8.3.2 Percent body fat derived from dual-energy x-ray absorptiometry versus 
skinfold anthropometry 
The major limitation of comparing PBF derived from DXA and skinfold 
anthropometry is that neither technique is considered to be a gold standard. 
Furthermore, both techniques incorporate several assumptions as discussed in 
previous sections of this Chapter. However, these two techniques are commonly used 
to assess body composition in children with CP, so which one is more accurate, and 
which one should clinicians use to assess body composition?  
In conclusion, before skinfold anthropometry and DXA can be widely accepted as 
accurate measures of nutritional status in children with CP, both techniques need to be 
validated against a 4C model of body composition. A 4C model of body composition, 
which divides body weight into fat, water, protein and bone, is more robust to 
interindividual variability in the composition of FFM, and allows evaluation of 
several assumed constant relations that are central to the 2C model (Wells et al. 1999). 
8.4 Study 3 - Resting energy expenditure and dietary intake 
8.4.1 Limitations of estimating energy requirements 
The Schofield equations are the most commonly used equations to estimate the energy 
requirements of children, including those with CP. These equations are based on data 
collected from several studies over many decades. In addition, 75 % percent of the 
studies used as source data for these equations were conducted before 1939, and 
predominantly in the USA. At that time most of the measurements were made with a 
respirometer. It has been found that REE determined by the ventilated hood technique 
is lower than REE measured with a respirometer (Clark and Hoffer 1991).  
In the current study, and others, it was shown that these equations do not provide an 
accurate estimate of the energy requirements of children with CP. Thus the logical 
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conclusion would be to develop predictive equations based on data collected in 
children with CP. Unfortunately, CP populations tend to be quite heterogeneous with 
differing degrees of severity. Even in the current study of children with an apparently 
similar severity of CP, wide variation was found in their measured REE. Furthermore, 
regression analysis showed that there was no single variable that could adequately 
account for a significant proportion of the variation making it quite problematic to 
develop an equation that could accurately predict energy requirements in this group. 
Thus the current recommendations are to either measure REE by indirect calorimetry, 
however such sophisticated technology is not available at all centres; or to roughly 
estimate energy requirements using the currently available equations and adjust 
energy intake according to weight change. 
8.4.2 Limitations of estimating energy and nutrient intake  
Accurately estimating an individual’s dietary intake is particularly difficult. There are 
several methods that can be used to estimate dietary intake, namely 24-hour recall, 
food frequency questionnaires, diet history, and estimated or weighed food records. A 
weighed food record was chosen for this study because it is considered to be the most 
precise method available for estimating food and nutrient intake of individuals 
(Gibson 1990). Weighed food records minimise errors resulting from memory lapses 
and inadequate estimation of portion size that can occur with other methods (Gibson 
1990). However, weighed food records have several limitations. Firstly, they are 
laborious and time consuming. It is possible that in this study the food records were 
inaccurate simply because the parents or carers did not have enough time to complete 
them accurately. Secondly, it has been reported in other studies that people change 
their diet for the days that the food intake is being recorded either to simplify the 
weighing process, or alternatively, to impress the investigator (Gibson 1990). It is 
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possible that parents or carers were reporting what they believe their child should eat 
rather than what they were actually eating. Related to this, it has been shown in other 
studies of the general population that low dietary intakes tend to be overestimated and 
high dietary intakes underestimated (Gibson 1990). This is known as the “flat slope 
syndrome” or is sometimes referred to as “talking a good diet”. In this study, it may 
have been that the parents or carers wanted the study investigators to believe that their 
child had an adequate energy intake, despite their child being markedly underweight. 
The parents or carers may have been afraid that if it was shown that their child had an 
inadequate dietary intake, an intervention such as a gastrostomy tube may have been 
recommended. However, that would not explain the overestimation of energy intake 
also found in the tube-fed group.  
In this study, the parents or carers were instructed to record their child’s intake for 
two days of the week plus one weekend day. However, most of the food records 
included two weekend days, and some parents reported keeping their child home from 
school during the week in order to record their food intake. The parent’s explanation 
for this was that due to the time consuming nature of weighed food records it would 
have been too difficult for school teachers to do while having to care for and feed 
several disabled children. Furthermore, anecdotal evidence suggests that children with 
severe CP eat more when at home because their parent or carer is able to feed them 
better than anyone else. So it may have been that the food records were in fact 
accurate for the three days that they were recorded, but because the child normally 
spends five days per week at school, this high energy intake is not sustained and is 
therefore not representative of their usual intake.  
In conclusion, for whatever reason, in this study it was shown that energy intakes 
from food records were grossly overestimated and therefore invalid in this study 
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population. Food records are time consuming for the parents / carers and appear to be 
of little value, and are therefore not recommended to assess dietary intake in this 
population. 
8.5 Study 4 - Nutritional rehabilitation 
As discussed in Chapter 7, this study was limited firstly because of the small numbers 
of participants and, secondly because the oral-fed CP group appeared to have less 
severe disease than the gastrostomy tube-fed group and therefore comparisons were 
unable to be made. These limitations are discussed in more detail below. 
8.5.1 Inability to conduct a randomised controlled trial 
The original plan for the nutritional rehabilitation study was to conduct an RCT of 
gastrostomy tube feeding versus oral feeding with speech therapy. However as 
previously mentioned in Chapter 7, no parents / carers agreed to their child 
participating in an RCT. Other researchers have attempted to conduct RCTs of 
feeding in children with severe CP, yet none have been successful. Sleigh & 
Brocklehurst endeavoured to conduct a systematic review of findings from RCTs to 
assess the risks and benefits of gastrostomy tube feeding, yet no RCTs were found 
(Sleigh and Brocklehurst 2004). Furthermore, Sullivan et al suggested that an RCT of 
gastrostomy tube versus oral feeding, or the use of an oral-fed control group for 
comparison, may be unethical because it would involve delaying intervention in a 
situation in which it would be clinically indicated (Sullivan et al. 2005). The authors 
suggested that in the absence of an RCT the next best thing would be a longitudinal, 
prospective, uncontrolled cohort study of gastrostomy tube feeding. This type of study 
was attempted yet it was difficult to recruit a large number of participants. The 
reasons for this are discussed in section 8.5.1.3 (pg 229). 
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8.5.1.1 Unstructured follow-up 
One limitation of the nutritional rehabilitation study was the lack of structured follow 
up and the difference in time between baseline and repeat measures in the gastrostomy 
tube-fed children. As discussed in the previous section the original plan for an RCT 
with structured follow-up appointments had to be abandoned due to a lack of willing 
participants. Much time, approximately 10 months, was spent attempting to recruit 
participants to the RCT. After the RCT was abandoned, it was decided to monitor and 
conduct repeat testing on any of the 39 oral-fed children who took part in the cross-
sectional study, who then received a gastrostomy tube as part of their routine care. 
Different lengths of time elapsed from when the child participated in the cross-
sectional study, to when they then received a gastrostomy tube, and to when they 
achieved significant weight gain. Because the original aim of the study was to assess 
what changes occurred in body composition when these children gained weight, the 
children were not remeasured until they had gained significant weight – this occurred 
over varying lengths of time in each participant (range of 3.7 to 80.4 months). 
Therefore, in many of the participants, weight gain was slower than anticipated and 
three children from the cross-sectional study who received a gastrostomy tube failed 
to gain weight altogether and were therefore not re-measured. The possible reasons 
for the lack of weight gain are discussed in the next section. Moreover the TBN 
machine was unable to be used for a period of 12 months while the radioactive 
sources were replaced and the machine extensively recalibrated. During this time 
repeat testing of study participants was delayed, thereby further complicating any 
structured follow up. Therefore, a study with set follow up times may not have 
necessarily improved this study. 
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8.5.1.2 Slow and lack of weight gain 
As mentioned in the previous section some of the gastrostomy tube-fed children 
experienced slow weight gain, and some, lack of weight gain altogether. In most of 
these children this was due to complications post surgery, including wound 
dehiscence and infection, leakage around the gastrostomy tube site, intolerance of 
feeds, development of dumping syndrome, and development of GOR post 
gastrostomy tube insertion requiring a subsequent fundoplication, all resulting in lack 
of, or slow, weight gain. Studies have shown that 11 - 26 % of children experience 
complications post-gastrostomy tube insertion (Davidson et al. 1995; Gauderer et al. 
1988; Heine et al. 1995; Sullivan et al. 2005), including one study (Pearl et al. 1990) 
that reported children with severe neurological disability have more than twice the 
complication rate, four times the re-operative rate, and three times the mortality rate 
of neurologically normal children requiring a gastrostomy tube such as those with 
cystic fibrosis or congenital heart disease. These complications contributed to the 
reduction in the number of children undergoing repeat testing. Further reasons for the 
small numbers of participants in the study are discussed in the next section.  
8.5.1.3 Small numbers of participants 
Despite there being 39 oral-fed children in the original cross-sectional study, only 26 
opted to receive a gastrostomy tube, and only 15 of these consented to have the tests 
repeated. The parents / carers of the remaining 13 oral-fed children from the cross-
sectional study declined a gastrostomy tube. Therefore, despite these children being 
referred to the Dysphagia Clinic because of severe nutritional and feeding problems 
there was a resistance, or reluctance, for gastrostomy tube feeding. Several groups of 
researchers, through extensive interviews with parents of disabled children, have 
examined reasons why parents / carers may be reluctant for their child to receive a 
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gastrostomy tube and why they take so long to make the decision. The studies 
revealed that parental decisions to have a gastrostomy tube inserted in their child 
involved a series of complex and interrelated issues. Some of these issues are 
summarised in the following points:  
▪ Loss of mother-child interaction - parents felt that gastrostomy tube feeding would 
have negative impact on the parent-child relationship because it lacked the 
closeness of oral feeding (Craig et al. 2003; Guerriere et al. 2003; Sleigh 2005; 
Spalding and McKeever 1998; Thorne et al. 1997).  
▪ Enjoyment of eating – Parents felt that gastrostomy tube feeding would remove 
one of the few pleasures and basic human abilities that their children appeared to 
enjoy (Craig et al. 2003; Guerriere et al. 2003; Sleigh 2005; Spalding and 
McKeever 1998; Thorne et al. 1997). 
▪ Maintaining skills – parents raised concerns that their child might become 
dependent on the gastrostomy tube for feeding and lose or fail to acquire feeding 
skills (Craig et al. 2003).  
▪ Maintaining a normal family life - for families with a chronically ill or disabled 
child any normal activities, such as eating, are highly valued (Brotherson et al. 
1995; Sleigh 2005; Thorne et al. 1997).  
▪ The insertion of a gastrostomy tube is a surgical procedure - although the insertion 
of a gastrostomy tube may be considered a “low tech” procedure by clinicians, the 
parents regarded it as an invasive procedure with an unjustified risk to their child 
(Craig et al. 2003; Spalding and McKeever 1998; Thorne et al. 1997). 
▪ Giving up hope - for some parents a gastrostomy tube signalled that their child 
was never going to feed properly (195), and the suggestion by health professionals 
that their child needed a gastrostomy tube implied that the professionals had given 
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up hope for recovery (Craig et al. 2003; Thorne et al. 1997). Parents also believed 
that the presence of a gastrostomy tube emphasised, and increased the visibility of, 
their child’s disability (Brotherson et al. 1995; Guerriere et al. 2003; Spalding and 
McKeever 1998). One study revealed that, although some parents agreed to their 
child having a gastrostomy tube they did not use it to its full potential, preferring 
to rely on oral feeding which may partly explain why not all children who receive 
a gastrostomy tube will gain weight (Craig et al. 2003).  
▪ Impact of gastrostomy tube feeding on social relationships – feeding through a 
tube was seen as having a negative impact on feeding as a social activity, and 
parents expressed concern that gastrostomy tube feeding might exclude their child 
from participating in school and family life. Several studies described families 
wanting more information about the gastrostomy tube prior to its placement, not 
only about medical aspects but also about how the gastrostomy tube would affect 
their everyday life (Craig et al. 2003; Guerriere et al. 2003). 
▪ Perceived benefits and the need for evidence – the issue of whether the child 
needed the gastrostomy tube and the lack of convincing evidence was a strong 
theme. Not all parents accepted that their child’s weight was the main priority and 
different views were expressed about the possibility, or desirability, of weight 
gain. Concerns that the child might become too heavy to handle and that carer 
support might be withdrawn because of weight restrictions placed on lifting. 
Parents also commented on the lack of evidence or good advice about the growth 
potential of their child (Craig et al. 2003; Sleigh 2005).  
▪ A more challenging source of ambivalence hinted at by some parents was that the 
renewed health of the child raised some new problems – such as getting too heavy 
to lift. In addition, in eliminating the terrible episodes in which parents were faced 
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with thoughts of “What if my child dies?” the gastrostomy tube raised the new and 
different spectre of “What if my child lives?” In contrast to the uncertain and 
tenuous hold on life that the child may have had in a malnourished state, the 
gastrostomy tube-fed child now seemed physically strong enough to live in this 
debilitated state indefinitely (Thorne et al. 1997).  
The above points help to explain why not all parents / carers will consent to a 
gastrostomy tube when it may appear to the health professional to be a straight-
forward and clear-cut decision. Two of the studies reported that it took anywhere from 
six months to two years for the parents / carers to give consent for their child to get a 
gastrostomy tube from when it was first suggested (Craig et al. 2003; Spalding and 
McKeever 1998). Although in the current study there was no information collected on 
when a gastrostomy tube was first suggested to parents / carers, in the children who 
did receive a gastrostomy tube there was a median time difference of 19 months 
(range 12 to 78 months) from when they first visited the Dysphagia Clinic for 
assessment to when they received a gastrostomy tube. 
In summary, parental decisions about gastrostomy tube insertion are complex, 
difficult and emotionally laden. Most often, professionals are convinced of the need 
for a gastrostomy tube long before it is acceptable to parents (Spalding and McKeever 
1998; Thorne et al. 1997). Health care professionals need to understand the 
significance of being unable to be nourished by mouth, and recognise that these 
aspects of the decision are important to parents. These studies emphasise the need for 
a family advocate when professionals fail to appreciate the family’s feelings and fears 
associated with gastrostomy tube feeding (Thorne et al. 1997). A better understanding 
and acknowledgement of these issues may help in future nutritional rehabilitation 
studies involving gastrostomy tube feeding. 
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8.5.2 Quality of life 
Many people may question the benefit and purpose of weight gain and gastrostomy 
tube feeding in severely disabled children with CP. Why do we want to make their 
growth and body composition more “normal”? One of the answers to this question is 
that we hope it will improve the overall health and quality of life of the child. The 
nutritional rehabilitation study in this thesis revealed that body protein can be 
significantly increased with gastrostomy tube feeding; and as mentioned in Chapter 2 
(section 2.7, pg 85), adequate body protein is important for immune function, 
response and recovery to illness, as well as respiratory skeletal muscle function. 
Therefore, it may be hypothesised that an improvement in body protein may lead to an 
improvement in quality of life. Unfortunately, an assessment of quality of life was 
beyond the scope of the current study. However, other studies of children with CP 
have found positive correlations between nutritional status and quality of life (Chapter 
2, section 2.6.3, pg 84). Future studies should endeavour to include a measure of 
quality of life pre- and post-nutritional rehabilitation.  
8.6 Future directions 
In summary, this research has provided valuable insights into nutritional assessment 
and the effects of nutritional rehabilitation on the body composition of children with 
quadriplegic CP. Despite the limitations of this study, the results indicate that 
nutritional rehabilitation does improve body fat and protein and therefore it is a 
worthwhile exercise. Further studies are recommended to build on the work that has 
been done so far. Future directions for research include: 
1. Conduct a 4C model of body composition in order to validate DXA and skinfold 
anthropometry as accurate measures of body composition in children with CP;  
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2. Continue collecting data on a larger number of children undergoing nutritional 
rehabilitation via gastrostomy tube feeding. Include longer term and more 
structured follow-up pre- and post-gastrostomy tube feeding.  
3. Include a measure of quality of life pre- and post-nutritional rehabilitation. 
4. Consider the inclusion of a family advocate, or the development of a support 
group, for families who are making the decision for their child to receive a 
gastrostomy tube.  
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Appendix A - Parent Information Sheet & Consent Form 
 
PARENT / CAREGIVER INFORMATION  
 
Nutritional Assessment  
in Children with Cerebral Palsy 
 
 
STUDY INVESTIGATOR'S DETAILS
Mrs Fiona Arrowsmith  Study Coordinator and Dietitian  
    Department of Gastroenterology 
The Children's Hospital at Westmead,  
Ph: (02) 9845-3983 
 
Dr. Ted O’Loughlin   Gastroenterologist, Department of Gastroenterology  
The Children's Hospital at Westmead,  
Ph: (02) 9845-3999 
 
Dr. Helen Somerville  Paediatrician 
The Children's Hospital at Westmead,  
Ph: (02) 9845-2146 
 
Professor Kevin Gaskin Gastroenterologist, Department of Gastroenterology  
The Children's Hospital at Westmead,  
Ph: (02) 9845-3999 
 
Dear Parent or Carer,  
 
We are undertaking a nutritional study in children with severe Cerebral Palsy and would like 
you to consider your child participating. 
 
Why are we doing the study? 
Usually, the assessment of nutritional status in children is relatively straightforward. Just 
measuring weight and height provides us with enough information to determine whether there 
is a problem. However, in Cerebral Palsy, nutritional assessment is often complicated by 
muscle wasting from brain dysfunction, muscular spasms and scoliosis. These factors make 
the usual height and weight measures unreliable for determining nutritional status. We are in 
the process of developing simple measures that accurately predict nutritional status. We 
expect these measures will be useful in determining whether a child with Cerebral Palsy has a 
problem with nutrition that requires further assessment. We would like the measures to be 
used in a community setting where specialist equipment and staff are not always available. 
 
Who can participate in the study? 
Any child with a diagnosis of quadriplegic cerebral palsy between the ages of 4 and 18 years. 
 
What does the study involve? 
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The measurements will be conducted at The Children’s Hospital at Westmead mostly in the 
Department of Gastroenterology. We will ask you to accompany your child to the hospital for 
one morning. The testing should take approximately 2.5 hours. This study requires that your 
child be fasted from midnight. Water only is permitted during this fasting period. 
 
1. We will take simple measurements (also called "anthropometry") of your child’s weight, 
upper arm circumference (with a tape measure) and measure the thickness of skin folds 
at several sites on the body. This is not in any way painful or uncomfortable.  
 
2. Your child's metabolic rate (also called resting energy expenditure or REE) will be 
measured when they are fasted and resting. This procedure is painless and requires your 
child to lie quietly on a bed with their head under a soft, large and clear plastic headbox. 
Room air is continually flowing through the headbox, so that your child is able to breathe 
normally. At the same time, the air that your child breathes out is continually being 
analysed. In this way, we can determine how much energy is being used (rate of 
metabolism). The test will take about 20 minutes. After this test has been completed your 
child may have something to eat or a tube feed. 
 
3. The amount of fat tissue and bone mineral density will be measured by a DXA machine. 
This test takes approximately 10 minutes and involves a very small radiation dose. 
(Please read attached "DXA information sheet" for more details). This test requires your 
child to lie quite still, therefore, we might need to administer a light oral sedation (similar 
to Valium, it will make your child relaxed, they will not go to sleep). Medical staff will 
administer the sedation. Nursing staff will be present to monitor your child closely during 
the testing. The sedation lasts for approximately 1 hour. Please note that the sedation is 
NOT the same as a general anaesthetic, your child will not go to sleep and they will not 
require ventilation. 
 
4. The amount of protein (or muscle) in the body will be measured using a total body 
nitrogen (TBN) machine. The TBN involves your child lying on a table and being scanned 
much the same as for DXA. This involves a very small radiation dose. 
 
5. At home, after the above tests have been completed, we will ask you to record your 
child's food and drink intake for 3 days in a row. This will require weighing or measuring of 
all food and drink consumed during this period. We will provide you with electronic scales 
and measuring cups. If your child has tube feeds only, there is no need to complete a 
food record. 
 
Once the measurements are complete, we will compare the very accurate measurements of 
DXA and TBN with the simple anthropometric measurements to determine which most 
accurately reflect nutritional status.  
 
Are there any risks? 
The weight, arm circumference and skin fold measures are risk free. DXA and TBN are safe. 
They involve extremely low exposure to radiation - the equivalent to 2 months exposure to 
radiation from the atmosphere. These tests have been approved as completely safe for 
children and have been used for more than 10 years in our hospital.     
 
What are the benefits for your child? 
We will obtain very accurate measurements of your child’s nutritional status. The information 
will be of assistance in any recommendations we make regarding further tests or treatment 
and you will be provided with a full report of these findings. This information will also be 
available in your child’s medical record and to the doctors and other staff involved in your 
child’s care.    
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What if you don’t want to participate?
Participation in this project is voluntary and if you decide not to take part or decide to withdraw 
at any time this will not otherwise affect your child’s care at the Hospital. 
 
All data will be stored under lock and key and in computer files protected by passwords. Only 
investigators involved in the study will have access to these data. We will treat all information 
provided as strictly confidential and your child will not be identified in the results of the study. 
 
If you have any concerns about the conduct of this study, please do not hesitate to discuss 
them with any of the investigators listed on this information sheet or with Ms Anne O'Neill (ph: 
9845-3013) the secretary of the Ethics Committee which has approved this study. 
 
This Information Sheet is for you to keep. If you decide for your child to participate in this 
study a copy of the signed Consent Form will be given to you. 
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DXA  
(Dual Energy X-Ray Absorptiometry) 
Information Sheet 
 
DXA or DEXA is short for “Dual-Energy X-ray Absorptiometry”. DXA is used to measure the 
amount of bone mineral in the bone and thus give an estimate of bone density. Bone density 
is a measure of how strong the bones are.   
 
Additionally, DXA is used to determine body composition as the technique can measure the 
amount of lean tissue and fat tissue in the body. 
 
At the Children's Hospital at Westmead, DXA measurements are made of the total body, 
lower spine and the top of the femur. The skin entrance dose for the three scans is less than 
75 μSv, (effective dose less than 2 uSv) which is less than that normally received daily from 
natural sources of radiation (effective dose of 6 μSv/day). 
 
DXA is an easy, painless test. There are no needles or injections. 
The only preparation required is the removal of any pieces of 
clothing and accessories that contain metal or thick plastics. 
 
 
All you need to do is lie on a table for approximately 15 minutes. 
Whilst you lie on the table, an x-ray beam is passed through your 
body. As the x-ray travels through your body, air, bone and tissue 
stop some of the x-ray. By knowing how much x-ray your body 
stops, the machine can work out how much bone and tissue your 
body contains. (It also uses the information to make a picture like 
that shown on the left.) 
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CONSENT FORM FOR PARENTS/CAREGIVERS 
 
Nutritional Assessment in Children with Cerebral Palsy 
 
INVESTIGATORS 
 
Mrs. Fiona Arrowsmith 
Dr. Ted O’Loughlin 
Dr. Helen Somerville 
 
I have read and understood the Parent/Caregiver Information Sheet, and give consent for my 
child to participate in this research study, which has been explained to me by _____________ 
I understand that this project involves the exposure of my child to radiation measuring <0.152  
mSv. 
I have been advised by ___________________that the total exposure of my child to radiation 
for research purposes to age 18 years is restricted to a total of 5 mSv. It is also recommended 
that my child should not be exposed to more than 0.5 mSv in one year, for research 
purposes. 
My child 
  Is or has not been involved in any other research projects involving the use of ionising 
radiation. 
  Is or has participated in other research projects and to date has been exposed to ______mSv 
(For research purposes only) 
 
I understand that I am free to withdraw from the study at any time and this decision will not 
otherwise affect my child’s treatment at the Hospital. 
 
 
Name of child (please print): Please print
 
Name of parent or guardian: Please print
 
Signature of parent or guardian:  Date:  
 
Name of witness: Please print
 
Signature of witness:  Date:  
 
Name of interpreter: Please print
 
Signature of interpreter:  Date:  
 
270 
APPENDICES 
Appendix B - Anthropometric equations 
 
1 Knee Height (KH) 
The following formula was used for estimating stature (S) in children with CP less 
than or equal to 12 years of age (Stevenson 1995b) 
Knee height   S = (2.69 x KH) + 24.2 
The following formulae were used for estimating stature (S) in children with CP 
aged 13 years and above (Chumlea et al. 1994). 
Boys 
6 - 18 years    S = (2.22 x KH) + 40.54 
19 - 59 years   S = (1.88 x KH) + 71.85   
Girls     
6 - 18 years   S = (2.15 x KH) + 43.21 
19 - 59 years   S = (1.86 x KH) - (age x 0.05) ± 70.25 
 
2 Body mass index (BMI) 
BMI = weight (kg) / height (m)2 
3 Upper arm muscle area (UAMA) 
  UAMA = (MUAC – π x TSK)2 / 4π 
Where MUAC is mid upper arm circumference; TSK is triceps skinfold thickness.
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Percent body fat 
(a) 
Brook (for prepubertal children) (Brook 1971): 
Males:  Db (g/ml) = 1.1690 – 0.0788(logΣX4) 
Females Db (g/ml) = 1.2063 – 0.0999(logΣX4) 
Durnin and Rahaman (for pubertal children) (Durnin and Rahaman 1967) 
Males:  Db (g/ml) = 1.1533 – 0.0643(logΣX4) 
Females:  Db (g/ml) = 1.1369 – 0.0598(logΣX4) 
Where Db is body density; ΣX4 is the sum of the four skinfold thicknesses (biceps + triceps + 
suprailiac + subscapular). 
For the above two sets of equations, body density (Db) was converted to 
percent body fat using the following equation (Siri 1993): 
 PBF = {(4.95 / Db) – 4.50} x 100 
(b) 
Slaughter equations (Slaughter et al. 1988) 
Males 
Prepubertal PBF = 1.21(ΣX2) – 0.008(ΣX2)2 – 1.7 
Pubertal PBF = 1.21(ΣX2) – 0.008(ΣX2)2 – 3.4 
Postpubertal PBF = 1.21(ΣX2) – 0.008(ΣX2)2 – 5.5 
Females 
All  PBF = 1.33(ΣX2) – 0.013(ΣX2)2 – 2.5 
Where ΣX2 is the sum of the triceps and subscapular skinfold thicknesses. 
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Appendix C - Total body protein predictive equations 
 
The following equations were developed from the TBP control database (34F, 5 – 
14.4y; 27M, 4 - 15.9y) and were used to predict TBP for age, height and weight in the 
children with CP. 
 
1 Total body protein predicted for age: 
Males TBP = 2980 + [2.564 x age(y)3]  
Females TBP = 2790 + [2.27 x age(y)3]  
 
2 Total body protein predicted for height: 
Males TBP = 2212 + [(6.444 x 10-8) x height(cm)5] 
Females TBP = 2157 + [(5.563 x 10-8) x height(cm)5] 
 
3 Total body protein predicted for weight: 
Males TBP = 293 + [160.7 x weight(kg)] 
Females TBP = 759 + [133 x weight(kg)] 
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Appendix D - Hydration constants 
 
1 Hydration constants of fat-free mass used for children aged less than or equal to 7 
years (Fomon et al. 1982). 
 Hydration constant of FFM (%) 
Age (y) 1 Males Females 
4  77.0 77.7 
5  76.6 77.6 
6  76.3 77.5 
7  75.9 77.3 
 
2 Hydration constants of fat-free mass used for children aged 8 years and above 
(Lohman 1986). 
 Hydration constant of FFM (%) 
Age range (y) 1 Males Females 
8 – 9 76.8 77.6 
10 – 11 76.2 77.0 
12 – 13 75.4 76.6 
14 – 15 74.7 75.5 
16 – 17 74.2 75.0 
18 - 20 74.0 74.8 
 
1 The age of the study participant was rounded to nearest whole number.  
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Appendix E - Medications 
 
 
Subject 
Number 
Medication 
Group 
Subject 
Number 
Medication 
Group  
Subject 
Number 
Medication 
Group 
1 a 21 b,c,d,e  41 Nil 
2 a,b 22 a,c  42 a,b 
3 a,d,e,f 23 b,d  43 f 
4 a,b 
 
24 a,b,d  44 Nil 
5 a,b,c,d  25 a,b  45 a 
6 a,b,d  26 a,b  46 a 
7 c,f  27 a,b  47 No subject 
8 a,d  28 b  48 b 
9 a,b,f  29 a,f  49 b,c 
10 a,d  30 a,b,e  50 a,b 
11 a,b  31 a,b,d  51 a 
12 a,b,e,f  32 a,b,c,d  52 a 
13 e  33 d,e  53 a 
14 d,e  34 a,d,e  54 a,d 
15 a,b  35 a,d,f  55 a,b 
16 c  36 a  56 a,b 
17 a  37 a,d  57 a 
18 Nil  38 b,c  58 b 
19 a,f  39 a  59 b,e 
20 a,e  40 c  60 a,d 
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Medication Group Code Name of medication 
Group (a) Anti-epileptic Phenobarbitone 
  Epilim 
  Tegretol 
  Lamictal 
  Rivotril 
  Frisium 
  Vigabatrin 
  Gabapentin 
  Topamax 
  Dilantin 
  Lamotrogine 
   
Group (b) Anti-reflux Losec 
  Zantac 
  Prepulsid (cisapride) 
  Acimax 
   
Group (c) Constipation Parachoc 
  Coloxyl 
  Actilax 
  Senokot 
  Duphalac 
   
Group (d) Anti-anxiety Valium 
  Mogadon 
  Ativan 
  Diazepam 
   
Group (e) Movement disorders Baclofen 
  Madopar 
  Sinemet 
  Artane 
   
Group (f) Asthma prophylaxis Atrovent 
  Ventolin 
  Pulmicort 
  Seretide 
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Appendix F - Equations used for predicting resting energy 
expenditure 
 
1 Schofield predictive equations based on weight (Schofield 1985): 
Males 
Age range (y) REE (kJ / 24hr) 
3-10 {[0.095 x weight (kg)] + 2.110} x 1000 
10-18 {[0.074 x weight (kg)] + 2.754} x 1000 
  
Females  
Age range (y) REE (kJ / 24hr) 
3-10 {[0.085 x weight (kg)]  + 2.033} x 1000 
10-18 {[0.056 x weight (kg)]  + 2.898} x 1000 
 
2 Predictive equations developed from control database based on fat-free mass 
measured by skinfold anthropometry (FFMSKIN): 
Males:   REE (kJ / 24hr) = 2778 + [102.7 x FFMSKIN (kg)]  
Females:   REE (kJ / 24hr) = 1370 + [108.2 x FFMSKIN (kg)] 
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Appendix G – Nutritional rehabilitation study 
information sheet 
 
PARENT/CAREGIVER INFORMATION  
 
 
Nutritional Therapy in Children with Cerebral Palsy 
 
 
 
 
INVESTIGATOR'S DETAILS 
Ms. Fiona Arrowsmith  Study Coordinator and Dietitian 
Department of Gastroenterology 
The Children's Hospital at Westmead, Ph:(02) 9845-3983 
 
Dr. Ted O’Loughlin   Gastroenterologist, Department of Gastroenterology  
The Children's Hospital at Westmead, Ph:(02) 9845-3999 
 
Dr. Angie Morrow  Paediatrician 
The Children's Hospital at Westmead, Ph:(02) 9845-3039 
 
Dr. Helen Somerville  Paediatrician 
The Children's Hospital at Westmead, Ph:(02) 9845-2146 
 
Professor Kevin Gaskin Gastroenterologist, Department of Gastroenterology  
The Children's Hospital at Westmead, Ph:(02) 9845-3999 
 
 
Dear Parent or Carer, 
 
We would like you to consider your child participating in a nutritional study of children with 
severe cerebral palsy that will be conducted in the Department of Gastroenterology at the 
Children’s Hospital at Westmead. 
 
What is the study about? 
Many children with Cerebral Palsy suffer from undernutrition because of difficulties in 
swallowing resulting in the inability to get in enough calories (energy). Swallowing problems 
can also contribute to chest disease if the food is inhaled into the lungs. There are several 
therapies used to overcome these problems. We are interested in studying two therapies that 
are currently used as routine therapies at this hospital, (1) basic speech pathology combined 
with dietary advice, and (2) tube feeding.  
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Speech pathology is designed to improve swallowing by means of proper positioning of the 
child’s body and head during feeding, adaptation of cups or other utensils, a programme of 
oral exercises, and changing food choices, for example, choosing different textures of food, 
and increasing the thickness of fluids. The aim of dietary advice is usually to increase the 
energy and nutrient content of food, for example, by choosing high energy foods, or by adding 
fats, or with specific high energy nutritional supplements. Speech pathology and dietary 
advice go hand-in-hand to maximise your child’s oral intake. Whereas tube feeding bypasses 
the swallowing problem by placing "food" directly into the stomach. Both therapies aim to 
improve nutritional intake and therefore improve your child’s nutritional status.  
 
We wish to study these therapies to determine if they result in improved nutrition and also to 
determine the benefits and disadvantages of either approach. It is also important to know if 
improved nutrition results in improved general health and quality of life.   
 
Who can participate in the study? 
Any child with a diagnosis of spastic quadriplegic cerebral palsy, between the ages of 4 and 
18 years, who does not currently have a nasogastric or gastrostomy tube. 
 
What does the study involve? 
The study will be conducted at The Children's Hospital at Westmead. Ideally, we would like to 
randomly allocate your child to either group (I) Basic Dietary Advice and Speech Pathology 
Programme, or (II) Tube Feeding Programme, for a period of 6 months. This means that your 
child will be placed into either of these groups based on a computer-generated allocation that 
is random. In other words, yourself or your doctor does not determine this. If you agree for 
your child to be randomly allocated to either group, this will not prevent the use of speech 
therapy or tube feeding after the 6-month trial if the initial therapy is unsuccessful. 
Alternatively, you may have strong feelings about which therapy is suitable for your child and 
will not agree to this random allocation process. You can discuss this with any of the study 
investigators listed on the first page of this information sheet. 
 
If you agree to join this study, your child will undergo an initial evaluation which involves some 
measurements of nutritional status as outlined in the parent information sheet entitled 
“Nutritional Assessment in Children with Cerebral Palsy”.   
 
The treatment will be slightly different depending on which group your child enters.  
 
Group 1
If your child enters the Basic Dietary Advice and Speech Pathology Programme they will 
undergo an evaluation by a speech pathologist and a dietitian (Fiona Arrowsmith). This entails 
two consultations (one with the speech pathologist and one with the dietitian); a modified 
barium swallow to assess your child’s swallow, observation of your child’s eating pattern, and 
discussion of your child’s usual dietary intake and food choices. The speech pathologist and 
dietitian will give you recommendations to improve your child’s swallow and nutritional intake. 
Please see Table 1 on the following page for the timetable of assessments during the 6-
month study period. 
 
Group 2  
If your child enters the Tube Feeding Programme they will have either a tube inserted into 
the stomach via the nose (nasogastric tube) or through the skin of the stomach (gastrostomy 
tube). A special tube feeding formula will be administered via the tube to provide nutrition in 
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addition to oral intake of food. Our study dietitian (Fiona Arrowsmith) will advise you about the 
type and amount of formula to use. You will also be given instruction in how to do this at 
home. Please see Table 1 on the following page for the timetable of assessments during the 
6-month study period. 
 
During the study period you will be in weekly contact with study co-ordinator (Fiona 
Arrowsmith). The programmes will continue for 6 months during which time we will monitor 
growth and nutritional parameters as outlined in Table 1 and in the “Nutritional Assessment in 
Children with Cerebral Palsy” information sheet. In addition, your child will be regularly 
examined by one of the doctors involved in the study.  
 
We are also interested to know how the treatment affects the quality of life of your child and 
importantly whether it affects you and your family. You will be asked to fill out a questionnaire 
and invited to join a discussion group with other parents and carers to express your views 
about your child’s treatment.  
 
TABLE 1 – Timetable for 6-month study period for both programmes 
 
Tests 
Month 
0 
Month 
1 
Month 
2 
Month 
3 
Month 
4 
Month 
5 
Month 
6 
Anthropometry X X X X X X X 
TBN X      X 
DXA X      X 
REE X      X 
Food Record X  X  X  X 
Quality of Life X      X 
Blood Sample X      X 
Medical Ass. X   X   X 
Please read the Parent/Caregiver Information Sheet entitled “Nutritional Assessment in 
Children with Cerebral Palsy” for details of the tests listed in Table 1.  
Are there any side-effects and risks associated with this study? 
We are not proposing to undertake any investigation or treatment that is not already routinely 
offered to children with cerebral palsy except for the DEXA, TBN and resting energy 
expenditure measurements described in the “Nutritional Assessment in Children with Cerebral 
Palsy” information sheet.  
 
There are no medical risks associated with the Basic Speech Pathology and Dietary Advice 
Programme unless your child has proven food inhalation with swallowing. This will be 
investigated prior to your child being included in the study.  
 
Nasogastric or gastrostomy tube feeding can be a medical risk in children with reflux and/or 
food inhalation. If your child suffers from either reflux or food inhalation with swallowing, they 
may require anti-reflux surgery to prevent complications from tube feeding. This will be 
explored by your doctor and explained in detail if anti-reflux surgery is required. Please note 
that the surgery is routinely offered to children with cerebral palsy if their doctors are 
concerned about reflux or inhalation.  
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Are there any benefits for my child participating in the study? 
Your child will be under the care of doctors and health professionals who are experts in the 
field of cerebral palsy. The therapy that your child receives will be examined to determine if it 
is of benefit to your child in terms of improved nutrition and importantly in terms of quality of 
life for your child, yourself and your family.  
 
We hope the information we obtain from this study may enable us to design therapies that are 
of proven benefit in cerebral palsy.  
 
What if I don’t want to participate? 
We would be very grateful for the opportunity to undertake these investigations on your child. 
However, participation in this study is voluntary. If you decide not to participate, or decide to 
withdraw your child from the study at any time, this will not otherwise affect your child's care 
at the Hospital. 
 
All data will be stored under lock and key and in computer files protected by passwords. Only 
investigators involved in the study will have access to these data. We will treat all information 
provided as strictly confidential and your child will not be identified in the results of the study. 
 
If you have any concerns about the conduct of this study, please do not hesitate to discuss 
them with any of the investigators listed on this information sheet or with Ms Anne O'Neill (ph: 
9845-3013) the secretary of the Ethics Committee which has approved this study. 
 
This Information Sheet is for you to keep. If you decide for your child to participate in this 
study a copy of the signed Consent Form will be given to you. 
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Appendix H - Baseline and repeat measures of oral-fed 
children 
 
 
 
Table H1: Baseline and repeat anthropometric characteristics  
of oral-fed children with cerebral palsy 
Oral-fed 
(4F, 4M) 
 Baseline Repeat 
Age (y) 8.6 (7.4, 12.3) 10.9 (10.3, 15.4) 1
Weight (kg) 21.0 (16.6, 24.7) 25.1 (19.4, 31.7) 1
Weight SDS  -3.1 (-4.0, -2.1) -3.9 (-6.5, -2.0) 
Height (cm)  120.3 (105.0, 128.2) 133.0 (118.1, 135.6)1
Height SDS  -3.0 (-4.3, -1.8) -2.7 (-4.7, -1.3) 
Ideal weight for height (%) 85.9 (75.7, 102.5) 86.7 (78.4, 103.8) 
UAMA (cm2)  19.7 (15.5, 21.7) 21.5 (19.0, 25.3) 
UAMA SDS  -1.4 (-2.2, -0.9) -0.9 (-3.1, -0.5) 
UAFA (cm2)  5.3 (3.0, 6.0) 5.5 (4.1, 7.7) 
UAFA SDS  -1.9 (-2.9, -0.8) -0.2 (-2.6, 1.0) 
FFMSKIN (kg)  18.5 (15.2, 20.2) 21.3 (17.0, 26.1) 1
FMSKIN (kg)  2.5 (0.9, 4.3) 2.9 (1.8, 5.0) 
PBFSKIN (%) 10.7 (5.8, 17.7) 12.0 (8.6, 18.0) 
Data is median (inter-quartile range). FFMSKIN, fat-free mass by skinfold anthropometry; 
FMSKIN, fat mass by skinfold anthropometry; PBFSKIN, percent body fat by skinfold 
anthropometry; SDS, standard deviation score; UAFA, upper arm fat area; UAMA, upper 
arm muscle area. 
1 p < 0.05; significantly different between baseline and repeat test; Wilcoxon Signed Ranks 
test. 
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Table H2: Baseline and repeat body composition measures by DXA  
of oral-fed children with cerebral palsy 
Oral-fed 
(4F, 4M) 
 Baseline Repeat 
BMC (g) 564 (515, 717) 1 721 (623, 991) 1,2
BMC for age SDS -2.0 (-2.2, -1.2) 1 -3.0 (-3.4, -1.6) 1
BMC for height SDS -0.7 (-2.7, 0.1) 1 -1.0 (-2.7, 0.2) 1
BMC for LTM & ht SDS -1.6 (-1.9, -0.8) -1.4 (-1.5, -0.8) 1
LTMDXA (kg) 16.9 (14.0, 19.3) 21.0 (16.3, 24.2) 2
LTMDXA for height SDS -0.2 (-2.0, 1.7) 1 0.1 (-2.2, 0.7) 
FMDXA (kg) 3.2 (1.3, 4.6) 2.5 (1.9, 6.6) 
PBFDXA (%) 14.2 (7.1, 19.8) 13.2 (8.3, 23.8) 
Data is median (inter-quartile range). BMC, bone mineral content; DXA, dual-
energy x-ray absorptiometry; FMDXA, fat mass by DXA; LTMDXA, lean tissue 
mass by DXA; PBFDXA, percent body fat by DXA; SDS, standard deviation 
score. 
1 n = 7 
2 p < 0.05; significantly different between baseline and repeat testing; 
Wilcoxon Signed Ranks test. 
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Table H3: Baseline and repeat measures of total body protein  
of oral-fed children with cerebral palsy  
Oral-fed 
(4F, 4M) 
 Baseline Repeat 
TBPNAA (kg) 3.3 (2.4, 3.6) 4.7 (3.9, 5.9)1
TBP NAA for age (%) 57.2 (43.8, 77.5) 66.8 (46.6, 71.1) 
TBP NAA for height (%) 83.1 (64.4, 95.1) 112.1 (84.0, 120.6)1
TBP NAA for weight (%) 85.6 (72.8, 99.1) 114.5 (99.6, 118.9) 1
Data is median (inter-quartile range). FFMSKIN, fat-free mass measured by 
skinfold anthropometry; NAA, neutron activation analysis; TBPNAA, total body 
protein. 
1 p < 0.05, significantly different between baseline and repeat test; Wilcoxon 
Signed Ranks test. 
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Table H4: Annualised change in body composition parameters in the oral-fed 
children with cerebral palsy 
Oral-fed 
(4F, 4M) 
 
Weight (kg) / y 1.6 (0.8, 4.7) 
Height (cm) / y 4.0 (2.1, 6.6) 
UAMA (cm2) / y 2.3 (0.0, 3.6) 
UAFA (cm2) / y 0.5 (0.1, 1.4) 
FMSKIN (kg) / y 0.4 (0.2, 1.2) 
FFMSKIN (kg) / y 1.3 (0.5, 3.5) 
PBFSKIN (%) / y 1.1 (0.4, 2.0) 
BMC (g) / y 77.1 (43.3, 116.1) 1
LTMDXA (kg) / y 1.3 (0.7, 3.2) 
FMDXA (kg) / y 0.4 (1.2, 1.6) 
PBFDXA (%) / y 0.5 (-0.3, 2.5) 
TBPNAA (g) / y 567 (301, 986) 
Data is median (inter-quartile range). DXA, dual-energy x-ray 
absorptiometry; UAMA, upper arm muscle area; UAFA, upper arm fat 
area; FMSKIN, fat mass by skinfold anthropometry; FFMSKIN, fat-free mass 
by skinfold anthropometry; PBFSKIN, percent body fat by skinfold 
anthropometry; BMC, bone mineral content; LTMDXA, lean tissue mass by 
DXA; FMDXA, fat mass by DXA; LTMDXA, lean tissue mass by DXA; 
PBFDXA, percent body fat by DXA; TBPNAA, total body protein by neutron 
activation analysis; y, year. 
1 n = 7 
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Table H5: Baseline and repeat measures of resting energy expenditure and 
energy intake 
Oral-fed 
(4F, 4M) 
 Baseline Repeat 
MREE (kJ / 24hr) 2331 (1749, 3637) 4612 (3699, 5371) 1,4
MREE / PREE (%) 62.4 (45.0, 81.1) 97.1 (79.9, 157.0) 1,4
Energy Intake (kJ / 24hr) 4296 (3793, 6800) 1 5602 (4223, 5685) 2
Energy Intake / MREE (%) 191 (175, 283)1 123 (79, 255)3
Data is median (inter-quartile range). MREE, measured resting energy expenditure 
by indirect calorimetry; PREE, predicted resting energy expenditure adjusted for 
fat-free mass using equations developed from control database. 
1 n = 7, 2 n = 4, 3 n = 3 
4 p < 0.05, significantly different between baseline and repeat measurements, 
Wilcoxon Signed Ranks test. 
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Table H6: Baseline and repeat measures of resting energy expenditure and 
energy intake excluding REE >140% 
Oral-fed 
(2F, 4M) 
 Baseline Repeat 
MREE (kJ / 24hr) 2267 (1633, 3947) 4329 (2947, 4991) 1,4
MREE / PREE (%) 53.5 (42.0, 80.0) 85.5 (70.8, 104.4) 1
Energy Intake (kJ / 24hr) 6778 (4045, 6870) 1 5602 (4223, 5685) 2
Energy Intake / MREE (%) 272 (171, 344)1 123 (79, 255)3
Data is median (inter-quartile range). MREE, measured resting energy 
expenditure by indirect calorimetry; PREE, predicted resting energy 
expenditure adjusted for fat-free mass using equations developed from 
control database. 
1 n = 5, 2 n = 4, 3 n = 3 
4 p < 0.05, significantly different between baseline and repeat measurements, 
Wilcoxon Signed Ranks test. 
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